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Abstract
Cerebral autoregulation is the process by which blood flow is maintained over a chang-
ing cerebral perfusion pressure. Clinically autoregulation is an important topic because
it directly effects overall patient management strategy. However accurately predicting
autoregulatory state or even modelling the underlying general physiological processes is
a complex task. There are a number of models published within the literature but there
has been no active attempt to compare and classify these models. Starting with the
hypothesis that a physiologically based model would be a better predictor of autoreg-
ulatory state than a purely statistically based one has led us to investigate approaches
to model comparison. Using three different models: a new mathematical arrangement
of a physiological model by Ursino, the Highest Model Frequency (HMF) model by
Daley and the Pressure reactivity index (PRx) statistical model by Czosnyka, a gen-
eral comparison was carried out using the Matthews correlation coefficient against a
known autoregulatory state. This showed that the Ursino model was approximately
three times as predictive as both the HMF model and the PRx model. However, in
general, all of the models predictive accuracies were relatively poor so a number of
optimisation strategies were then assessed. These optimisation strategies ultimately
were formed into a generalised modelling framework. This framework draws on the
ideas of mathematical topology to underpin and explain any change or optimisation
to a model. Within the framework different optimisations can be grouped into four
categories, each of which are explored in the text of this thesis:
• Model Comparison. This is the simplest technique to apply where the number of
models under examination are reduced based on the predictive accuracy.
• Parameter restriction. A classical form of optimisation by constraining a model
parameter to cause a better predictive accuracy. In the case of both the HMF
and PRx we showed between a two hundred and six hundred percent increase in
predictive accuracy over the initial assessment.
• Parameter alteration. This change allows for related parameters to be substituted
into a model. Four different alterations are explored as a surrogate measure
for arterial-arteriolar blood volume the most clinically applicable of which is a
transcranial impedance technique. This latter technique has the potential to be
a non invasive measure correlated with both mean ICP and ICP pulse amplitude.
• Model alteration. Allows for larger changes to the underlying structure of the
model. Two examples are presented: firstly a new asymmetric sigmoid curve to
overcome computational issues in the Ursino model and secondly a novel use of
fractal characterisation which is applied in a wavelet noise reduction technique.
The framework also gives an overview of the autoregulatory research domain as a whole
as a result of its abstract nature. This helps to highlight some general issues in the
domain including a more standardised way to record autoregulatory status. Finally
concluding with research addressing the requirement for easier access to data and the
need for the research community to cohesively start to address these issues.
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Intensive care management of critically ill patients is one of the most expensive health
care costs to hospitals. Estimates vary but costs of at least £1000 per day per bed are
common [28]. One nurse to one patient nursing care is a major part of this cost but so
too are the capital equipment and consumable costs of the intensive care physiological
monitoring, laboratory and imaging investigations.
Continual developments in medical technology mean that intensive care units (ICUs)
are routinely monitoring more physiological parameters and improvements in hospital
IT infrastructure allow more of this data to be archived as part of the patient record.
However, despite these advances in technology for acquiring data, the complicated
nature of such multiple time-series data makes it difficult to interpret and use clinically
in the acute management of the patient.
The application of mathematical modelling to detect specific events such as loss of
cerebral blood flow autoregulation or to predict clinical outcome and length of intensive
care stay have been investigated in a number of specific patient populations. Although
some success has been achieved with time-series modelling in specific disease domains,
there has not been a systematic study comparing different modelling approaches within
a given population of patients nor whether some of the more robust models show efficacy
across different intensive care patient populations.
Cerebral autoregulation is the process by which cerebral blood flow is maintained con-
stant over a varying cerebral perfusion pressure, and it is important to the treatment
and outcome of traumatic brain injury (TBI) patients. The non-surgical management
of patients with TBI focuses upon the prevention of secondary insults such as drops in
blood pressure (BP) or increased intracrainial pressure (ICP). The latter (raised ICP)
is of particular concern as increases in ICP will decrease cerebral perfusion pressure
(CPP = BP - ICP) and can lead to decreases in cerebral blood flow (CBF), ulti-
mately leading to ischemia and cell death. Cerebral autoregulation is a physiological
mechanism that maintains CBF constant in the face of changing cerebral perfusion
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pressure (CPP) although it can become impaired following brain injury. PET [108],
SPET [36] and Xenon-CT [17] can be used to measure CBF and autoregulatory status
but these methods do not lend themselves to frequent measurement of autoregulation
in patients that are physiologically unstable and where there is a significant clinical
risk in transferring them from the intensive care unit. Howells et al, developed a
Bayesian Advanced Neural Network (BANN) model and showed that the slope of the
mean arterial pressure (MAP) to ICP relationship could be used as a classifier for
choosing whether therapy should be targeted at either raised ICP or reduced cerebral
perfusion pressure [39]. The work by Howells is suggestive that if autoregulation is nor-
mal, therapy should be targeted for CPP. CPP therapy is based on increasing BP by
using pressors which, if autoregulation is present, will cause a reflex cerebral vasocon-
striction, thus a decrease in cerebral blood volume which will lower ICP and improve
CPP. Conversely if autoregulation is impaired, therapy should be targeted more to-
wards raised ICP since targeting CPP by raising BP will just increase ICP further if
the cerebral vascular bed is acting in a pressure-passive manner. Currently, there is
considerable clinical interest in using an index of autoregulation in the management
of raised ICP and reduced CPP and to this end it is an extremely important area of
study and has generated a number of mathematical models to predict the state of the
autoregulation process. Approaches used include linear [69] and non-linear regression
models [69,70], spectral analysis [15,16,50], transfer function analysis [11], cross corre-
lation function analysis [22, 23], impulse response analysis [72] and the application of
neural networks [39,67].
Over the last fifty years the understanding of the mechanisms underlying the delivery
and maintenance of adequate blood flow to the brain has advanced significantly, no
more so than in the subject area of understanding the mechanism underlying this
process: cerebrovascular pressure autoregulation.
There are, in my view, three main developing areas in the autoregulatory field: those
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of physiology and anatomy, mathematical modelling and statistical analysis and lastly
physical measurement and detection of events.
The amalgamation of developments in physiological, mathematical and physical event
detection is probably a key step to better care for and our understanding of head injury.
However, to be able to perform this task elegantly and efficiently each of these subject
areas will have to complement each others strengths. One simple approach to this
problem would be to develop a mathematical model for the physiological systems and
then adapt it to be used as a predictive measure of the physical events under question.
This would then balance the known clinical domain knowledge with any advancements
in the scientific modelling and event detection fields. Thus with this general approach
in mind a review and summary of the literature in this field will be required.
1.1 Literature Review Methodology
To reduce the likelihood of omitting key papers in this literature review, a systematic
approach to defining a structured search method was applied and tested [85]. This
methodology used an automated cyclic search approach which was based on the previ-
ous results. A tailored search string was crafted to maximise the initial search which
showed an 80 percent increase in the applicability to the search subject as evaluated
by four set criteria: Audience, relevance, currency and reliability. The process then
will go on to search again looking for other papers by the authors and keywords used
in the titles of the original search. This search cycle would then repeat for a specified
number of iterations, which was three in this case. Then all of these results were stored
and cross referenced in a database.
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Figure 1.1: Classical autoregulatory curve of CBF vs CPP.
1.2 Autoregulation
Autoregulation, no matter where in the body it is found, can be thought of as the
mechanism preventing change of blood flow through an organ as the pressure perfusing
the arteries in the organ is varied. Autoregulation occurs between certain perfusion
pressure limits and if the pressure drops too low or rises too high, autoregulation fails
and organ perfusion is compromised. So, at low pressures the perfusion drops and at
high pressures excessive flow occurs. More specifically cerebral autoregulation can be
thought of as the process by which cerebral blood flow (CBF) is maintained relatively
constant over a given cerebral perfusion pressure (CPP) range. Which is illustrated in
figure 1.1.
The optimal CPP range quoted throughout the literature is a varying target, that is
sometimes a little less sometimes a little more [21, 98], but it is normally quoted as
between 60− 160mmHg [60].
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1.2.1 Cerebrovascular and cardiovascular systems.
To better understand this concept it is useful to consider the basic anatomy of the
circulatory system and that of the cranial space. There are five types of major blood
vessels in the body and these are arteries, arterioles, capillaries, venules and veins [60].
The main differences between the types are size and direction, the arterial system takes
blood from the heart through the body and the venous system returns blood back to
the heart. While the arteries are larger than the arterioles which in turn are larger
than the capillaries. A similar step size change happens in the venous system with the
capillaries being the smallest and the venules being larger and finally the actual veins
being the largest of these types [98].
These two systems generally meet in two places [60], firstly in the capillary beds and
secondly in the arteriovenous anastomoses. The capillaries are the smallest of the five
blood vessel types and play a vital role in the cardiovascular system. They provide
the ability to allow fluid and gaseous diffusion from the blood to the surrounding
tissue as well as being a connecting channel between the arterial and venous sides.
Capillaries are usually to be found clustered into networks known as capillary beds [98]
and can also be coupled with the second type of connection: the anastomosis [60]. The
arteriovenous anastomoses are a larger conduit between the arterial and venous sides
of the circulation than a capillary and therefore would allow for more blood to flow
across the boundary. This anatomical feature can be important for the overall control
of flow when coupled with that of a capillary bed.
The basic anatomy of an arterial or venous vessel is similar to one another. Each can
be thought of as having three main sections the tunica intima, tunica media and tunica
externa [60] with varying connective tissues between each (Figure 1.2).
The arterial structure starts with the lumen which is the space the blood flows through
then immediately superficial is the first section which in major arteries is composed
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Figure 1.2: Cut away diagram of both an artery and a vein.
of the endothelium layer, the basement membrane and an internal elastic lamina. En-
dothelial cells in the inner most layer provide a surface which reduces turbulence in the
flow of blood through the lumen and thus allowing further flow for the same amount of
work [98]. The basement membrane and internal elastic lamina provide strength and
resilience for tissue stretching and contracting [60] and the elastic lamina is a fibreous
boundary between the tunica intima and the tunica media.
The tunica media is composed of a smooth muscle layer and the external elastic lamina.
The smooth muscle is responsible for active change in diameter of the vessel which plays
a crucial role in the regulation of blood flow and change in downstream pressure. It is
this layer that varies the most over all the five vessel types [98] with the major arteries
having the most smooth muscle whilst the capillaries having none and the rest of the
vessel types varying in between these two extremes. The external elastic lamina, much
like the internal is a fibreous connective boundary layer between the tunica media and
the tunica externa.
The tunica externa is the outer most layer of the arterial structure and consists of both
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collagen and elastic fibers. These both help to protect the artery and anchor it to the
surrounding tissues [98]. Overall the arterial structure provides both strength from the
tissue layers and precise control over lumen diameter during either reduction, which is
known as vasoconstriction or expansion which is known as vasodilation.
The venous structure has some distinct features over that of the artery. They normally
have less smooth muscle than an artery of a similar size and the connective tissues is not
as thick which means in general that the vein has less structural strength than an artery.
This can be seen easily on inspection where an artery will tend to keep its circular shape,
a vein will deform [60]. The endothelial layer of a vein has more contractility than that
of the arterial system . This is best observed during vasoconstriction of an arterial
vessel where the endothelium will tend to compress into folds which does not happen
on a venous endothelium layer. However the most distinctive feature separating the
two systems, is the addition of valves in the lumen of some of the large peripheral veins.
The valves stop gravity causing the back flow of blood to the capillaries as a result of
the pressure in the venous system can be as low as 10% of arterial pressure [60].
Let us now look closer at the anatomical complexities of blood vessel organisation in the
cranial space. The brain’s blood supply is provided by four main arteries: the left and
right carotid arteries and the left and right vertebal arteries. These vertebral arteries
then join together into the basilar artery on the surface of the pons and finally traverse
up the brainstem and before joining with the carotid arteries [60]. This structure is
known the circle of Willis (Figure 1.3).
The joining of carotid and vertebral arteries provides a redundancy to the cerebro-
system in that any occlusion which may occur in one branch will be compensated
by a reciprocal increase in flow from the other branch [49]. However the circle of
Willis is incomplete anatomically in about fifty percent of people [21] so this “built in”
redundancy may not be relied upon.
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Figure 1.3: A schematic diagram of the circle of Willis. Detailing the major arteries
involved
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Figure 1.4: A schematic diagram of the skull. Detailing the inflow and outflow of blood
and external influences.
The brain is contained with the skull which is a ridged box and this influences some
of the flow and pressure dynamics. As the circulatory system is contained in a rigid
container the arteriovenous pressure gradient is subject mainly to the greatest of the
extra-vascular pressures which is intracranial pressure [21], figure 1.4. This ultimately
leads to the conclusion the cerebral perfusion pressure is mainly driven by the arterial
blood pressure (ABP) which has been influenced by the intracranial pressure, that is
mathematically expressed as CPP = ABP − ICP .
1.2.2 Mechanisms underlying autoregulation
The current literature suggest there are three processes that can influence the regu-
lation of blood flow. These are: Myogenic effects, Metabolic effects and Neurogenic
effects.
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Myogenic
This mechanism proposes that the smooth muscle in the vessels has the ability to
contract in response to any stretch that is caused by an increased intravascular pressure
[21]. It has been shown that the smooth muscle depolarises when exposed to stretching
causing the muscle to contract [49]. The time course for the myogenic response has
been recorded at between 10s and 2mins. This reflex generally holds up to direct
visual scrutiny under a pial artery window technique [21] and as such has most weight
in the literature as the primary mechanism underlying autoregulation.
Metabolic
There is evidence that the active metabolising cells that surround the arteries can
release vasoactive substances that can cause vasodilation. This is to ensure that the
tissue has a good supply of oxygen (O2) and any metabolising products like carbon
dioxide (CO2), hydrogen ions (H
+) and lactate are removed from the tissue [49]. In
other vascular systems there is some evidence that hypoxia, depriving a tissue of its
supply of O2, and hence lowering its partial pressure for O2, pO2, can cause a vasodila-
tory response [98]. However in the cerebrovasculature the partial pressure of arterial
O2, paO2. has to fall to below 60mmHg before there is a measurable response. This
adds evidence that cerebral autoregulation occurs in response to a direct change in
O2 content and not paO2 changes because of the nature of the haemoglobin oxygen
disassociation curve at the partial pressures indicated [21].
A number of metabolites could play a part in metabolic based autoregulation with the
main substances being listed in Table 1.1.
The dominant metabolic process is that of carbon dioxide diffusion which causes vasodi-
lation via H+ production in the cerebrospinal fluid by action of carbonic anhydrase [49]
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Metabolic factor Comment
Adenosine This is a vasodilator and there is evidence that it
increases as paO2 falls [21]
CO2 This has an important role in blood flow regulation [49].
It has also been shown that partial arterial pressure of
CO2 (paCO2) has a distinct effect on flow [98].
H+ An increase in H+ shows a decreasing pH and this
normally causes vasodilation. However in the
cerebrovascular system there is mixed evidence for this
effect [21].
Lactic acid This is linked to the pH of the system however it again
has mixed evidence for being involved in the metabolic
mechanism [21].
Endothelial Derived This is probably a chemically bonded version of Nitric
Relaxation Factor (EDRF) Oxide (NO). Which is a known vasodilator [60].
Table 1.1: The main metabolic factors that could play a role in CBF regulation.
via the following reaction:
CO2 +H2O
CarbionicAnhydrase−−−−−−−−−−−−→ HCO+3 +H+
Neurogenic
The third underlying mechanism for autoregulation is a neurogenic one. There is
neuronal control of the cerebrovascular system from autonomic innervation involving
mainly two processes, a baroreceptor or a chemoreceptor reflex.
The baroreceptor measures the amount of stretch in expandable organs in the body [60].
It is a likely candidate sensor however it has been shown that the reflex loop between
the baroceptor and the central nervous system can be severed without the loss of
autoregulation [21].
A chemoreceptor measures changes in the levels of O2, CO2, pH in the cerebrospinal
fluid (CSF) and blood [60]. If the peripheral chemoreceptors are disconnected the cere-
brovascular responsiveness is not effected by either hypoxia, hypercapnia or increased
CO2 [21]. This is not quite as clear cut as the baroreceptor response because there is
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evidence that the chemoreceptors in the medulla oblongata do perform some control
over the blood flow to the brain as a secondary function. This means that if an in-
crease in CO2 is detected in the CSF the chemoreflex will cause a vasodilation in the
cerebrovasculature resulting in an increase in cerebral blood flow and an increase in
oxygen delivery.
These two sensory based control mechanisms do play a large role in regulatory control
in other parts of the body. The ability to inhibit both of these processes and still leave
autoregulatory responses intact is the main reason that it is less likely to be the main
cause for cerebral autoregulation.
While all of these mechanisms have merits I suspect it is likely that it is a combi-
nation of all three that will ultimately be at the root of the cerebral autoregulatory
phenomenon. There are a number of physiological models for cerebral autoregulation
in the literature and the most widely accepted [21, 66] has cerebral autoregulation de-
livered by appropriate dilation or constriction of the cerebral blood vessels through a
combination of mainly the metabolic and myogenic mechanisms [49,60].
1.2.3 Cerebrospinal fluid dynamics and ICP
Any discussion of cerebral autoregulation would be incomplete without looking at the
dynamics of cerebrospinal fluid (CSF) and how it interacts with ICP. Below is a brief
description of a physiological model of this system and its implications for autoregula-
tion.
As previously mentioned, the brain is housed inside a rigid cranium and is surrounded
by cerebrospinal fluid which is considered a Newtonian or non-compressible fluid. The
CSF itself is produced from the arterial blood supply via the choroid plexus of the
ventricles in the brain which circulates round the cranial space where it is eventually
absorbed again across the arachnoid villi and lateral lacunae of the large cerebral
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Figure 1.5: Overview of the different types of model and their commonalities
sinuses enroute to the venous circulatory system [60]. It is this balanced production and
reabsorption mechanism that is the initial starting point for the Marmarous 1978 [58]
paper on the dynamics of CSF. This model took an analytical approach to investigating
how changes in the CSF volume affect ICP and produced a mathematical model which
described the space in physiological terms. This model is especially important as it
has become the basis for other autoregulatory models.
1.3 Modelling
There have been a number of modelling approaches used in the literature which can
be broadly classified (Figure 1.5) between purely mathematical or statistical and com-
putational.
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With a purely mathematical model you would start with a number of assumptions
about the system itself and generate a model and only going back to real world data
to define the detail of the model. With a statistical or computational model you
would start with real world data and generate a model using any one of a number of
techniques. In Panerai et al’s [66] review of the literature of cerebral autoregulation he
classifies each of the modelling approaches purely by type and whether they operate
on static or dynamic cerebral autoregulation. This I feel is an over simplification as
it misses the genuine advantages of one general class of model over another. A purely
mathematical model will always give you insight into the underlying system, whether
it is that the model is accurate and the underlying system can generally be assumed
to follow your modelled system or that the model is wrong so the underlying system
must be different. A statistical model will only give information on the collected data,
whether it fits or not, and from that you have to make assumptions on what that means
for the underlying system.
There is prevalence in the literature towards statistical or computational modelling
purely for the reason most model fitting studies are performed with existing collected
data. This does not mean, however, that these studies are subordinate to the mathe-
matical approaches as there are a number of accurate predictive computational models
in existence.
Statistical models described in the literature range from the easily calculated but in-
accurate at modelling the underlying system, like most of the linear regressions tech-
niques attempted; to the effective but complex modelling approaches using nonlinear
equations or Bayesian neural networks.
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1.3.1 Simple Linear Regression Models
Most studies initially attempted simple linear regression techniques, for example Lam
et al [51] proposed a simple measure of dependency of CBF on CPP, or mean ABP
in the absence of CPP, in which he proposed a threshold of the correlation coefficient
r = 0.5 for the separation between normal and absent autoregulation. This was an
oversimplification of the actual system, although easy to evaluate and understand.
There are a number of variations on this theme, papers of note using a similar technique
would be the Czosnyka M. et al’s Pearson Product-Moment correlation papers [23,
24].
A Product-Moment correlation indicates the strength of a relationship between two
variables that are assumed to be measured on an interval or ratio scale. It can also
be called a moving average correlation if more than two datasets are involved. In
his 1996 paper, Czosnyka defined a Mean index or Mx as a correlation between the
time averaged mean flow velocity in the middle cerebral artery and CPP. This was
shown to have a good link to clinical outcome as measured by the Glasgow outcome
scale (GOS). In his 1997 paper a Pressure Reactivity index or PRx is defined using
the correlation coefficient between 40 consecutive samples of values for ICP and ABP
averaged over a period of 5 seconds. this was found also to correlate well with outcome
in traumatic brain injury patients. However in Kirkness et al’s [48] paper they found
that if they tried to generalise this result to acute brain injury which included both
TBI and other cerebrovascular pathology then the result did not follow. On further
investigation they were able to show that the effect in the cerebrovascular pathology
group was not significant but they were able to reproduce the original finding with the
TBI group.
In Panerai et al [66] there is a suggestion that the absolute values of the correlation do
not provide a reliable threshold for clinical decision making. A classification criterion
based both on the significance (p-value) and slope of the regression has been proposed
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in Panerai et al [71] and was shown to provide a more predictive measure. This would
tie in with the findings in Kirkness et al’s [48] paper which shows that the statisti-
cal significance of the relationship between PRx and Outcome in the cerebrovascular
pathology group has to be considered when using the PRx model.
Most of the linear regression approaches work on what could be classed as static cerebral
autoregulation, that is evaluation of cerebral autoregulation performed under steady-
state conditions: a measurement of CBF is obtained first at a constant baseline ABP
and constant CBF, followed by another (steady-state) measurement that is taken af-
ter the autoregulatory response to a manipulation of ABP has been completed. The
Czosnyka [23] paper is one of the few that have tried their approach with dynamic
cerebral autoregulation. Dynamic cerebral autoregulation testing uses the rapid drops
in ABP caused by the release of, for example, thigh mounted blood pressure cuffs, as
an autoregulatory stimulus and compares ABP and CBF velocity (CBFV) during the
autoregulatory process. Cerebral blood flow velocity responses are usually measured
with a noninvasive transcranial doppler ultrasonography (TCD) method introduced in
Aaslid et al [1].
In Tiecks’ [97] paper, he compared two linear models: one for static autoregulation and
one for dynamic. The static model being compared is the index of static autoregula-
tion (sARi) which is defined to be the percentage change in cerebrovascular resistance
(CVR) divided by the percentage change in CPP:
sARi =
%∆CV R
%∆CPP
(1.1)
Where mean ABP replaces CPP in cases where ICP is negligible or unavailable [61].
The dynamic model used was the dynamic autoregulatory index (dARi) which is defined
[1] to be
dARi =
%∆CV R
%∆T
%∆ABP
(1.2)
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Both indices were shown to be highly correlated.
1.3.2 Complex Non-Linear Modelling
Nonlinear modelling is one way to overcome the limitations of the simplistic nature of
the linear model. Nonlinear is a rather catch all term for any higher order differential
modelling techniques.
In the comparative review [66] of linear and nonlinear models a number of techniques
were used including a second order differential model proposed by Tiecks [96] and a
moving-average approach using Volterra-Wiener kernels. Volterra-Wiener kernels stem
from a functional analysis technique to classify nonlinear systems [83]. Both modelling
approaches were found to significantly improve model accuracy for the same segment
of data used to estimate model parameters with the linear equation which is attributed
to the second order components in the nonlinear system. The main draw back of this
approach found was that you can not accurately extend the second order component
onto another section of data and have it accurately predict the nonlinear nature of
that section. So from this point of view nonlinear analysis has a lot to offer as a more
accurate real time detector as it can accurately model given data but not as a predictor
because given a previously derived model the system breaks back down to its linear
components when applied to another dataset.
One of the other common non-linear analysis techniques used is “frequency domain
analysis”. This is a phrase which represents a number of methods which all have a
central theme of representing a waveform by plotting the amplitude of its constituent
components against their frequency. In general when frequency domain analysis is
discussed the method most used is Fourier or fast Fourier analysis, or the associated
method of transfer function analysis. Fourier analysis being a branch of mathemat-
ics concerned with the decomposition of time series data in to its component wave
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parts using fourier transforms. In Birch [10] Fourier analysis is used to extract the
phase difference between the fundamental components of cerebral flow velocity and
ABP. This phase difference was used to show a significant reduction in phase lead of
velocity over ABP with hypercapnia and a highly significant increase in phase lead
with hypocapnia. It was proposed that these changes could be used as an indicator of
cerebral autoregulatory state.
In Reinhard [78] the detection of autoregulatory state with phase shift was shown
to be possible in patients with carotid artery stenosis. The paper itself was mainly
concerned with using the detection of autoregulation as a better method of assessing
hemodynamic impairment than the more standard CO2 reactivity method but it was
also shown that the phase shift method during Valsalva manoeuvre (VM) correlated
well with the autoregulatory slope index (ASI) introduced in Tiecks [96].
The other main frequency domain analysis method, transfer function analysis, is gen-
erally used to investigate the relationship between the input and output of a linear
time-invariant system. The technique has been used effectively to model cerebral au-
toregulation within a constrained frequency range [109] and that the transfer function
phase and gain can be used as a characterisation method for dynamic cerebral autoreg-
ulation [79].
However there is a draw back to using these frequency domain analysis techniques
which are based on Fourier transform. There is an assumption that the signals are
stationary, that is the mean and standard deviation of the periodic signals do not vary
under time shift. This however is often not the case as many physiological signals
are non-stationary but reflect transient changes in the physiological state [68]. This
assumption about the non-stationary nature of the signals may have an effect on the
results obtained from an analysis although the potential error has not been thoroughly
assessed [14].
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There is now a trend in the literature to use computers to implement models which
are becoming too complex to model by hand. This is especially so of artificial neural
network modelling.
Artificial neural networks (ANN) are essentially a computer program that has a number
of nodes or artificial neurons which are connected together to process an input function.
The nodes can be dynamically altered by the provision of data thus training the network
to accurately process any input data. With enough training accurate models which have
been constrained by the boundaries of the provided data can be produced.
This technique has been used to successfully model the dynamic relationship between
ABP and CBFV. It was shown that there was a significant improvement in this mod-
elling approach over transfer function analysis but not of the normal time series tech-
niques used [67].
1.3.3 Mathematical Modelling.
The difference in classification of techniques between mathematical or statistical may
be subtle as all the previously mentioned models have rather complex mathematics at
their core, however the insight they provide on any situation is based purely on the data
used to develop them. A purely mathematical model should be derived without the
need for interaction with the main data, beyond the environmental constraints of the
system. That is any intrinsic properties of the model itself which come from domain
knowledge used to construct it.
In the literature the best example of a purely mathematical model would be compart-
mental models. A compartmental model is best described as a flow model where one
or more entities are being transferred between compartments according to a set of flow
rules. As an example to illustrate this figure 1.6 shows a one compartment model with
a total of substance z in the system at time 0 of z(0) and the amount of z in the
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Figure 1.6: A basic one compartment model and a graph of its mathematical model of
amount of z in the compartment vs time.
compartment, which has a background value of z equal to zbg, at time t can simply be
modelled by an exponential decay curve (Equation 1.3).
z(t) = zbg + (z(0)− zbg) exp(−kt) (1.3)
The number of compartments and the complexity of the rules can be thought of as
defining characteristics of the model. These types of model are used prevalently in
pharmacokinetics to model drug behaviour [3, 94,95].
One of the first uses of this approach was to model a near complete system of cran-
iospinal dynamics [100, 101]. This was however too complicated to be used clini-
cally [102]. This model or the general technique was used as the basis for a number of
other papers which tried to focus more on cerebral hemodynamics.
There have been trends in the literature over the optimal number of compartments for
such a model to use. For example three compartments were used in Czosnyka’s [22]
model of the cerebrovasculature. Then four compartments were used in the models
described by Ursino [100], Kadas [47] and Gao [32] subsequently increased to eight by
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Figure 1.7: A three compartment model of cerebrohaemodynamics and its electronic
equivalence circuit.
Ursino [103] and Banaji [7]. An illustration of these types of model can bee seen in
figure 1.7. This is the Czosnyka three compartmental physiological model on the left
as well as a circuit diagram which is an electronic equivalent model on the right. This
electronic model is normally easier to understand and convert into a set of mathematical
equations which describes both of these models. As such many of the models above
are represented by them in their respective papers.
The main paper in this group is Ursino’s 1997 [102] paper. The model itself is a cut
down version of his earlier work in craniospinal dynamics [100,101], making that model
much easier to understand and use. The model itself is a two compartment model which
includes simulation of the hemodynamics of the arterial-arteriolar cerebrovascular bed,
CSF production and reabsorption processes, the nonlinear pressure-volume relationship
of the craniospinal compartment and a standard Starling resistor mechanism for the
cerebral veins. Using this model Ursino shows a number of positive outcomes including
an accurate representation of the CBF against CPP autoregulatory curve, in both
states of intact and failed autoregulation. There is also, uniquely, evidence of b-waves
being present in the model if you create the correct environment with the models
defining constants. B-waves are periodic waves with a frequency of between 0.5 and
4 oscillations per minute which are manifested clinically in patients exhibiting a low
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compliance state. These b-waves, from the modelling view point, show instability of
the mathematical system and demonstrate from a physiological point of view that there
exists a set of environmental minima which if met will cause b-waves.
The Kadas et al [47] model is similar to the Ursino 1997 model with one general differ-
ence, that being the flow resistance at the capillary-artery compartmental boundary is
a function of the pressure and not a constant. This modification showed that a con-
stant flow between the artery and capillary compartment could be maintained by a flow
resistance which is directly proportional to the pressure difference between the two com-
partments. Oscillatory flow is re-established in the model at the capillary-cerebrospinal
fluid and capillary-venous interfaces. There has been no direct comparison of both the
Ursino and Kadas models to see which one better represents real patient data.
The last of the four compartmental models [32] takes a slightly different approach
to defining the compartments. Each compartment is used, like the models before, to
control CBF. However each compartment is made up of an increasing number of parallel
vessels instead of the normal classical physiological model of the previous papers. The
model itself accurately predicts the cerebral autoregulatory CBF/CPP pressure curve
along with upper and lower limits as well as slopes. The model itself however is limited
to only discussing autoregulation as, unlike the previous models, it isn’t initially based
on physiology.
Most of these models have only looked at the physical effects and the general flow
between the compartments. They have largely ignored the biochemical interactions in
the system. Banaji et al [7] goes some way to addressing this omission. The main
compartmental model is based on the later Ursino et al paper [103] and it has been
extended to include a vascular system including a chemical transport and interaction
model. The model has been shown under a set of preliminary simulations to accurately
model the CBF - CPP curve which implies that the new biochemical model hasn’t had
an adverse effect on the original physiological model of Ursino’s. However, despite the
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increased complexity introduced, it is still possible to generate predictions of a number
of physiological quantities associated with the original data from a patient.
In general all the models, either mathematical or statistical, in the literature give an
adequate way of assessing the state of cerebral autoregulation in a patient. Out of the
two types, the mathematical models provide more information about the underlying
mechanism under investigation.
1.4 Hypothesis
My working hypothesis is that by adapting a purely mathematical model into a pre-
dictive index for cerebral autoregulation will give greater insight into the underlying
physiology and be a more accurate predictor compared with statistical models.
1.4.1 General Approach to Testing the Hypothesis
1. Initially assessing the mathematical model of Ursino et al in his 1997 paper,
assess if the autoregulatory index generated from the Ursino mathematical model
is either predictive or not against gold standard data with known autoregulatory
state.
2. Develop an approach for ensuring a fair comparison of the derived index against
widely accepted statistical models
3. Identify weaknesses in both the Ursino mathematical model and the test data-set
and investigate approaches to addressing the limitations.
4. Consider the design of a prospective multi-centre study using the model found to
be most accurate at predicting the current experimental and clinical data.
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1.4.2 Experimental approach
Using a previously developed compartmental model of Ursino et al [102] a predictive
variation on this has been developed. This variation shall first be validated using the
high resolution animal data set with known autoregulatory state donated by the late
Michael Daley [26]. The Daley data is a 6 piglet multi-channel recording with a gold
standard measure of cerebral pressure autoregulation function using a cranial window
technique which allows monitoring the diameter of surface blood vessels, before, during
and after physiological challenges. This validation will be carried out by running the
model on the data and checking to see the amount of correlation between the actual
measured autoregulatory state and the predicted one.
Once validated the Ursino mathematical model will be compared to the other more
accepted statistical modelling methods of autoregulatory prediction. Each of these
models will be compared, not only against the new model but against each other. The
Daley data would be used again for all model comparisons. From the model predictions,
a measure of correlation will be calculated between the test model and the new Ursino
variant model, also between the test model and the Daley dataset autoregulatory state
information. This approach should place the new model in context with the other
existing models.
The main intention of mathematical or statistical modelling is to improve clinical un-
derstanding of the underlying patho-physiology and aid clinical management decisions.
With this in mind any given model will have to be accurate with not only the high
resolution experimental data but also with glsMBM vital signs data which is the res-
olution most typically captured and available in the clinical setting. To assess this,
there are a number of good quality minute by minute (MBM) datasets available for
testing the new models upon [13].
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1.5 Research Plan
During my research, it was not always clear where the next step would take me. To
those who read this thesis they too may be wondering if there was a plan? Hind-sight
is a wonderful thing and only having completed the research is it clear to me now
where I have travelled and why. This brief section attempts to provide a view of the
forest.
Chapter 2: As a mathematician, Ursino’s mathematical model was immediately at-
tractive as the base from which to start. My interest in model comparison drove me
to rearrange the Ursino model to yield an index of autoregulation as the main output.
In so doing, a number of parameters in the final equation clearly were not practical to
measure clinically. A few approaches were looked at to produce surrogate measures to
replace these key parameters, some more practical than others. However, those found
to be more practical were limited by the dataset so a venturi-flow model was used as
a compromise surrogate to at least allow a model comparison to proceed.
Chapter 3: Three models were compared: Ursino’s mathematical model with two
statistical models (Czosnyka’s PRx and Daley’s HMF). The startling poor performance
of all the models tested led to approaches to optimisation with a subsequent 10 fold
improvement in performance in some of the models.
Chapter 4: The limitation of the Venturi-flow model remained an issue and so the
use of mutli-frequency transcranial impedance was investigated in both experimental
animal models and clinically as a potential surrogate for Ca(t) (arterial-arteriolar com-
pliance) in the guise of intracranial compliance (CIC). The application of impedance
to the re-worked Ursino model was investigated.
Chapter 5: There remained a considerable variation in all the model outputs and
in particular the Ursino model clearly showed that the variance in the autoregulatory
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index was a better fit to the dataset than the mean value. So at this point I investigated
the application of Fractal Methods to study the inherent variation and fractal nature
of these types of dataset. One resulting benefit being the development and use of
wavelets for filtering the dataset and how it can be used to improve the re-worked
Ursino model.
Chapter 6: Having developed an understanding of several models of autoregulation,
their relative performance and their limitations, it would be remiss to not assess their
performance on a clinical dataset and especially to study their correlation with clinical
outcome. This proved to be feasible as I had access to the BrainIT group [13] dataset,
which is a unique multi-centre dataset of minute by minute physiological monitoring
data which also included a measure of clinical outcome in the form of the Glasgow
Outcome Scale (GOSe) at 6-months post-injury.
Chapter 7: Some “out of the box” musings on a general framework for autoregulatory
model comparison and model space definition: the study of Topology.
Chapter 8: What has become clear is that any model comparison results are only as
valuable as the quality of the data upon which they are tested. My “Gold-Standard”
piglet dataset was the best available to me at the time, but clearly also had limitations
in terms of size and noise. The study of cerebral autoregulation in patients with
brain injury is not a new field and has many practitioners, each of whom have their
own datasets in their own non-standard format. Having been encouraged to see what
the BrainIT group have achieved in the realm of standardising and sharing general
intensive care data from patients with brain injury, I thought I might try to test the
feasibility of a similar model in the field of autoregulation research. My goal being fairly
modest in trying to gain access to a number of other autoregulatory datasets so that I
could ascertain if my general model comparison framework could be validated in other
datasets and found useful by other groups. The response to the call of our inaugural
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meeting of the Cerebral Autoregulation Research Network (CARNet) truly was un-
expected and seems to have caught the interest of a large group of researchers from 15
countries including USA, Japan, Australia, Canada, China and of course Europe. The
network is young and it remains to be seen whether it succeeds or flounders, but in
starting this network - I have at least given myself access to a number of other datasets
for testing the utility of my autoregulatory comparison framework.
Chapter 2
Description and the mathematical
reworking of the original Ursino
model.
29
CHAPTER 2 30
2.1 Introduction
Using the Ursino et al [102] model a predictive variation of this model has been cal-
culated. This earlier model was chosen instead of the more recent [100] model as it
is mathematically less complex. This yielded a model equation containing parameters
that were not readily measurable in a clinical environment. Research was undertaken
to identify and develop surrogate measures of these variables more practical to mea-
sure clinically. This initial predictive model has been calculated by fully assessing the
original model and simplifying the dependent variables, where it was possible, then
rearranging this for the autoregulatory index parameter. This gives a model with an
output measure for autoregulation dependent on a set of clinically measurable phys-
iological variables. This new model will be assessed using the gold-standard Daley
data [26] and other prospectively collected datasets. The rearranged model contained
two parameters not readily measured clinically, thus approaches are described to de-
velop alternative parameters to estimate these variables with a view to providing a
re-worked mathematical model that can be practically compared with a range of sta-
tistical data driven models.
2.2 Aims
The main aim of this chapter is to provide a detailed assessment of the construction of
the reworked Ursino model. It will investigate the issues surrounding a direct mathe-
matical reworking of the original model including the application of this new revision
in the real world. This will culminate in a basic assessment of the model against a
retrospectively collected experimental dataset.
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Figure 2.1: The main components of cerebral autoregulation according to the Ursino
Model.
2.3 Basic description
Ursino’s original model is a two compartment model which includes: hemodynamics of
arterial-arteriolar cerebrovascular bed, cerebrospinal fluid production and reabsorption
processes, the pressure volume relationship of the craniospinal compartment and a
starling resistor mechanism for cerebral veins. The paper uses this model to explore
a number of situations including the effects of arterial hypotension on ICP, the ICP
response to a protracted cerebrospinal fluid (CSF) infusion and finally the instability of
ICP dynamics when there is raised CSF outflow resistance and decreased intracranial
compliance. Autoregulation in the model can be thought of as a combination of three
processes affecting arterial-arteriolar compliance for a given percentage change in CBF
(figure 2.1).
The first process is the autoregulatory gain, the next is the static sigmoidal shaped au-
toregulatory response function and the last component is a low pass transfer function.
The maximum autoregulatory gain (G) is defined by the slope of the static autoreg-
ulatory curve at its centre point. Ursino’s paper goes on to give the range of values
for G to cover normal healthy cerebral autoregulation through to those with impaired
cerebral autoregulation.
It is from this autoregulation gain parameter that the new model is derived as this
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Figure 2.2: The original physiological model. The parameters used in this model are:
Firstly the pressures where Pa(t) is the arterial blood pressure, PICP (t) is the intracra-
nial pressure, PC(t) is the capillary pressure and PCPP (t) is the cerebral perfusion
pressure. Secondly the compliances Ca(t) the arterial-arteriolar compliance and CIC
the Cerebral Compliance. Thirdly the resistances in the system Rf the cerebrospinal
fluid formation resistance, RPv the proximal venous resistance, Rdv the bridging vein
resistance and Ro which is the CSF Out flow resistance. Fourthly the flow rates mea-
surable in the system beginning with q(t) which is the cerebral blood flow rate, qf the
CSF inflow rate, qo the CSF outflow rate and If a CSF infusion rate. Then finally
Va(t) the arterial-arteriolar volume and Ra(t) which is the arterial resistance.
gain parameter G is essentially a continuous index for cerebral autoregulation so with
this in mind Ursino’s original model has been reworked to predict G.
2.4 Summary of the mathematical reworking
The original mathematical model is based on the physiological equivalence model in
figure 2.2. The mathematical formulae derived from this model have been manipulated,
as can be seen in appendix A, to give a direct output of G. This will allow continuous
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measurement of the autoregulatory state. This is shown below.
G(t) =
− log
(
−2∆CaPCPP (t)2
H(t)
− 1
)
∆CaqnRfRPv
4((RPv +Rf )(PICP (t)− PC(t)) + qnRfRPv)
Where
H(t) = (2Can −∆Ca)PCPP (t)2 −
(
2τ
d
dt
Va(t) + 2Va(t)
)
PCPP (t) + 2τVa(t)
d
dt
PCPP (t)
and ∆Ca differs based on the sigmoid case split.
x(t)

< 0⇒ ∆Ca = ∆Ca1
> 0⇒ ∆Ca = ∆Ca2
This means that as x(t) changes the value of ∆Ca it will switch from ∆Ca1 to ∆Ca2
or vice-versa. This form (equation A.28) of the reworked Ursino model has two main
impediments to direct use in most clinical settings.
2.5 Remaining issues with the reworked model and
how they can be addressed
As mentioned in the introduction of this chapter, before we can use the re-worked
Ursino model, two model parameters which are not practical to measure in a clinical
environment must be estimated by other variables. This section describes a number
of approaches to achieve this step. The first issue concerns the measurement of Va(t)
and because of equation A.1: Ca(t), both of these properties are difficult to measure
accurately at the bed space. So a surrogate value will need to be calculated to estimate
the dynamic change in these variables. The second is the general problem with the
case based asymmetric sigmoid caused by the discontinuity at the inflection point on
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Figure 2.3: A flow chart showing the influence knowledge of vessel diameter and/or
ICP wave form amplitude has on the chosen surrogate methodology
the sigmoidal curve (see figure B.4).
2.5.1 Surrogate values for Va(t) and Ca(t)
In all subsequent analyses of the model a surrogate value for either arterial-arteriolar
volume or arterial compliance has been used. Which method out of the following was
chosen was based solely on applicability to the dataset being used. The flow chart of
decisions made in this regard is shown in figure 2.3.
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Figure 2.4: A basic venturi flow model. With Pa being the arterial-arteriolar pressure,
Pc being the capillary pressure and Q is the flow rate. Then v1, v2 are the flow velocities
in their respective areas and d1, d2 are the diameters of the tube at either end as well
as a change between each in the centre.
Surrogate for Va(t)
One approach to estimating Va(t) is based upon the venturi flow effect [9]. Any fluid
flowing through a tube will experience a change in pressure when moving from one
diameter size into another, figure 2.4. This technique is normally used to find the
flow rate of the fluid but it can also be used to estimate the volume in the system.
Bernoulli’s principle states that on a horizontal reference plane, with respect to gravity,
the pressure in a fluid filled system and the velocity of that fluid are balanced so that
as one increases the other must decrease and vice versa. Mathematically speaking this
can be expressed as equation 2.1 where ρ is the density of the fluid, p the pressure, h
is the height above the reference plane which in this case is 0, g is the gravitational
constant, v¯ is the velocity of the fluid and ks is the system constant.
ks =
v¯2
2
+ gh+
p
ρ
=
v¯2
2
+
p
ρ
(2.1)
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Since ks will be the same for any distinct part of the system this can be used to equate
these parts which in this case are either side of the constriction in the venturi system.
If this is rearranged we end up with equation 2.2.
Pa(t)− PC(t) = ρ
2
(v¯21 − v¯22) (2.2)
Consider the fluid dynamics continuity equation which is centred on the idea that
inflow equals outflow so with a constant density fluid the total flow rate in one part of
the system is the same as in another. The basic definition of volumetric flow rate is
velocity multiplied by the cross sectional area, Q = v¯A. These two facts combine to
with equation 2.2 to give equation 2.3.
Pa(t)− PC(t) = ρ
2
((
Q
A(d1)
)2
−
(
Q
A(d2)
)2)
(2.3)
Where the A(d) function is the classical area of a circle in terms of the diameter and
where d1 and d2 are the diameters of the arteries and arterioles.
A(d) =
1
4
pid2. (2.4)
Then if we solve equation 2.3 for flow Q we get
Q =
√(
2(Pa(t)− PC(t))
ρ
)
A(d1)√((
A(d1)
A(d2)
)2
− 1
) (2.5)
substituting equation 2.4 into this and letting that equal the flow equation A.3 from
Ursino’s original paper
q(t) =
Pa(t)− Pc(t)
Ra(t)
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and then solving for Ra(t) we get
Ra(t) =
√
8(d41−d42)
d42
(Pa(t)− PC(t))
pid21
√
Pa(t)−PC(t)
ρ
(2.6)
Then equating this to the arterial resistance from the paper, equation A.2
Ra(t) =
krC
2
an
Va(t)2
and then solving for Va(t) we get equation 2.7.
Va(t) = ±
Cand1
√
2pikr(PA(t)− PC(t))
√(
8(d1−d2)(d1+d2)(d21+d22)
d42
)(
Pa(t)−PC(t)
ρ
)
(PA(t)− PC(t))
√(
(d1−d2)(d1+d2)(d21+d22)
d42
) (2.7)
This method is only practical when there can be a direct measurement of these diam-
eters which in reality will only be in experimental animal models such as that used in
the cranial window pial artery model used by Daley et al [27]. Although this approach
may seem to be merely an academic exercise it may be worth considering in the future
should clinically practical methods for estimating a representative arteriolar diameter
become available, possibly based upon high resolution ultrasound imaging. Therefore
other more clinically applicable methods were also sought.
Surrogate for Ca(t)
To find surrogate parameters that could be used here that have a good enough fit
to the model and don’t introduce much noise, it is worth exploring the relationship
between arterial-arteriolar compliance and intracranial compliance. Going back to
Ursino’s original paper it describes the intracranial compliance (CIC) as a function of
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arterial-arteriolar blood volume (Va(t)) as shown in equation 2.8.
d
dt
Va(t) = CIC(t)
d
dt
PICP (t) +
(Ra + 1)PICP (t)−RPvPa(t)
Rf (RPv +Ra)
+
PICP (t)− PV S
RO
(2.8)
The general solution to this equation for Va(t) is found by integrating equation 2.8 and
is shown in 2.9.
Va(t) =
1
RfRORPv +RaRfRO
∫ (
(RfRORPv +RaRfRO)CIC(t)
d
dt
PICP (t)
+ (RfRPv + (Ra + 1)RO +RaRf)PICP (t)−RORPvPa(t)
)
dt
− PV sRfRPvt− PV sRaRf t+ Va0 (2.9)
Now from equation 2.9 we can see that Va(t) changes in proportion to the integral of
CIC(t) which is both time dependent and a intracranial compliance dependent upon
the arterial-arteriolar volume. As an illustration of this consider a static compliance in
which the system will not deform with time so that the only effect on volume will be
how long a fluid flows into the system, much like filling a cup with water. If however
the compliance changes in a linear fashion then as fluid flows into the system the
system also changes to increase in size, so both the contained volume of fluid and the
system’s overall volume is changing. This would be like filling a balloon or in our case
a vasodilating artery and arteriole.
We also know from equation A.1 that Va(t) ∝ Ca(t) so this would give the following
relationship
Ca(t) ∝
∫
CIC(t) dt (2.10)
The approach taken here is to use a measure of total intracranial compliance and then
relate that back to arterial compliance via equation 2.10. It is a well known fact, partic-
ularly from the work of Avezaat and Van Eijndhoven [4,5], that there is a relationship
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Figure 2.5: Diagram of an ICP wave trace with the diastolic level P1 and systolic level
P2 marked to allow the amplitude of the waveform PAMP to be calculated.
between the intracranial pressure pulse amplitude and the total compliance of the sys-
tem [77]. The dependence of ICP upon intracranial volume (VIC) and the compliant
properties ( 1
E1
) is described in equation 2.11. Using this form with an exponential
scaling factor to simulate the relationship
PICP (t) = Peqe
ElVIC(t) + P0 (2.11)
Using an exponential inequality for any a > 1 we have xa > 1 + a(x − 1). If the ICP
wave amplitude is PAMP , as shown in figure 2.5 , then
PAMP = P2 − P1
= Peq
(
eElV2 − eElV1)
> Peq ((1 + ElV2(e− 1))− (1 + ElV1(e− 1)))
> ElPeq(e− 1)(V2 − V1) (2.12)
this effectively means that PAMP (t) ∝ El assuming V2−V1, considered as the intracra-
nial cerebral pulse volume, remains constant. Then coupling this with the fact that
CIC =
1
El
and the relationship between Ca(t) and CIC(t) gives a basic arterial-arteriolar
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compliance of
Ca(t) ∝
∫
1
PAMP (t)
dt (2.13)
and therefore an arterial volume, with reference to equation A.1, of
Va(t) = kIC(Pa(t)− PICP (t))
∫
1
PAMP (t)
dt (2.14)
Where kIC is a constant of proportionality. Thus, using this approach based upon
measuring the ICP pulse amplitude, both Ca(t) and Va(t) can be estimated.
Other methods for estimation
The least accurate models of Va(t) are the ones only based on equation A.1 that make
assumptions that Ca(t) is constant and only using PCPP as a trending agent or similarly
has to assume Va(t) is constant itself. With any of these other methods of estimation it
becomes a question of how much inaccuracy is acceptable with respect to introducing
noise into the model. Where possible both of these methods have been avoided in the
use of the model unless explicitly stated.
2.5.2 Asymmetric sigmoid
Ursino’s original sigmoid curve was asymmetric and initially proposed as two functions
which worked on separate cases of the parameter set. However when re-engineering the
methodology this dual function had a tendency to become unstable in the simulation at
the crossover point of the two sets so a new asymmetric sigmoid function was devised
to overcome this limitation (appendix B). Using this new asymmetric sigmoid function
B.8 in the place of equation A.11 we would then end up with the following version of
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Ursino’s model. Starting from equation A.10 we get
G(t) = σ−1
(
τ d
dt
Va(t)− τCa(t) ddtPCPP (t)
PCPP
+ Ca(t)
)
1
x(t)
However because of the numerical nature of the solution to this inverse sigmoid, as has
been detailed in appendix B, producing a clean mathematical formula here is impos-
sible. To find the inverse value the algorithmic function only needs the modification
shown in equation 2.15 to convert it from a function in y to one in t.
y =
τ d
dt
Va(t)− τCa(t) ddtPCPP (t)
PCPP
+ Ca(t) (2.15)
Then you would just solve for the roots of the equation and transform that into the
inverse sigmoid value.
2.6 Testing the feasibility of the model.
2.6.1 Daley experimental dataset
The main data set for all of the initial analysis was donated by Dr Michael Daley from
a previously carried out set of animal experiments. As this dataset did not have to be
created from scratch this allowed a faster start to the analysis portion of this thesis
however as the rudimentary analyses were being carried out a number of questions
started to arise over what experimental manipulations were present in the data. It
became clear quite quickly that a deeper understanding of the provenance of the data
were needed. To this end a trip was arranged to spend a week with Dr Daley in his
lab and learn how the data were collected and to better understand the experimental
protocol.
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Figure 2.6: An example of the experimental set up used in the recording of the piglet
dataset.
Basic animal preparation
The dataset consists of six healthy piglets which range in weight from between 1.5kg
to 3.3kg with the average being 2.35kg. They all received the following standardised
set up, firstly both ketamine and acepromazine were given intramuscularly to initially
anaesthetise the animal. Secondly they were then intubated and mechanically ven-
tilated at rate between eight and twenty four breaths per minute. A 2cm diameter
opening was cut over the left parietal cortex and a cranial window was then placed
and sealed with dental acrylic, mock CSF was then infused below the window. A video
camera is set up over the window so that the vessel diameters can be recorded dur-
ing the experiment. Lastly the tip of a fluid percussion injury (FPI) apparatus was
mounted on the skull over the exposed dura of the right parietal cortex and is sealed
in place. During the course of the experiment pCO2, pO2, pH and haemoglobin levels
were monitored and these were used to assess and maintain ventilation so that the ani-
mal remains physiologically stable. The temperature of the animal was also monitored
and was kept steady between 38◦C and 39◦C. The full experimental set up can be seen
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Figure 2.7: A picture of the fluid percussion injury equipment used to used in the
injury model.
in figure 2.6.
Fluid percussion injury.
The equipment used to simulate a traumatic brain injury has been validated in a study
by Shibatal [88]. It is essentially a water cannon which projects a fluid, in this case a
0.9% saline solution, in a controlled manner at a specified area. The equipment can
be seen in figure 2.7. The force is supplied by a weighted pendulum which swings
and strikes a syringe plunger. This then pushes the fluid out of the system via the
tube and effect nozzle at the end. For this dataset the pressure exerted on impact is
approximately 3.55± 0.88 bar.
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With any injury model there is a question over how much impairment can be considered
global and how much any focal component of the injury will affect the overall global
measurement approach. The FPI is considered a diffuse type injury model as when
the pressure is released at the focal point of impact, the pressure wave will radiate out
through the brain parenchyma and as it is being performed in a closed environment,
in this case the skull, this means the pressure disturbance will be relatively quickly
and evenly distributed throughout the brain tissue. Certainly the brain pathology seen
with this type of TBI model shows marked similarities to that observed in patients
presenting with diffuse TBI. Thus it is reasonable to assume that the injury model
deployed produces predominantly features typical of a diffuse brain injury.
However, one should also consider that with this type of injury model, there will be a
varying degree of impairment between blood vessels on the surface which have more
exposure to the affects of this travelling pressure wave front and any vessels that are
located more deeply within the cerebral matter. This degree of variability however will
not prevent the impairment of these vessels as larger pial and sub-cortical vessels are
all close to a fluid-filled compartment which will rapidly transmit the pressure wave
front.
Artery diameter measurement
The cranial window and the cranial window video is used primarily to measure the
pial artery diameters as an indication of the overall autoregulatory state in the system.
For example a pressure passive increase in pial vessel diameter is an indication of
autoregulation impairment. The measurement of the actual diameter from the video
was done by hand using the marked scale from the cranial window recording. Ten
consecutive values for an artery were taken and the average value used. A raw still
photo from a video can be seen in figure 2.8.
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Figure 2.8: A sample video frame from which the artery diameter can be measured.
The scale, in this case 100µm, is overlayed on the recording by the camera.
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Figure 2.9: A representative raw dataset from a single piglet with both ABP and
ICP traces. Dashed line indicates the fluid percussion injury and the circles indicate
detected BP challenges.
Experimental manipulations
Some of the main routine issues with this type of dataset include: basic flushing of
the arterial line to keep it patent after blood samples and movement artifacts. Two
manipulations of the experimental animals resulted from two different physiological
challenges to the animal. Firstly norepinephrine infusion was given to increase the
ABP and secondly 5% CO2 was added to the inspired gases to effect the ICP through
stimulating CO2 reactivity. The norepinephrine was administered via infusion over a
period of five minutes and the CO2 was given over ten minutes.
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Data collection
This is a high resolution data set with recording of ICP and ABP sampled at 250Hz.
Figure 2.9 gives a sample from one piglet’s data of a set of ICP and ABP traces before
and after fluid percussion injury also showing blood pressure challenges. Finally, using
the cranial window preparation allowed the pial vessel diameters to be measured before
and after BP challenge as well as before and after fluid percussion injury.
2.6.2 Feasibility study
Before going on to perform a definitive model comparison study between the re-worked
Ursino model and several statistical models, it was necessary to initially test the feasi-
bility of the re-worked model on real data. This feasibility study was then performed
in a representative animal dataset drawn from the Daley six piglet database. During
the course of testing this model which included the new asymmetric sigmoid curve
and the venturi effect Va(t) estimate, it was observed that it has very good temporal
discrimination and this is probably because of the dynamic approach it uses with the
time measurement within the model. This of course is a double edged sword as the
sampling rate between time points changes as the model changes with it to incorporate
this new information. If the frequency of the collected signal is increased then the num-
ber of points over the same length of time increases and because the gain of the model
will essentially predict a one to one relationship with the sampling rate there will be
more predictions for the autoregulatory state over the same period of time. Since it is
known that autoregulation of the system is itself a dynamic process which is constantly
changing, then the predictions of G will reflect this, however this increased variability
can often obscure larger picture of overall autoregulatory state by making the dataset
noisier. To reduce the model noise, two summary measures were calculated as moving
averages of both the mean and the variance averaged over a fixed time window. All of
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Model Summary Measure P-value
Basic model 0.09
Moving Average 0.06
Moving Variance 0.03
Table 2.1: P-values for each t-test of the different model summary measures
the moving windows were calculated with a 1 minute window which was approximately
0.5 percent of the total time series length. Figure 2.10 shows an example segment from
the time-series data-set of a single animal over which the model, and the two summary
measures, were calculated. To initially assess each of these measures against one an-
other the dataset was taken and was split into before FPI and after FPI and twenty
points were sampled from each group. Using the known autoregulatory state assessed
using the pial artery window methodology these groups can be broadly generalised into
intact autoregulation before the injury and impaired autoregulation after. So which
ever summary measure shows a difference between these randomly sampled groups in
a Students t-test would give the best chance at detecting a good model. Table 2.1
shows the results of evaluating the t-test for each measure. To highlight this figure
2.11 is a box plot of the before and after fluid percussion injury groups per summary
measure. It can be seen that the variance is the better predictor of the autoregulatory
state. This makes sense physiologically because a cerebral vessel will dilate or constrict
appropriately in response to changes in cerebral perfusion pressure so one would expect
the system to be more unstable or variable.
The last point that needs to be addressed before the model can be used in the wider
setting is how is autoregulation actually predicted from the numeric variance. To
help answer that a receiver operator characteristic analysis was performed using the
previously calculated testing data. The level above which the test subject would be
considered to have an impaired autoregulatory status was varied and the false positives
and true positives were recorded. The results led to using a cutoff level of 0.0074.
Anything below this has intact cerebral autoregulation and anything on or above it
impaired.
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Figure 2.10: Three plots of a single animal showing the output of the three summary
approaches: Firstly the original G then the moving average G and finally the moving
variance G. The autoregulatory impairment is shown as a vertical dashed line. With
each subsequent approach it can be seen there is visibly less variability “noise” in the
trace.
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Figure 2.11: Box plots of each summary measure approach illustrating the difference in
distribution between before and after FPI. With the circular point showing the outlying
data points in the sample.
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2.7 Conclusion
All of the aims which were detailed in section 2.2 were obtained and they raise the fol-
lowing notable observations: The re-worked Ursino model for cerebral haemodynamics
provides a good base to build upon for creating a clinically practical mathematical
model of cerebral autoregulation. This process was not without its hurdles to over-
come which includes the estimation of arterial-arteriolar blood volume and the presence
of a case based sigmoid function which is mathematically unstable. These issues have
been addressed by: firstly deriving a new sigmoid function which was continuous at
all points which solves many of the problems with the original. Secondly the use of
several surrogate measures for model parameters to deal with the estimation problem
of arterial-arteriolar volume were explored. In the absence of a method for direct or
indirect measurement of these surrogate parameters, a Venturi-flow model as a prag-
matic solution for working with the available data has also been derived. The model
was then explored and a summary measure based upon variance appears to be a bet-
ter predictor of outcome compared to the basic model or an average based summary
measure. Finally the level for deciding on the autoregulatory state was found.
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3.1 Introduction
Literature on approaches to comparing these types of models, in terms of their relative
accuracy, is sparse. This deficiency could be attributed to the difficulty in direct com-
parison of different model types; such as comparing physiological models that include
known autoregulatory parameters with other models that focus primarily on generat-
ing an indexed autoregulatory status using a “black box” approach regardless of the
underlying physiology.
Another difficulty concerns the lack of high quality data upon which to compare mod-
els. Without high frequency “gold standard” data on autoregulatory status, any model
could be placed at a disadvantage during such a comparison. Furthermore a major
problem in model comparison concerns the range of tests that can be used for compar-
ison and the choice of test is key to the meaningful comparison of the models.
As an example, Signorini et al [90] conduct an analysis of secondary insults (eg arte-
rial hypertension or raised intracrainial pressure (ICP)) from a physiological data set
obtained from patients with traumatic brain injury (TBI). For their model comparison
they used the Hosmer and Lemeshow goodness of fit test statistic. This test, although
superficially a good choice for the comparison, has been shown in Hosmer et al’s later
paper [38] to be flawed in that the comparison outcome is dependent on the size of
the deciles that are initially chosen which could cause the comparison and analysis
to be biased. The later Hosmer-Le Cessie “omnibus lack of fit test” has more power
and doesn’t have any of the former’s initial problems about the arbitrary binning of
probabilities. This test may yield a better chance at more accurate model comparison.
This illustrates a growing problem when choosing a test, in their case for a logistic re-
gression, that as the problem complexity increases, the chance of incorrectly analysing
the data also increases.
The above discussion indicates that advancement in this area of research will need to
CHAPTER 3 54
have these problems overcome. One approach which could be proposed would be to
perform the comparison on a related statistic but not necessarily one which is originally
generated by any of the models. For example, by taking two models, one of which
outputs a direct measure of autoregulation via an index and a second model which
outputs a time series trend for intracranial pressure, both of these could generate a
third statistic to a known value for autoregulation. This then could be used as the
basis for direct comparison of the models.
3.1.1 Study aims
This chapter reports on the results of our application of this approach to autoregulation
model comparison focused upon three models:
1. Pressure Reactivity indeX (PRx) [22]
2. Highest Modal Frequency (HMF) [27]
3. Reworked Ursino [102]
Each model will have a normalised autoregulatory parameter generated to ease com-
parison and a common high resolution data set will be used to ensure all model com-
parisons are not biased by data sampling rate. The analyses leading to best choice for
model comparison statistic and finally a method for optimising the data window size
to yield the best performance of a given model for estimating the status of autoregu-
lation is also reported. Models will be compared in terms of performance at detecting
baseline autoregulation status from a dataset generated from an experimental model
of autoregulation disruption using pial vessel imaging before and after fluid percussion
injury. This dataset has been described in detail in chapter 2. Models will also be com-
pared against each other as well as before and after application of our data window
size optimisation method.
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3.2 Methods
3.2.1 Models
Reworked Ursino model
Ursino’s original model is a two compartment model which includes: hemodynamics
of arterial-arteriolar cerebrovascular bed, cerebrospinal fluid production and reabsorp-
tion processes, the pressure volume relationship of the craniospinal compartment and
a starling resistor mechanism for cerebral veins. It is from this autoregulation gain
parameter that the new model is derived. The gain parameter G is essentially a con-
tinuous index for cerebral autoregulation. With this in mind Ursino’s original model
has been rearranged in chapter 2 to predict G.
There are however two issues which have been addressed by using the new asymmetric
sigmoid (appendix B) and estimating the arterial-arteriolar volume for the system
under study via a venturi flow model. This uses the test data set which has a cranial
window preparation through which the diameters for the various vessels can be used
to estimate the volume in the system.
However, in a pilot study of this new index parameter G [87], it was shown that the
variance of G changes more predictably with autoregulatory status than does G itself.
An explanation for this would be that when autoregulation is active there are dynamic
changes to the system as a whole and hence the variance in any continuous index of
autoregulation will also be large.
HMF autoregulatory predictor.
Using a technique called modal analysis it was found that when cerebral arterial flow
regulation is intact, changes in the highest modal frequency (HMF) are inversely related
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to changes in cerebral perfusion pressure. In contrast, when the arterial-arteriolar
vascular bed demonstrates autoregulatory impairment i.e. cerebral blood flow (CBF)
shows a cerebral perfusion pressure (CPP) dependency, changes in HMF are directly
related to changes in CPP (Figure 3.1). The HMF method published by Daley et al [27]
is briefly described below. HMF is calculated using an autoregressive moving average
with exogenous inputs (ARMAX) method from the model of ICP dynamics proposed
by Czosnyka et al [22]. Cerebrovascular pressure transmission is described by a third-
order system equation relating arterial blood pressure (ABP) to ICP. The resultant
difference equation from this model can then be converted to a differential equation
via the following methodology. Using a Taylor expansion of three generic functions a
vector space basis can be derived, then using a simple substitution onto that basis a
set of functions can be derived that relate the difference to the differential of the same
order. This topic is explored in more detail in appendix D. Solving those equations
one can calculate the eigenvalues of the original differential. These eigenvalues are the
modal radian frequencies of the cerebrovascular pressure transmission. The highest
modal radian frequency is ultimately converted to HMF via division by 2pi. These
HMF’s are then grouped and a linear fit is performed. The slope of this fit is then
related to the autoregulatory status in the subject.
PRx
The pressure reactivity index (PRx) or pressure reactivity index described by Czosnyka
et al [22] is a moving Pearson’s correlation between ABP and ICP. This method looks
at the amount of correlation between the two variables and the decision on whether
there is pressure reactivity or not is based on a pressure passive model. If the corre-
lation is positive, ie the ICP is reacting passively with ABP then it can be assumed
that the subject is not autoregulating. If the correlation is negative or near zero then
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Figure 3.1: Two examples of the HMF calculations for (a) Intact autoregulation and
(b) Impaired autoregulation. Where the slope of the fitted line denotes the switch
between predictive states.
the opposite is assumed that autoregulation is still intact and indicates that the cere-
brovasculature is reacting to the change in ABP. Examples of both of these correlations
are shown in figure 3.2. This has been shown to be predictive of outcome [23] and has
been generally adopted as a standard of autoregulatory assessment.
Other models
When this experiment was initially considered the plan was to compare all the above
models to what was an accepted measure of autoregulation of the Bouma’s methodology
[12]. However during the analysis this technique turned out to be consistently at
odds with most of the other models which normally had some degree of agreement
between them. One of the difficulties in this area is that many of the approaches for
measurement of autoregulation, such as methods using the Bouma Index, have been
developed using blood flow measurement relying upon tracer clearance techniques.
These methods tend to give at best spot measurements of cerebral blood flow separated
over many minutes which generally have produced estimates of autoregulation which
many consider to be “static” autoregulation. The methods that have been chosen for
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Figure 3.2: Two examples of the PRx calculations for (a) Intact autoregulation and (b)
Impaired autoregulation. Where the slope of the fitted line denotes the switch between
predictive states
the comparison are believed to be a representative sample of the approaches used to
measure “dynamic” autoregulation.
Each of these models have strengths and weaknesses associated with them with the
PRx the most widely adopted surrogate measurement for autoregulatory performance
in use today. It does however suffer from noise and “binning” artefact in that it is
sensitive to the choice of data set size for the analysis. There have been publications
that have tried to address this via a histogram methodology which is essentially a
smoothing technique. The HMF methodology is more stable than the PRx however it
has a reliance on higher resolution data, 250Hz sampling, to perform the analysis. The
reworked Ursino model does not rely on a specific resolution of data but will predict
more accurately given higher resolution sources. However that accuracy is tempered
by the dynamic nature of the signal becoming noisier at the highest resolutions.
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AR Intact AR Impared
25 32
Table 3.1: Counts of the cumulative autoregulation states measured via the cranial
window across all six piglets
3.2.2 Model Comparison
Across all six animals there were 57 measures of autoregulation: 25 intact and 32
impaired (Table 3.1). This dataset formed the baseline measure of autoregulation
status for model comparison. Figure 3.3 is a diagram representing the analysis protocol,
showing the data windows used for model input.
Firstly for the model comparison this data set was prepared differently for each model
so that at the end of the process there were a similar number of calculated results
for each model. Thus for the PRx the data were resampled to give a value every 6
seconds therefore giving 30 points per three minutes that the model requires. This
was then run across the full data set in a moving window giving a calculation for PRx
every 6 seconds. For the HMF the ARMAX process was carried out using the 250Hz
data using a 150 point window then this information was used to solve the difference
equation problem resulting in a HMF calculation every 0.6 of a second thus also giving
a model output every 6 seconds. Lastly the modified Ursino model was just run on
resampled data of six second ICP and ABP data, which in turn gave a prediction for
the autoregulatory state every six seconds.
For these continuous traces for autoregulatory state, the points at the start of each
blood pressure (BP) challenge were picked as points for comparison, to minimise the
likelihood of system compromise from the challenges themselves. This then allows
the autoregulatory prediction from each of the models to be compared to what would
be the standard which is what was observed through the cranial windows before and
after injury. So for example a non autoregulatory passive artery diameter change is
observed with an increase in flow during BP challenge after the injury compared with
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Figure 3.3: A generalised flow chart of the methodology used in the comparison of the
basic models. It also shows the loop used in the optimisation stages of the process.
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an “autoregulatory” pial artery contraction with decreasing flow. Initial consideration
of the data in the experiment has shown that multiple challenges have a detrimental
effect on the autoregulatory status of the subject which obviously affects the intact
autoregulatory side more than the non autoregulating side of the tests. So for all of
the comparison data only the first hour of data is selected before and after injury. With
the intention this should make the testing more comparable to a binary intact versus
impaired status.
Comparison Statistic
A number of comparison techniques were considered as approaches to this analysis:
Fishers exact tests, Chi-squared tests, F-measure, Matthew’s Correlation Coefficient
and ROC curves. The choice of methodology ultimately will be driven by the data set
in use. A rigorous comparison of the methodologies was performed to narrow down
and finally single out the optimal method to use as described in appendix C. From
this analysis the Matthew’s correlation coefficient (MCC) method has been selected as
the fairest model comparison test. This is based on a simple contingency table of the
frequencies of predicted against actual status.
M =
 TP FN
FP TN

Where TP , TN , FP , FN are the usual number of true positives, true negatives, false
positives and false negatives respectively. The Matthew’s correlation coefficient (MCC)
is then calculated directly as
MCC =
TPTN − FPFN√
(TP + FP )(Tp + FN)(TN + FP )(TN + FN)
There are a number of ways to compare the models using the MCC with the first
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presented being to base line the MCC against the known autoregulatory status via
the pial artery window response to BP challenge of the piglet. This will give an MCC
figure both before and after the optimisation (see below). Each of the models can
also be compare against the PRx as the widely accepted standard for autoregulatory
measurement thus allowing for a relative inter-model comparison to be performed. As
the data set in use for the comparison has well defined observational end points they
can be used as a target for optimisation.
Optimisation
Each of the models assessed have at their core a window of data over which an analysis
or comparison is occurring. For the PRx it is the amount of data used to determine
the correlation function, with the HMF it is the collected data over which the slope of
the line of the modal frequency change with time.
The modified Ursino model, while it has a window over which data is being processed,
the model itself takes this into consideration as increasing the window would only
linearly increase sampling frequency and thus merely smooth the output. Therefore
lower values would result in the model prediction being more accurate where longer
time windowed values will cause the prediction to deviate from the optimal value. The
optimisation for this model could be considered finding the point between noisy and
smoothed where the prediction is still accurate enough. However this is beyond the
scope of this analysis. For these reasons the focus is on optimising the PRx and HMF
models.
The optimisation itself is carried out using a quasi-Newton method [64] specifically the
Broyden, Fletcher, Goldfarb and Shanno implementation in R [75]. This method max-
imises the determinant (Equation 3.1) of the sensitivity specificity matrix calculated
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at a variable window size for each of the models in turn.
Det(M) = TPTN − FPFN (3.1)
The use of the determinant is merely for efficiency as there is no need to normalise this
to calculate the MCC when optimising to a maximum value. The window sizes involved
in the calculations are measured in the number of points used in the calculation.
3.3 Analysis and Results
In the case of an optimised solution to any of the models it does raise the question is
the solution optimal for the number of points in the calculation or the underlying time
windows those points would represent.
3.3.1 Optimisation of duration
To investigate this, the time base for the PRx was effectively doubled by increasing
the frequency at which the original signal was initially sampled. The optimisation was
then carried out again to see if an optimal solution could be found at the same number
of points or at twice that which, if the latter, would show that it is the length of time
which is important and not the points in the optimisation.
3.3.2 Modelling Time Effects
Initially a modelling analysis of variance (ANOVA) was performed to test whether
the time difference measured from either start of the protocol or from time of the
injury has any effect on predicted autoregulatory state of any of the models under
examination. This was done by specifying a comprehensive general linear model of
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Model AIC Weight
Status ∼ ARPred ∗ Time ∗ModelType 667.0304
Status ∼ ARPred+ Time 621.7237
Status ∼ Time 618.8410
Table 3.2: Significant factors in autoregulatory status. Showing the Akaike Information
Criteria weight reduction.
Model Baseline MCC Optimised MCC Optimised window (mins)
PRx 0.09 0.25 66
HMF 0.09 0.55 72
Ursino 0.3 n.a. n.a.
Table 3.3: Model predictive ability using MCC
Autoregulatory status (before or after injury) related to the interaction of predicted
status, time difference and finally model type. A stepwise reduction in the model
was then used to test the minimum number of factors that significantly contribute
to the autoregulatory status. This analysis showed that time difference dominates
in the model when run across the full time spectrum which can be interpreted as a
contributory effect of the BP challenges in the assessment of autoregulation (AR) status
in the model. The results shown in Table 3.2. This shows the Akaike information
criteria (AIC) [2] of a set of models, which are denoted in the standard Wilkinson-
Rogers notation [105], describing factors which may have a relationship to the known
autoregulatory status. As the AIC becomes smaller relative to the initial model the
fit to the data becomes better. If the AIC rises then the loss of that parameter would
have been in error.
Inter-model Comparison Baseline MCC Optimised MCC
PRx compared to the HMF -0.55 0.47
PRx compared to modified Ursino -0.75 n.a.
Modified Ursino compared to HMF 0.73 n.a.
Table 3.4: Intermodel Comparisons using MCC
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3.3.3 Model Comparison Pre-optimisation
To minimise the effect of this confounding effect of duration of BP challenge on model
output, the MCC was only used on the first hour of challenge from the protocol start
point. This gives the baseline comparisons as seen in Table 3.3 and inter-model com-
parisons as seen in Table 3.4. From table 3.3 the MCC results from the comparison
between the model prediction and the known autoregulatory status were for the HMF
0.09 and the PRx 0.09 while the reworked Ursino showed an MCC of 0.3. The MCC
correlation, much like the Pearson correlation r value from linear regression, ranges
from -1 to 1 where 1 is a perfect correlation and -1 is perfect correlation with an in-
verse value. The inter model comparison results from table 3.4 showed slight agreement
between the HMF and the reworked Ursino model and a general disagreement between
the PRx and both other models.
3.3.4 Optimisation Time Effects
The optimisation of both the PRx and HMF gave optimal window results of 660 and
720 points respectively. The re-optimisation of the PRx to investigate whether the
solution reflected the number of points sampled or the represented the time period
sampled gave a maximal model at 129 points which being double the previous number
of points when sampled at twice the frequency indicates that it is the time period which
is the relevant factor to optimise. This would give a final optimal value of 60 mins and
72 mins for each of those models respectively (Table 3.4). These optimal points can
clearly be seen in the graphs of window size against determinant (Figure 3.4 and figure
3.5).
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Figure 3.4: PRx model contingency table determinant vs. window size. The most
optimal window size being estimated by the highest point which may not be shown on
the figure due to the resolution of the plotted data.
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Figure 3.5: HMF model contingency table determinant vs. window size. The most
optimal window size being estimated by the highest point which may not be shown on
the figure due to the resolution of the plotted data.
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3.3.5 Model Comparison Post Optimisation
Post optimisation the baseline model comparison can be seen in table 3.3 and the inter
model comparison between the HMF and the PRx can be seen in table 3.4. Table
3.3 shows that the MCC for the PRx compared to the baseline known AR status is
0.25 and for the HMF is 0.55. Which if compared to the pre-optimisation values in
table 3.3 shows there is between a two hundred and six hundred percent increase in
predictive power after optimisation. From table 3.4 the MCC for the PRx compared
with the HMF is now equal to 0.47 a distinct improvement over the initial inter-model
comparison shown in table 3.4.
3.4 Discussion
With several models to choose from clinically, using the one which will derive the most
accurate results from the vital signs data is important, and will impact heavily on the
outcome and treatment plan for the patient undergoing the monitoring. The choice of
model in the past has relied on what was clinically collectible and which model was in
vogue at the time with no real methodology for rigorous comparison of multiple models
either against a gold-standard or compared to each other. The reasons for this are easy
to understand, as has been stated earlier, the general lack of a similar model output
and a standardised statistical test for the comparison of models.
An important step in any comparative methodology would be standardising a data
set to compare the models upon. Any data set could be used but to be fair to any
model it would have to have a number of features. Firstly it has to have a known
AR state so that you can definitively state whether the status is impaired or intact.
Secondly it has to be of a high enough temporal resolution to evaluate all of the
models, by this it is meant that if a model needs 250Hz data then minimally your
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comparative data set would have to meet this resolution so as not to disadvantage
the model under comparison. The dataset used in the study does meet these key
points making it a viable candidate for the analysis however the question could be
raised whether the end points used for comparison are correctly chosen. There is an
accepted assumption that the each of the AR models are predicting a global measure
of autoregulatory status. However, in this data set as the autoregulatory status are
derived from the pial artery response recorded via the cranial window, do cover a
relatively small area of observation with a small number of vessels being observed in
each case. This could introduce a number of complications, firstly are the vessels under
observation representative of the pial vasculature and secondly because of the small
area under the cranial window, can this sample reasonably be thought of as a global
measure of autoregulation. To address these points the method used to impair the
cerebral autoregulation in this data set [27] should be considered. This was carried
out via the fluid percussion injury model which has been used in many studies and is
considered a standard experimental method for impairing AR. It has been shown to
have a global effect on the physiology [88] even though in the collected data set it is
monitored very locally via the pial artery-cranial window methodology. The general
assumption is that the injury model is sufficient to give enough impairment to the pial
vessels to be used as an analysis target. However intersubject variability including that
of the vessel variability also needs to be considered [20].
Another key methodological issue is the choice of a comparison test. It is easy to lose
sight of the goal of a simple but accurate assessment of the goodness of fit of the models
to the data, when presented with the wide range of analysis options available in the
literature to analyse the prediction data. On closer inspection however these options
narrow to give a simple choice between only a couple of general analysis techniques.
The first and possibly most crucial piece of information that the choice of test is based
on is the output of the models, actual or surrogate, as this influences the range of tests
that can be chosen. If the AR state prediction, intact or impaired, has been chosen
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as the surrogate target then only tests on nominal data will be applicable as this is a
dichotomous set of values. As shown in appendix C a compelling case can be made, in
the case of the PRx, HMF and the surrogate G parameter from Ursino’s model, that
model comparison using the Matthews correlation coefficient is optimal.
The application of this methodology was not without its challenges. For example the
physiological dataset has missing data, artifacts and the occurrence of multiple BP
challenges to assess AR status and other experimental manipulations that will reduce
the amount of clean and usable data for the comparison. To address this point only
the data directly preceding an AR assessment challenge was taken in order to reduce
any physiological manipulation interfering with model predictions. Secondly, only data
from the first hour was used to reduce sampling recovery effects after the autoregu-
latory impairment. This is pertinent as it was identified that AR impairment shows
a clear time dependence with more intact AR assessment appearing the longer after
the fluid percussion injury (FPI) they were assessed indicating that the cerebrovascu-
lar physiology gradually recovers post fluid percussion. Once these issues had been
overcome the comparisons were assessed in two distinct ways: to the known AR status
in each data set and also compared to each other. More specifically focusing on the
comparison of each model to the PRx as this is considered the accepted AR assessment
standard.
From the results of these comparisons (Table 3.3) it is easy to see that with the initial
model configurations from their respective original papers, pre-optimisation, that the
general predictive accuracy of all of the models are quite poor. This could be attributed
in part to the data set used in respect to the inherent variability in the AR assessment
using the pial artery diameter methods but also there will be variability due to choices
made to try and reduce manipulation interference in the comparison data sampling. It
is interesting to note how little inter model association (Table 3.4) there is between the
HMF and PRx initially which does suggest that these models are predicting different
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things.
As the predictive accuracy is much lower than expected for all of these models it led to
the question whether the predictive accuracy of most of these models could be increased
by the correct choice of window over which the data is sampled and analysed.
Optimisation relies on accurately understanding what is happening in a system and
the correct choice of an optimisation target. In this case the underlying physiology of
each of the piglets and the state of autoregulation. The methodology for autoregulation
impairment has been shown already [88] to have a global effect on the physiology. Using
this AR target, intact or impaired, it was straight forward to apply the technique of
Nocedal and Wright [64] to optimise each of the models. The reason the Ursino model
wasn’t optimised along with the other two models is because the model in question is
“temporally” independent. By that I mean it will work over any temporal resolution
with the only consequence being smoothing the data set at lower resolutions. The
less data you put in to the model the less data you get out of the model. So trying
to increase the window size will only result in the window minimising to the same
temporal resolution as the original data set as this will naturally increase the number
points under consideration in the comparison and hence increase the chance of better
prediction accuracy of the surrogate target. In essence this means that the variance
of G from the Ursino model will predict more points accurately if it has more points
to work with and at its maximum that point would be a continuous estimate for the
AR state. This of course is an idealised situation as there would probably be a point
where there is more noise than signal at the extremely high temporal resolutions so it
could decrease predictive ability at the highest resolutions.
The results from the optimisation of the HMF and PRx can clearly be seen to have had
both an affect on the predictive ability of the models (Table 3.3) and the inter associ-
ation of the two models (Table 3.4). One question is whether this optimal window size
is defined by the number of points used for optimisation or is it related to the duration
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time window fixed by the data. This was tested by rerunning the optimisation with
double the sampling resolution for the PRx optimisation so it could be gauged if the
optimisation result was point based or time based. With the result being that the more
intuitive option of the optimisation is time windows dependent. These optimisation
methods have been using the data set of the six piglets as a lumped model considering
each of the piglets interchangeable with each other. To check whether this assumption
was the correct, the optimisation was run again with each determinant calculated sep-
arately for each piglet and then a median value used as the maximisation end point.
This approach provided a better approach for optimising, generating a maximal posi-
tion which was more distinct from the rest of the trend, see figures 3.4 and 3.5. The
window size however didn’t deviate significantly from what was originally calculated
in the first lumped determinant model.
With a methodology now in place for both model comparison and also optimisation
there is a need to validate this on a second prospectively collected data set. Particularly
a dataset providing a longer monitoring period post injury to allow investigation of
optimisation windows beyond two hours, which was the maximum window size possible
with the piglet data set. Application of single data set validation techniques like
the K-fold cross validation approach frequently used in neural network training and
testing wouldn’t be appropriate here because of our finding that autoregulatory status
is dependent on time post injury.
3.5 Conclusion
This work has provided a methodological approach to optimising data window size for
testing models of autoregulation. A case has also been made for the use of Matthew’s
correlation coefficient (MCC) as a method of choice for model comparison. In the
dataset we had available (Piglet data with fluid percussion injury using pial artery
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visualisation), Ursino’s physiological model performed best overall without any form of
data window size optimisation. Post data window size optimisation only the data driven
models could be compared of which Daley’s HMF model showed better performance
than the PRx model as a measure of the status of autoregulation. In view of the
observed large variation in the autoregulation status with this dataset, further model
comparison studies with other datasets and methods for testing dynamic autoregulation
are warranted.
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4.1 Introduction
Fifty percent of the years individuals spend with disability are caused by brain disease
of which brain injury now carries an equal burden to patients as do those of cerebrovas-
cular and depressive illness disorders [65]. The non-surgical management of patients
with traumatic brain injury (TBI) focuses upon the prevention of secondary insults
such as drops in arterial blood pressure (ABP) or intracranial hypertension. The lat-
ter, raised intracrainial pressure (ICP), is of particular concern as increases in ICP will
decrease cerebral perfusion pressure (CPP = ABP − ICP ) and can lead to decreases
in cerebral blood flow (CBF), ultimately leading to ischaemia and cell death. Cerebral
autoregulation is a physiological mechanism that maintains CBF constant in the face
of changing CPP although it can become impaired following brain injury [37].
A number of indirect methods for determining autoregulatory status have been devel-
oped under these conditions which can be classed as “data driven” approaches. For
example, Czosnyka et al have studied the correlation between inherent fluctuations in
blood pressure (BP) and ICP deriving an index called the pressure reactivity index
(PRx) which has been shown to relate to clinical outcome of patients and indirectly to
the degree of autoregulatory impairment [25,91].
The main limitations of general data driven approaches is that they rely on invasive
measures of physiological time-series (such as ICP) and do not provide clinically use-
ful information about the underlying mechanism for autoregulatory impairment which
would prove useful in the appropriate targeting of medical management. An alterna-
tive to the data driven approach is to base autoregulatory status assessment upon a
mathematical model of cerebrovascular fluid dynamics.
The best example of a purely mathematical model would be the class of “compartmen-
tal” models. These types of model are used prevalently in pharmacokinetics to model
drug behaviour. One of the first uses of this approach in this area was to model a near
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complete system of craniospinal dynamics [100, 101]. This all encompassing model
however was considered too complicated to be used clinically and was later refined into
a simplified form [102].
This model is only a simple two compartment model which includes: hemodynam-
ics of the arterial-arteriolar cerebrovascular bed, cerebrospinal fluid production and
re-absorbtion processes, the pressure volume relationship of the craniospinal compart-
ment and a Starling resistor mechanism for cerebral veins. Autoregulation in this model
can be thought of as a combination of three processes affecting arterial-arteriolar com-
pliance for a given percentage change in CBF. The first process is the autoregulatory
gain, the next is the static sigmoidal autoregulatory response function and the last
component is a low pass transfer function. The maximum autoregulatory gain is de-
fined to be the slope of the static autoregulatory curve at its centre point. It is from
this autoregulation gain parameter that our new model is derived. The gain parameter
G is essentially a continuous index for cerebral autoregulation. With this in mind,
Ursino’s original model has been adapted to predict G.
However one limitation in the reworked Ursino model is that it needs a measure of
arterial-arteriolar compliance which is difficult to measure in a clinical setting. In
previous testing of the model this has been approximated in the past by the mea-
surement of the arterial diameters and estimation of the volume using the physics
of a venturi flow-meter [86] or a scaled version of intracrainial pressure (ICP) pulse
amplitude [87].
A more direct non invasive method of measurement is required and transcranial impedance
measurement is a possibility. Impedance rheoencephalography is not a new method
[33]. However impedance measurements are now routinely carried out clinically as a
gauge of intra and extra cellular water content across the whole body which in turn
can be linked to the subjects’ general well being. When this technique is applied to the
cranial space the tissue impedance will depend upon intracellular swelling and the size
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of the extra cellular space and so too does intracranial compliance. As there is a well
defined exponential relationship between intracranial pressure and intracranial compli-
ance there should also be a definable relationship between raised ICP and transcranial
impedance.
4.2 Aims
This chapter aims to show the viability of a non invasive technique of measuring tran-
scranial impedance and its relationship to ICP and ICP pulse amplitude. This will be
achieved through both an experimental study in sheep and a normative study in hu-
mans. With these relationships between impedance and ICP established this provides
an approach for relating a non-invasive estimate of compliance for use as a practical
surrogate measure in the reworked Ursino Model.
4.2.1 Total body water measurement
Total body water (TBW) or whole body impedance (WBI) measurement is a measure
of the ratio of intracellular to extracellular water content. To be more precise consider
the circuit diagram, figure 4.1, the extracellular component is modelled by the bottom
leg of the diagram and the intracellular component by the upper leg of the circuit.
When an electrical signal of variable frequency is passed through a biological tissue
modelled by such a circuit the signal passes mostly through the extracellular resistor
at low frequencies but passes through both legs of the circuit simultaneously at high
frequencies due to the reduced cell membrane reactance at higher frequencies.
If the resistance and reactance is measured and then plotted on a complex plane each of
the vectors to those points will be an impedance (Z) reading (Figure 4.2). Cole-Cole
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Cell membrane capacitance Intracellular resistance
Extracellular resistance
Low frequency
High frequency
Figure 4.1: Cellular equivalence circuit for the basic path the current can take depend-
ing on the frequency of the signal.
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Figure 4.2: A basic example of an impedance plot with a Cole model fit. z¯ is the
vector of impedance the points where the circular fit crosses the axis are R0 and R∞
respectively and the turning point of the fit is zc the characteristic impedance.
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analysis [19] can then be used on these impedance measurements to estimate non-
measurable features of the system. Firstly a circular fit to the data is then made and
the resistance at infinite frequency, R∞, and zero frequency, R0, can be estimated from
the crossing points. The characteristic impedance, Zc, can also be estimated from the
turning point for the fit. From these values a TBW value is then calculated, normally
from either R∞ or Zc.
There are a number of mature technologies in clinical use which apply the above tech-
nique, Maltron Bioscan 916S [55] and the Impedimed SBF7 [43] to name two. All
of the following studies have been carried out with the latter, the ImpediMed SBF7.
This device has an operational variable frequency range of 3kHz to 1MHz and ap-
plies the Cole-Cole technique to calculate TBW values. This device has been assessed
against a normative database with claimed accuracy close to 5% compared with direct
measurement methods.
The feasibility of using this type of commercial technology for assessing transcranial
impedance has been shown experimentally in a neonatal piglet model of brain tissue
hypoxia, showing that transcranial impedance correlates well with both direct cerebral
tissue impedance and raised ICP [53].
4.2.2 The main aims of the research
There are three main questions that need to be answered to give a basis for any further
research into application of this methodology to be used as a surrogate measure of
intracranial compliance. Firstly can a normal data range for the impedance when
used “transcranially” be established in healthy normals. secondly what influence does
electrode position have upon impedance in healthy normals? Lastly can evidence be
provided that transcranial impedance relates to actual intracranial events?
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Number of volunteers 50
Gender M = 19, F = 31
Age 21 to 64 (mean 39)
Height 150 to 188cm (mean = 170)
Weight 49 to 140kg (mean = 77)
BMI 19 to 51 (mean = 26)
Head Circumference 54 to 62cm (mean = 57)
Table 4.1: Volunteer demographics
} }} }
Forehead
Temporal
Mastoid
Occipital
Figure 4.3: A representation of the impedance electrode positioning on the head. Two
electrodes are depicted per position firstly for one end of the signal generation circuit
and the second for the one end of the sensing circuit.
4.3 Material and Methods
4.3.1 Experimental protocol for the normative study
Fifty normal adult volunteers were recruited, table 4.1, with a gender split of 19 males
and 31 females and an age range of between 21 to 64 with a mean of 39. On each of
the volunteers the following electrodes were placed on the head, figure 4.3, for both the
right and left sides at the following sites: forehead, temporal, occipital and mastoid.
The skin at each electrode site was abrasively cleaned (using a gel abrasive) in order
to ensure good electrode contact. All the electrodes were put in place before any
measurements were taken, and no electrodes were removed until after all measurements
were recorded. The volunteers details (height, weight, sex and age) were input into
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the impedance device. The subject lay on their back on a bed and closed their eyes.
Measurements were then taken from each pair of electrode sites: forehead to mastoid
(FM), forehead to temporal (FT), forehead to occipital (FO), temporal to mastoid
(TM) and finally temporal to temporal (TT). Where each measurement consisted of
20 signal sweeps from 3khz to 1Mhz in 256 steps, with total sweep time taking 40
seconds.
4.3.2 Experimental protocol for the animal study
Anesthesia
Five healthy adult female Blackface sheep were used for the experiments. They weighed
between 46 and 60kg and were fasted overnight. Anesthesia was induced by intravenous
etomidate (0.5mg/kg) and midazolam (0.5mg/kg) and the animal was intubated (Size
10.5 ETT). Ventilation was commenced with a tidal volume of 50cc/kg/breathe with
100% O2 and an isofluorane concentration of 1 MAC. Bilateral auricular artery cannu-
lae were inserted for ABP monitoring, together with a saphenous intravenous cannula,
see figure 4.4. Paralysis was with atracurium (0.5mg/kg). ECG, level of muscle paral-
ysis and Endtidal CO2, inhalational agent concentrations were all monitored continu-
ously. Buprenorphine (20µg/kg) was given IV prior to surgery. During the experiment
the animal received 10ml/kg/hr Lactated Ringers solution.
Neurosurgical Preparation
Once general anesthesia had been induced and all monitoring lines inserted and sta-
bilised the head was positioned prone, in a semi-sitting position, with the cranium
supported in a dedicated head rest. Two 21G needles were inserted into the lateral
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probe (2 cm)
Figure 4.4: Schematic view of the monitoring preparation.
Figure 4.5: Actual view of the monitoring preparation.
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side of each scalp and connected to the impedance monitor for measurement of in-
tracranial impedance.
A midline incision was then made starting between the horns and going posteriorly
5 − 6cm. A self-retaining retractor was positioned and the periostium elevated to
display the junction of the metopic suture and the coronal suture. An 11mm burrhole
was then drilled on either side of the midline (centre approximately 6mm lateral to
midline) with one being centred 1cm behind the metopic suture and the other 15mm
behind it. The dura was then diathermied and opened with an 11 blade. A dedicated
ventricular catheter (Codman) was then passed into the lateral ventricle on either side.
Accuracy of ventricular cannulation was confirmed by obtaining a good quality ICP
waveform. A Hemedex (Codman) cerebral blood flow measuring probe was then placed
in the brain parenchyma on the right side and a laser doppler flow probe on the left side
through the burrholes. All monitoring lines were secured to the scalp using 2.0 Silk.
The burrholes were then covered with chopped Surgicel (Johnson and Johnson) and
filled with cold setting methylmethacrylate cement to make them water tight.
ICP and arterial pressure manipulation and recording
The arterial blood pressure was elevated using an infusion of phenylephrine (10mg)
and adrenaline (200µg) mixed in 500ml normal saline. The ICP was elevated with
an infusion of mock cerebrospinal fluid (CSF) into the opposite ventricular line to
that used for the ICP monitor. All ABP and ICP monitoring was carried out via
a Spiegelberg Compliance-Monitor CMP 27.1 instrumentation amplifier. From these
monitors continuous waveform recording was carried out to a computer harddrive,
figure 4.6. The experimental protocol was carried out in two distinct sections pre and
post autoregulatory impairment. With the same main protocol steps being carried
out in each run: Firstly readings of all monitored parameters (blood gases, ICP, ABP
and Z) are taken and a baseline measurement of static autoregulation status via a BP
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Figure 4.6: Monitoring equipment used in the study.
challenge was recorded. Then a stepped increase in ICP of 10mmHg was performed
and all parameters measured again, this sequence was then repeated from baseline
to highest achievable ICP level which was approximately 50mmHg. Next normal
cerebral autoregulation was disrupted through a period of prolonged systemic arterial
hypertension (MAP > 150mmHg for 10 minutes) and the main sequence of actions
carried out again between an ICP of 10− 50mmHg.
Removal and examination of the brain
At the end of the experiment the animal was sacrificed with a lethal dose of pentobar-
bital. A craniectomy was then performed and the brain removed and placed in 10%
Formalin. After 48 hours fixation it was cut coronally and the parenchyma assessed
for intracerebral contusion or hemorrhage, and the ventricles for evidence of any intra-
ventricular hemorrhage. In all of the brains that were inspected post-mortem by an
CHAPTER 4 86
Electrode Position Male Range Female Range
Forehead to Mastoid (FM) 65.8± 15.0 98.8± 47.2
Forehead to Occipital (FO) 72.7± 15.6 88.2± 12.9
Forehead to Temporal (FT) 60.3± 16.3 89.0± 35.9
Temporal to Temporal (TT) 58.2± 24.2 78.0± 17.9
Temporal to Mastoid (TM) 41.7± 12.2 70.2± 55.2
Table 4.2: Normative ranges (mean± sd) for the characteristic impedance per electrode
position
experienced neurosurgeon, nothing out of the ordinary was observed. These inspec-
tions while cursory and only done macroscopically by eye, were felt to be sufficient
to be indicative of a viable experimental subject and hence the continued use of the
dataset.
4.4 Results
4.4.1 The normative study
For this study the mean of the characteristic impedance value, Zc, was taken across
each of the 20 readings per electrode position per volunteer. Firstly an analysis of
variance approach was applied to the data assessing the model dependence upon elec-
trode placement, gender and whether the measurement was taken on the left or the
right side of the head. This showed that there was no side to side bias in the data
but there were highly significant (p < 0.001) influences by both gender and electrode
position. Further investigation with a Tukey multiple comparison test then showed
that the temporal to mastoid reading had a significantly lower mean value than the
rest of the electrode placements. The gender split was then shown to have the female
impedance readings higher than their male counterpart on all electrode positions. The
main normative range is shown in table 4.2and illustrated in figure 4.7.
CHAPTER 4 87
ZC
m
ea
n
0
50
100
150
FM FO FT TM TT
Female
FM FO FT TM TT
Male
Figure 4.7: A box plot of the characteristic impedance per electrode position split by
gender. The plot shows the difference in the temporal-mastoid (TM) group.
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Figure 4.8: Plots per ICP level of the impedance versus frequency. Each colour repre-
sents a different animal.
4.4.2 The experimental study
For the animal study the data were analysed using a repeated measures analysis of
variance (ANOVA) which looks at both within subject and between subject interactions
in the model and accounts for any multiple sampling error that could occur. This
analysis looked at the variance difference in the mean impedance value per animal per
ICP step level, between 10 − 50mmHg in steps of 10mmHg. The impedance values
against their respective frequencies are shown in figure 4.8. This showed there was a
statistically significant difference (p < 0.007) in these values per level. There is however
a large inter animal variance in the data which is present at all ICP levels.
The absolute relationship between ICP and impedance has also been explored. To
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Figure 4.9: Regression plot through the mean normalised impedance per animal against
ICP with confidence intervals shown as a dashed line and prediction intervals shown
as a dotted line.
minimise the aforementioned variance in the data a normalisation technique was applied
to the impedance data which included dividing each value by the mean of a subset of
the data at the beginning of the set. This adjusts the output range of the independent
experimental samples into similar ranges which can then be directly compared through
adjusting the impedance for the animals baseline state. The mean value of this now
normalised range was then taken per ICP level giving an overall summary for that
ICP value. This was then plotted and the best fit simple exponential model ICP =
exp(a/Z + b) fitted to this data, see figure 4.9. This gives an r-squared correlation
of 0.7 and where a = 16.225 and b = −12.967. As can be seen in figure 4.9, there
is a relatively constant set of regression limits with respect to the model, this adds
CHAPTER 4 90
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
0.95 1.00 1.05 1.10
2
4
6
8
10
Normalised Z
IC
P 
pu
lse
 a
m
pl
itu
de
Figure 4.10: Regression plot through the mean normalised impedance per animal
against ICP Pulse amplitude with confidence intervals shown as a hashed line and
prediction intervals shown as a dotted line.
confidence that the model is correct for the given population and that any prediction
based the collected data will follow the proposed model.
To make this result more practical the analysis was revisited, but this time the rela-
tionship between impedance and ICP pulse amplitude was studied. A similar process
was carried out to the previous study where the impedance values were normalised
by a division by the mean of a subset at the beginning of the data. The same model
was then fitted to the data ICPamp = exp(a/Z + b) which yielded a = 12.059 and
b = −11.079. However the ICP pulse amplitude has more variability which results in
a fit of only r = 0.24. This model is shown in figure 4.10 in which the variability can
easily be seen in the widening predictive and confidence limits of the model.
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4.5 Discussion
From the normative study analysis it has been shown there is a distinct placement
effect for the temporal to mastoid electrode position measurement. Why this electrode
pair position is so different to the others is most likely due to the current path length
being considerably shorter for this electrode set compared to the other position pairs
and thus more likely that more current flow is extracerebral rather than intracerebral.
So in general any electrode set chosen for this type of measurement needs to have a
long enough path length and by inference needs to cover a large enough part of the
cranial space to ensure a stable intracerebral impedance value. This placement effect
is also highlighted again in the animal study where the large inter-animal variance in
the temporal to temporal electrode set is likely to be caused by placement differences.
With the better understood landmarks for the human head this variance seen on the
sheep should not be so prevalent in any further clinical studies.
It was also demonstrated from the normative study that there was no side-side bias
which has a two fold application, firstly, by merging the left and right electrode position
data, it effectively doubles our dataset per volunteer and yet keeps open the possibility
to test for side to side differences due to midline shift in future studies. However, despite
establishing a normative base-line for transcranial impedance these normative studies
do not really answer the question whether this technique actually relate impedance to
ICP and indirectly to compliance.
In the sheep study, the first of the five animals data were removed from the dataset
as they were found to be physiologically unstable with an assumed infection. This
made interpretation of the impedance data difficult, as all data values for this animal
were a factor of 10 higher than the maximal point on all other animals. So it was
deemed reasonable to exclude these outliers from the analysis. The remaining data
clearly shows that there is a definable, reproducible exponential relationship between
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Figure 4.11: The flow chart showing the influence knowledge of vessel diameter and/or
ICP wave form amplitude has on the chosen surrogate methodology now including the
impedance methodology.
transcranial impedance and ICP or to a lesser extent ICP pulse amplitude. This
has established the feasibility of using transcranial impedance as a surrogate measure
of intracranial compliance as needed by the Ursino model. This would modify the
surrogate measure flow chart, figure 2.3, in chapter 2 to be as shown in figure 4.11.
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4.6 Conclusions
In general it has been shown that the cerebral impedance measurements are a viable
and practical clinical technique and that it shows promise as a non invasive measure
of ICP and its related parameter ICP pulse amplitude. A clinical study directly com-
paring transcranial impedance with invasive ICP will be required before a conclusive
decision can be made on its use beyond the research domain. A normative range for
transcranial impedance has been established, with a gender bias of higher impedance
for females. Practically, any electrode positions that includes a large enough volume
of the cranial space have been identified with forehead to occipital or temporal to
temporal being the obvious choices. The dependence of Impedance measurement on
ICP has been established and the absolute relationship between these two parameters
has started to be explored. However further work is needed to identify which physical
and physiological factors need also be measured to provide a more stable and robust
measures of transcranial impedance.
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5.1 Introduction
Over the last two decades analysis techniques are moving from classical stochastic
process analysis using basic statistics to more nonlinear systems or chaos theoretical
based approaches which are looking at patterns in the variability of the time series. It
has been shown that physiological time series exhibit complex multi-fractal properties
[8]. So by designing a classification and analysis based on this nonlinear and chaotic
nature of the time series we should be able to detect changes and alterations in the
underlying physiological processes. To this end two different analysis scenarios were
tested to gauge the feasibility of the technique, this is followed by a study of a noise
reduction technique using wavelet thresholding. The first of the feasibility studies looks
at the raw intracrainial pressure (ICP) wave form and characterising the fractal nature
of a trending function itself based upon a windowing function of the raw waveform
data over time.
5.2 Aims
The main aims in this chapter is to investigate a chaos based modelling technique which
characterises physiological signals using a fractal summary measure and then to use
this measure as an estimate of non physiological noise in the original signal allowing it
to be removed via a modified hard thresholding wavelet smoothing technique. Initially
the idea of fractal characterisation is defined and explored through two analyses looking
at global and trending characterisation of a stable and unstable ICP signal. Then the
noise reduction aspects of the chapter are assessed via comparison to a standard noise
reduction technique.
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5.3 Materials
Twenty randomly selected ICP waveforms from the BrainIT dataset [74] were stud-
ied for feasibility of the fractal analysis then the method applied to all of the Daley
dataset [26] towards assessing its potential for reducing noise in the variability of the
autoregulation (AR) index G derived from the Piglet dataset. The R [75] statistical
package was used exclusively for algorithm implementation and analysis.
5.4 Methods
5.4.1 Wavelet transforms and fractal derivation.
The main idea used in the initial analysis and fractal characterisation of the wave form
leverages the relationship between the mathematical properties of a wavelet transform
and a signal’s localised fractal nature.
Wavelets [63] can be thought of as a time-frequency analysis technique analogous to
a Fourier transform but without the inherent frequency related problems of the latter
approach. This is mitigated by the fact the convolution is carried out with a scaling
factor and a translational factor applied to the convolving function. Like Fourier trans-
forms they can either be continuous or discrete the former implying that all scales are
calculated the latter only integer scales are calculated. The actual transform is carried
out via equation 5.1.
Wf(s, b) =
1
s
∫ ∞
−∞
f(x)ψ
(
x− b
s
)
dx (5.1)
This is a scalable convolution with the ψ() function being called a mother wavelet
function and a scaled “s” and translated “b” variant of it known as a daughter function.
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Figure 5.1: The basic stages of the characterisation technique a) Original ICP wave
form, b) A 2d Wavelet Modulus Maxima Transformation of (a), c) A 3d representation
of (b) and finally d) Ridge Extraction from (b) which selects the maximal points that
have a discontinuous transition from those points around it.
In all of the later tests a Mexican hat wavelet mother wavelet (5.2) was used
ψ(p) = (1− p2)e− p2 (5.2)
which is the second derivative of the Gaussian function. Figure 5.1 is an example
analysis using the above mother wavelet function on an ICP wave form.
Mandelbrot [56] defines a fractal as self similar signals repeating at different scales
within the same signal. He also defines the Hurst exponent as a way of characterisation
of the scaling properties of the signal that then can be thought of as an overview of the
whole signal. However as we are interested in the signal on a more localised level, there
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is a related value known as the Ho¨lder exponent [84]. This essentially characterises the
singularities of a signal at a single scale level. Where a singularity is defined to be a
discontinuity in a signal where the differential of the signal is not continuous at that
point. It can be shown that via the Taylor expansion [93] of the wavelet transform that
equation 5.3 holds over the set of all singularities of the time series.
Wf(s, x0) ∼= |s|h(x0) (5.3)
Where x0 is the set of all singularities, h(x0) is defined to be the Ho¨lder exponent of
the singularity at x0. However calculation of h by using the full continuous wavelet
transform is not efficient. If instead an optimised partitioning function and a counting
argument [93] the “local” Ho¨lder exponent can be calculated at a much reduced cost
in time and complexity.
Firstly the wavelet modulus maxima transform (WMMT) is performed and then the
ridges are extracted from this view [84]. This ridge representation of the signal is all
that is required to calculate the local Ho¨lder exponent; this should make the analysis
more efficient as no redundant information needs to be processed. This form is in fact
a representation of all the singularities in the signal. (Figure 5.1b, Figure 5.1d). Then
by using a partitioning function, 5.4, over the set of all singularities Ω(s) at a given
scale s
Z(s, q) =
∑
Ω(s)
Wf(ωi(s))
q (5.4)
we can define the mean wavelet transform value of all singularities at that scale s to
be equation 5.5.
M(s) =
√
Z(s, 2)
Z(s, 0)
(5.5)
Finally, the mean Ho¨lder (h¯) is then calculated by solving for the slope of the straight
line function 5.6.
log(M(s)) = h¯ log(s) + C (5.6)
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Figure 5.2: Schematic diagram of the relationship between the physiology, fractal char-
acterisation and the signal produced.
It can then be shown [93] that the local Ho¨lder exponent at scale s is calculated by
equation 5.7
hˆsSLslo (s)
∼= log(Wf(slo))− log(M(s))
log(slo)− log(sSL) (5.7)
where slo is the minimum scale used and sSL is the sample length.
This paradigm can be understood in terms that the waveform signal is caused by the
physiological system and this signal contains fractal content or information which is
directly related to the underlying physiology (Figure 5.2). This implies that changes
to physiology will directly alter the signal and hence the information contained within.
By using the above analysis techniques we gain an overview of this fractal information.
To test these ideas, two general applications of the above method are presented; Firstly
a global signal overview by looking at local Ho¨lder distributions and secondly a more
localised view of the data looking at the trending of the mean Ho¨lder exponent.
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Figure 5.3: Comparison of a stable (a) and a changing (b) local Ho¨lder exponent
distributions shown over all scales.
5.4.2 Basic feasibility studies
This first methodology can be thought of as an overview of the waveform signals local
Ho¨lder exponent. Such a global look at the nature of the singularities of the time
series should present a snap shot of the underlying physiology across the time range an
approach akin to a “fingerprint” of the signal. ICP wave form data from a single patient
was sampled from the BrainIT database and was split into a number of equal lengths:
a “stable” segment where the signal remains relatively steady and the amplitude of the
number of singularities remain low and a “changing” section, where the signal becomes
more unstable and the amount and amplitude of the signal singularities increases. The
local Ho¨lder exponent calculated for each of these sections and the distribution of the
local Ho¨lder exponent was then plotted and analysed over all scales (Figure 5.3).
The second analysis technique to be applied looks at the change or trend in the mean
Ho¨lder calculation over the full time course of a signal. It can be thought of as a moving
window approach, similar to a moving average, to viewing the Ho¨lder exponents of a
signal. This should represent the time course of changes in physiology of the patient.
Again six ICP wave form signals were randomly sampled from the BrainIT dataset and
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Figure 5.4: An example of an ICP signal (a) and corresponding mean Ho¨lder exponent
trend (b).
these were then cleaned and a moving data window approach was used to allow the
repeated application of the mean Ho¨lder function along the time course of the original
signal. The window size used for this analysis was 200 minutes with a 100 minute
overlap. The choice of this window size was arbitrarily defined by the signal length
from previous testing. Once this approach was applied to the signals a linear regression
was applied to give an overall trend for the calculated mean Ho¨lder exponents (Figure
5.4).
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5.5 Fractal characterisation as a noise estimate
5.5.1 Wavelet noise reduction
As the Ho¨lder exponent is an estimate, per scale level, of the physiological content of
the signal it can be used to dampen the noise using a classical wavelet noise reduction
algorithm. At the heart of any wavelet noise algorithm is the wavelet transform, see
equation 5.1, which decomposes a signal into a number of different scales and resolu-
tions. Within the original signal most of the lower frequency portions of the signal will
contain the overall trend of the original waveform and the higher frequency components
will contain more of the noise along with any detail for the signal. When the wavelet
transform is applied to the signal these frequency bands separate out and they then
can be filtered individually to tackle any noise contained within. The second important
fact is that wavelet decomposition transforms white, or gaussian, noise into white noise
making it invariant under transform [29]. This is important if only noise is to be re-
moved when executing the algorithm because the underlying signal will be transformed
but the noise will remain the same so any removal will do so in both domains.
In general the process of using wavelets to reduce the noise in a signal typically fol-
lows these steps: Initially the noisy signal is decomposed via a wavelet transform from
which the level of noise is then estimated. From this estimate a threshold is computed
and then applied to the transformed signal after which it is then reconstructed using
an inverse wavelet transform resulting in a signal which has had the noise compo-
nent reduced [30]. The concept of thresholding is typically associated with the higher
frequency components which after decomposition can readily be separated and once de-
tected a measure (threshold) of the noise content calculated. Following this, when the
signal is reconstructed, any signal above the threshold (noise) can be easily removed.
When you reconstruct this altered signal there will be no noise above the threshold re-
sulting in a less noisy signal overall without losing important physiological information.
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There are two types of thresholding in common use in wavelet noise reduction. The
first is hard thresholding which is what has been described previously and is essentially
setting any values that are considered noise to zero before reconstruction the second is
soft thresholding this is where the noise is set to zero and the signal reduced to make
it continuous from the zero level boundary. This second method has application in
image processing where discontinuities are easily spotted so reducing the hard change
between the original signal and where the noise has been removed is advantageous in
this context. However within the context of a physiological signal processing this in this
way is unwanted as any reduction in the reconstructed signal will change the meaning
significantly.
5.5.2 Noise estimation
Where fractal characterisation can play a role in this process is in the estimation portion
of this algorithm. From Donoho and Johnson 1994 paper [30] the noise threshold should
be calculated as equation 5.8.
t = σ
√
(2 log (d)) (5.8)
Where d is the number of wavelet coefficients in the lowest frequency decomposition.
This is intended to preserve the actual signal and find the level at which the correct
signal degrades into noise. From Donoho et al’s later 1995 paper [29] they give an
estimate for the standard deviation σ derived from the median absolute deviation
(MAD)
σ =
1
kw
median(|wi|) (5.9)
Where kw is constant equal to 0.6745 and wi are the wavelet coefficients again from
the lowest frequency decomposition. This calculated threshold will only estimate a
threshold based on the amount of information in the low frequency portion of the
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signal. However the Ho¨lder exponent may allow for a more tailored estimate of the
noise across the whole signal and hence a better estimate of an optimal noise threshold.
From equation 5.3 the relationship between the complete wavelet transform and the
exponent can be seen, more importantly the wavelet coefficients can be generated by
knowing the scale level and points of singularity within that scale. So if we firstly apply
equation 5.8 to equation 5.9
t =
1
kw
median(|wi|)
√
(2 log (d)) (5.10)
Then by applying this to only the coefficients generated by calculating the local Ho¨lder
exponent from equation 5.7, and then using these to calculate a set of wi from equation
5.3, we will end up with a tailored threshold for a specific scale level based on the fractal
characterisation of the signal at that scale level. This ultimately means that it can be
applied over all scale levels not just the low frequency levels of the original paper.
Which implies that it should cope with high frequency signals mixed in with the noise
as well.
5.5.3 Assessing the wavelet technique against other common
filtering approaches
Before carrying on with this analysis of this wavelet technique and its application to
the Ursino model. It should be examined in the context of other noise reducing filters
that are commonly used in signal analysis. To this end a simple comparison has been
designed with a common Butterworth filter. The Butterworth filter [82] has a number
of interesting properties: firstly it has a maximally flat frequency response at the point
where part of the signal is retained that makes it well suited for use in noise reduction.
Secondly it is easily adapted from one filter type to another, for example going from a
low pass filter, that is one which allows low frequency signals to pass and removes high
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Type Approximate Frequency (Hz)
Cardiac 1.3
Respiratory 0.25
Slow wave <= 0.1
Table 5.1: Basic harmonic frequencies found in a normal ICP signal.
frequencies to a high pass one that is a filter that allows only high frequency signals to
be retained.
To understand fully why the noise reduction comparison parameters and especially
those associated with Butterworth filter are valid it is important to explore the fre-
quency breakdown of ICP. Using a standard fourier methodology to create a peri-
odogram for a normal ICP waveform, that is one which is at a base resting state in
a healthy individual, it is expected to see a fundamental cardiac frequency at approx-
imately 1.3Hz with the other major frequencies shown in table 5.1. It is commonly
accepted that a physiological pressure wave is well represented by considering a maxi-
mum of 10 harmonics of the fundamental. Thus if we take a worst case of 120 beats per
minute heart rate, which is 2Hz, then to faithfully represent the blood pressure (BP)
signal would require a bandwidth of 20Hz. Assuming 5 times oversampling to avoid
aliasing artifacts than a sampling rate of 100Hz is appropriate. As the major frequen-
cies in the ICP signal are all less than what the butterworth filter has been designed
to filter this will ensure that none of the frequency components of the original signal
are lost during processing. In general filters also affect both the amplitude and the
phase of the returned signal compared to the original and this generally has to also be
considered. A Butterworth filter was originally created to be “maximally flat” which
means that the amplitude response in the part of the signal it passes should not be
affected but there will be a slight phase variance in the returned signal at frequencies
close to the cutoff frequency of the filter. For the purposes of this comparison the phase
response of the filter should not disadvantage it against the wavelet technique.
To examine the performance of the wavelet technique an ICP signal was extracted
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Figure 5.5: Plot of the evaluation stages of the noise reduction techniques where (a) is
the Wavelet technique and (b) is the butterworth filter. On the upper panel of both
plots is the raw ICP signal, in the centre is the raw ICP signal with noise added finally
on the lower panel is the reconstructed wave after the specific technique has been
applied. Each of the techniques are assessed via comparison to the original signal.
Noise reduction technique Pearson correlation Confidence Interval
Wavelet 0.83 (0.78, 0.86)
Butterworth 0.75 (0.71, 0.79)
Table 5.2: The two noise reduction techniques correlation with the original ICP signal.
from an experimental dataset. Normally distributed random noise was generated with
a mean of zero and a standard deviation of one. This was then added to the ICP
sample to give a measurable and consistent amount of additional gaussian noise on the
ICP trace. As this ICP signal was recorded at 100Hz and the noise was added one
to one with the signal a butterworth filter was constructed to remove all noise above
200Hz. The wavelet technique will estimate the variance as shown above.
Each of the noise reduction techniques were applied to the original ICP signal and
the results are shown in figures 5.5a and 5.5b. The reconstructed signals were then
compared to the original ICP signal. The results can be seen in table 5.2, the wavelet
techniques gave a correlation of r = 0.83 with a 95% confidence interval of (0.78, 0.86)
and the butterworth filter had a correlation of r = 0.75 with a confidence interval of
(0.71, 0.79).
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Figure 5.6: An example of the wavelet noise reduction technique applied to the re-
worked Ursino model.
Both of these results are quite close to one another but the wavelet technique has a
slightly better correlation. This is not the only advantage this technique offers, over the
Butterworth filter in addition, the fractal characterisation is fully automated. By that
I mean the noise estimate is deterministic and therefore repeatable. While techniques
do exist to estimate a required frequency cutoff [31] of the Butterworth filter it is
normally done manually which is an issue if this technique is to be used in a more
clinical setting.
5.5.4 Application to the reworked Ursino model
The usefulness of this noise reduction technique can be assessed by applying it to the
reworked Ursino model (Chapter 2) where its ability to optimise the prediction process
by suppressing the amount of ancillary noise in the output and thus allowing the actual
predictions to become more prominent. Using the Ho¨lder addition the wavelet noise
reduction algorithm was applied to the Daley dataset, an example of the resulting
smoothed signal can be seen in Figure 5.6. But to test this more fully, 200 random
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Model MCC Confidence Interval
Original 0.06 (-0.04,0.16)
Wavelet 0.21 (0.11,0.3)
Table 5.3: Predictive accuracy for both the original model and the wavelet smoothed
variant.
samples were selected from the dataset, before and after autoregulatory impairment
and the MCC calculated for both signals and the confidence interval estimated using
the Fisher’s z approach. The results can be seen in table 5.3.
5.6 Discussion
For the first analysis looking at the distributions of the Ho¨lder exponents between a
stable and unstable ICP signal, as can be seen from (Figure 5.3) there is not much
if any separation in the distributions and this is representative of all samples tested.
This is not totally unexpected as the differences in the ICP waveforms tested between
stable and changing signals are not significantly different mathematically. These types
of signals are minimally deterministic, that is they have both deterministic and random
processes [76] effecting them so are less likely to have greatly different fractal “infor-
mation” content. If this is the case then this technique should be then aimed at more
deterministic signals such as looking at ICP B-wave activity in the ICP trend.
In the analysis on trending of the mean Ho¨lder it can be considered to be inversely
proportional to signal fractal information content. However quantification of this is
difficult as we would need an independent measure of the signal stability to statistically
compare it with the trend gradient. That said over all the samples tested the gradient
does show a predictive ability (Figure 5.4) where it can be seen that the decreasing
trend in the Ho¨lder exponent appears to precede a marked increase in ICP instability
and ICP pulse amplitude. The technique itself with the moving window application of
the function needs more study to find the optimal size for the window measured and still
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provide enough signal to accurately represent it with the mean Ho¨lder exponent.
Finally, the most useful application of the localised Ho¨lder exponent is in a noise
reduction capacity. The addition of the Ho¨lder exponent as a measure of the signal
content allows for a more tailored noise reduction than the “standard” noise estimation
methodologies. This can be seen in the 350 percent increase in predictive accuracy
however I feel further study of this may be warranted as the confidence intervals are
quite large by comparison.
5.7 Conclusion
It has been shown in this chapter that the new noise reduction technique which mixes
the new fractal characterisation of the physiological system and a classic wavelet
smoothing technique is both a viable and practical alternative to more conventional
signal processing techniques. This has resulted in a 16 percent improvement over the
comparable alternate Butterworth filter method and a 350 percent improvement over
the base model. Overall this pilot study has only scratched the surface of possible
areas in which these techniques may find application. Further research is required to
study the implications of the links between the physiological systems and the fractal
information content of the signals they contain. In the context of cerebral autoregu-
lation research, fractal methods will find application in processing model output and
with removing non-physiological noise from these signals.
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6.1 Introduction
Cerebral autoregulation, as has been stated previously, is the process by which cerebral
blood flow (CBF) is maintained relatively constant over a specific cerebral perfusion
pressure (CPP) range. This has been shown to have a relationship with outcome using
other models of autoregulation [23] which raises the question does the reworked Ursno
model relate to clinical outcome in a similar fashion?
While direct comparison of the three models (pressure reactivity index (PRx), highest
modal frequency (HMF), Ursino) relationships to outcome would be preferable this is
unavailable at this time due to limitations in the dataset, namely lack of the temporal
resolution required to accurately execute both the PRx and HMF models, so only the
reworked Ursino will be assessed at this time.
To evaluate the reworked Ursino model’s relationship to outcome the performance of
the new model was tested firstly, directly against clinical outcome, secondly, when
combined with other clinical prognostic factors and finally to analyse its trend over
time to quantify how the level of autoregulation changes temporally post-injury.
6.2 Aims
With any new clinical model the question will arise of whether this new parameter
will add to the existing domain knowledge. To explore this, this chapter outlines work
investigating the relationship between the new model output to a model of clinical
outcome.
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6.3 Methods
As was shown in chapter 3 cerebral autoregulation in the original Ursino et al’s model
can be thought of as a combination of three processes affecting arterial-arteriolar com-
pliance for a given percentage change in CBF. It is from this continuous index for
cerebral autoregulation G that the new model is derived. With this in mind Ursino’s
original model has been rearranged to predict G. In the validation of the new model it
has been found that the variance of the G parameter is a closer predictor of autoregu-
lation [87].
As with previous testing of the model the relative change in arterial-arteriolar volume
has to be considered. This has been done in the past with the measurement of the
arterial diameters and estimation of the volume using the physics of a venturi flow-
meter [9]. This time however as there were no arterial diameter parameters available,
the intracrainial pressure (ICP) pulse amplitude technique was used as an estimate
for this parameter. As has been shown in chapter 2, this is a reasonable approach
to consider as there is good evidence that ICP pulse amplitude relates to intracranial
compliance (CIC) and that CIC can be related to arterial-arteriolar volume (Va).
6.4 Analysis
Twelve patients were sampled from the BrainIT database [73] with measurable ICP
pulse amplitude, it required patient’s with monitoring systolic and diastolic ICP values,
and had a good spread of clinical outcome as measured by the extended Glasgow
outcome scale (GOSe) [45]. This is an eight point scale, shown in table 6.1, which gives
a measure of the recovery process. It is based on the earlier Glasgow outcome scale
(GOS) [44] and is normally assessed via a structured questionare [106]. The GOSe has
become the gold standard measurement in clinical practice for outcome measurement
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Score Meaning
1 Dead
2 Vegetative state
3 Lower severe disability (completely dependent on others)
4 Upper severe disability (dependent on others for some activities)
5 Lower moderate disability (unable to return to work or participate in
social activities)
6 Upper moderate disability (return to work at reduced capacity, reduced
participation in social activities)
7 Lower good recovery (good recovery with minor social or mental deficits)
8 Upper good recovery
Table 6.1: Extended Glasgow Outcome Score (GOSe) and associated meaning
in patients with traumatic brain injury (TBI). The GOSe also compares well to other
scoring systems [52,107] which are in use in this population of patients.
Using the new model, the absolute value of G was calculated for the full patients mon-
itoring time course. The data for each of the patients was then split into three equal
time periods (early, middle and late) and the variance of G in each period calculated.
Patients were then grouped by a dichotomised GOSe (“good outcome” GOSe > 4 and
“poor outcome” ≤ 4). The outcome sets for the late time period were then compared
to each other time period using a one sided Student’s t-test. These late periods were
considered as they should show the greatest accumulative effect of autoregulatory state
on the outcome. This analysis was used to test if impaired autoregulation was rep-
resentative of poor outcome, specifically that the mean variance was greater for poor
outcome than good outcome.
Secondly the twelve patients were reanalysed with respect to outcome but in this case
the time period being considered was only during the first 48 hours post-injury as this
can be considered more clinically relevant. The model was then augmented to include
some of the more classical prognostic factors such as age, sex, Glasgow coma scale
(GCS) motor scores previously shown to influence clinical outcome (GOSe). One of the
latest predictive models for outcome in a head injured population, the International
Mission for Prognosis and Clinical Trial design in TBI (IMPACT) study, was used
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[54, 59] and those international mission for prognosis and clinical trial design in TBI
(IMPACT) parameters which were available from the BrainIT dataset for the original
twelve patient dataset were included and then the outcome analysis was performed
again. The new IMPACT model has a distinct similarity in the final model parameters
chosen with a number of older outcome studies [18, 41, 42, 90, 92]. Out of all the
parameters, age and GCS motor score on admission, were included in all models as they
have a high predictive value against outcome [40]. A stepwise regression technique [104]
was then applied on this model to assess how much of a contribution to the model
outcome the autoregulatory index gave.
The time course of autoregulation was also looked at over the duration of stay in all
patients. The length of stay was divided into ten distinct segments which will allow
a consistent overview of each of the time courses. These patients were then grouped
by their dichotomised GOSe thus allowing comparison of the basic trend. var(G) was
calculated for each of these sections and a median value was then taken across all
patients in each of the ten time groups, giving a ten point trend of autoregulatory
status over each patient.
6.5 Results
The general model output for all patients in the study is shown in table 6.3. With the
basic demographics of the patients given in table 6.2.
The results of the first analysis (Figure 6.1a) using a one sided t-test showed that there
was a significantly greater mean variance in the parameter G for autoregulation in the
poor outcome set compared with the good outcome set(p = 0.033). The results of the
second analysis (Figure 6.1b) using a one sided t-test showed that the mean variance
wasn’t significantly greater than the other time-points (p=0.871).
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Patient ID First 48hrs var(G) Percentage Late var(G) GOSe Outcome
04027262 1.325984e+03 1.428077e+02 1 poor
04816150 1.327917e+01 1.039321e+00 8 good
16137372 9.197743e+01 2.557953e+00 7 good
26248362 3.003330e+00 3.042090e+02 4 poor
27240484 2.448823e-03 3.028827e-03 1 poor
38351504 1.851523e+01 8.296829e+01 1 poor
48355050 6.402678e+00 2.089445e+02 1 poor
51573727 4.048400e+03 1.908241e+01 1 poor
61683383 5.619044e+01 8.150098e-05 8 good
73684838 2.712204e-02 1.220374e+00 1 poor
83815161 8.383307e+01 4.652178e+01 5 good
84861515 2.074122e+00 2.817550e-01 8 good
Table 6.2: Summary of var(G) for the first 48 hours and for the last third of the patients
stay.
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Figure 6.1: A comparison of the autoregulatory index dichotomised via “good” and
“poor” outcome groups in both (a) the “late” period analysis and (b) the first 48 hour
analysis
Model AIC Weight
Outcome ∼ Age ∗ Sex ∗GCSEye ∗GCSMotor ∗ ARIndex 22
Outcome ∼ Age+GCSEye+GCSMotor + ARIndex 10
Outcome ∼ Age+GCSEye+GCSMotor 8
Table 6.3: Akaike Information Criteria weight of each reduction step of the predictive
model
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Step Model Component Removed
1 Base Line Model (Nothing Removed)
2 −Age : Sex : GCSEye : GCSMotor : ARIndex
3 −Sex : GCSEye : GCSMotor : ARIndex
4 −Age : GCSEye : GCSMotor : ARIndex
5 −Age : Sex : GCSMotor : ARIndex
6 −Age : Sex : GCSEye : ARIndex
7 −Age : Sex : GCSEye : GCSMotor
8 −GCSEye : GCSMotor : ARIndex
9 −Sex : GCSMotor : ARIndex
10 −Age : GCSMotor : ARIndex
11 −Sex : GCSEye : ARIndex
12 −Age : GCSEye : ARIndex
13 −Age : Sex : ARIndex
14 −Sex : GCSEye : GCSMotor
15 −Age : GCSEye : GCSMotor
16 −Age : Sex : GCSMotor
17 −Age : Sex : GCSEye
18 −GCSMotor : ARIndex
19 −GCSEye : ARIndex
20 −Sex : ARIndex
21 −Sex : GCSMotor
22 −Sex : GCSEye
23 −GCSEye : GCSMotor
24 −Age : GCSEye
25 −Age : GCSMotor
26 −Age : Sex
27 −Sex
28 −Age : ARIndex
29 −ARIndex
Table 6.4: The set of terms removed from the original model by the stepwise reduction.
Where a term name is shown as standard italic text and x : y means x interacting with
y in the model. With greater influence being shown by a larger step number, although
not enough to remain in the final model.
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The next analysis results are shown in table 6.3 and in table 6.4. Using the Akaike
information criteria (AIC) relative reduction weights to find the best fit showed that
Outcome ∼ Age + GCSEye + GCSMotor was the best model. However it should be
noted that from the actual reductions (table 6.4) that both the autoregulation (AR)
index and the AR index’s interaction with age were the last to be removed. Indicating
that they have a more significant model contribution than any of the other removed
parameters. However not enough contribution, on this dataset, to warrant inclusion in
the final model.
Figure 6.2 shows the pilot data trending G for a patient with good outcome and one
with bad outcome. These autoregulatory time courses are quite variable and as such not
conclusive but it is interesting to note that the overall trending may also be predictive
of outcome.
6.6 Discussion
The first analysis was statistically significant showing that there was a good correlation
between the reworked Ursino model outputG with clinical outcome over the later stages
of stay in the intensive care unit (ICU). Though the numbers of patients analysed
was small these results warrant further investigation with larger numbers of patients.
When analysed by looking solely at the last third of the stay there is a strong statistical
difference (p = 0.034) between the good and bad groups using a t-test. This suggests
there is a definite temporal link with outcome via the degree by which the groups
separate then diverge as the length of stay for the patients increase.
In the previous study the data were divided into three sections based on total length
of stay, this of course isn’t very practical in a clinical setting so the study was revisited
and a more relevant time split was chosen. In general the first 24 or 48 hours post
injury is considered to be the critical time window for interventions and also considered
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Figure 6.2: A comparison of the trend in the variability of the autoregulatory index,
that is increasing instability with the percentage of length of stay which is split by
outcome group.
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the time period when autoregulation disruption is most likely to be present. So if the
model correlated as well with outcome over this time period than the model could
have greater clinical value. A Student t-test was performed between the early var(G)
and the two outcome groups (“Good”, “Poor”) and showed no statistical difference
(p = 0.8714). The reworked index is statistically not an early predictor of clinical
outcome, however over the whole time course of each group there appears to be a link
between worsening autoregulatory state and poor outcome. This negative result may
in part be due to underpowering the analysis with only 12 patients, due to the need to
use ICP pulse amplitude as a surrogate measure of Va(t) surrogate.
One of the interesting analyses was to assess if this autoregulatory index contributes
anything to a clinical outcome model compared to existing predictive models. To this
end a model comprising of a set of known predictive variables for outcome was chosen
based on the well described IMPACT model. These variables comprised of age, sex, the
GCS Eye score and the GCS Motor score on admission to which was added the reworked
Ursino var(G), for the same early period in the previous analysis. An automated
stepwise reduction routine was then applied. Although the autoregulation measure
was dropped out of the final model, it was the last parameter to be reduced out of the
model. This study, even though conducted in a small sample of patients, does seem
valid as the model showed the same key parameters remaining in the model of outcome,
namely age, GCS pupil and GCS Motor scores remain highly indicative of outcome.
The failure for the AR index to be included is again probably because of the under
powering of the study with only 12 patients. In Czosnyka’s 1997 paper [23] he stated
there was a distinct relationship between a negatively correlated PRx value and “good”
clinical outcome (p < 0.00001). However the correlation between the two variables was
only r = 0.48 showing less than half of the correlation relationship is explained by the
autoregulatory status. This fact could be more evidence that a larger study is needed
to show the relationship with the reworked Ursino model. It is interesting to note
about the Czonsnyka result that while it can be reproduced in traumatic brain injury
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populations it doesn’t hold up in other neuropathology groups [48].
As has been stated at the beginning of this chapter it would have been a more com-
plete analysis if all three models Ursino, PRx and HMF could have been assessed in
this outcome study however due to a lack of high enough resolution data in the patient
BrainIT dataset [74], which has a sampling frequency of once per minute, the calcu-
lation of both PRx and HMF could have been disadvantaged. However, pilot studies
are in progress collecting both waveform quality blood pressure (BP) and ICP data
together with the lower resolution minute by minute data with a view of comparing
the efficiency of the models performance on data of different sampling resolutions. If
those studies show that minute by minute data is feasible to use for the HMF or PRx
model, then a more comparative analysis can be carried out.
Due to the early analysis suggesting a temporal link between the autoregulatory index’s
prediction of autoregulation for the “late” period and clinical outcome, time-series
figures were plotted of G categorised by outcome group,“Good” Vs “Poor”. From
these figures the time dependence can easily be seen with the “good” group var(G)
decreasing over time and the opposite being true for the “poor” outcome group. What
is striking about the two group’s is that the “poor” group has increasing variability of
the G index as time goes on whereas the good group has low variability throughout.
With one notable exception around about half way through the ICU stay there is a spike
in this groups variability (figure 6.2), where it is likely that these patients are being
removed from sedation, woken up and tested clinically at this time to evaluate their
clinical progress. These results seem to make sense intuitively, in that those patients
with worse clinical outcome have increased autoregulatory variability than those with
better outcome.
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6.7 Conclusion
All outcome model studies rely on two linked processes. Firstly the model parameters
will have a high enough statistical power to show that they influence the outcome pa-
rameter over noise and random error and secondly that the study has enough subject’s
to allow the first point to be established. In this case the study did not have enough
subjects to show the relevant parameters were statistically significant. However be-
cause the autoregulatory prediction term added enough weight to the outcome for the
reduction process to remove it only at the very last step, this suggests that it does
influence outcome but it would need a larger number of subject’s to show this conclu-
sively. In general though the reworked Ursino model has been shown to have promise
as a predictor of autoregulation and now also has been shown to be linked to clinical
outcome especially when considered as part of the patient’s time course.
Chapter 7
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7.1 Introduction
The study of topology in mathematics is one of great importance as it underpins
advanced set theory, differential geometry and both algebraic and complex analysis [62]
but more than that it links many different and distinct topics in mathematics together.
A rigorous exploration of the application of topology to the subject of autoregulation
is beyond the scope of this chapter however a number of basic topological ideas will be
used as a starting point for developing a framework for the process of autoregulatory
model fitting and optimisation.
7.2 Aims
All of the previous work has been building up to the creation of a generalised framework
for modelling cerebral autoregulation. This chapter will attempt to amalgamate all of
the disparate threads of this work into a cohesive whole by drawing on the underlying
mathematical theories of topology. More specifically the need for the definition of a set
of topological spaces on which this framework can be based. Once this is completed
this new framework will be applied to the existing base reworked model and this then
assessed on the prospectively collected data set obtained from the impedance work
described in chapter 4.
7.3 Topology
Topology as a subject is the study of sets and their subsets, how they interact within
themselves and how each can be linked to other sets through functional mapping. A
topology is also a mathematical construct, it is a combination of a set with its subsets
that follow three axioms [89]:
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1. Any union of subsets is contained in the topology
2. An intersection of any two subsets is contained within the topology
3. The empty and trivial sets are contained in the topology
If they do conform to this you can state that the subsets form a topology, normally
denoted τ , over the set. The classic example of this is the four element set S =
{a, b, c, d} and the family of subsets φ, {a, b}, {c, d}, {a, b, c, d}. All of three rules (union,
intersection and membership) can be easily verified so this family of sets is classed as
a topology over S. It is worth noting at this point that it is not the only topology over
S, the two other classic topologies which also hold for all sets would be the discrete
and indiscrete topologies. The discrete topology being every subset on the main set
and the indiscrete being only the trivial set S itself and the empty set φ.
On the three dimensional space of real numbers R3 it is more common to define the
sets involved in defining a topology via a metric or distance measurement. This type
of topology is know as a metric space and in the special case of using the Euclidian
distance metric d =
√(
~i2 +~j2 + ~k2
)
the Euclidean space or Euclidean manifold. This
metric can be easily visualised as a sphere surrounding a point defining a subset of
three dimensional space. This idea of a metric of course extends to that of higher
dimensional spaces as well.
Once a basic set of topological spaces exist it becomes interesting to ask the question
how do they relate to one another and what can be inferred from one to another.
To understand this a study of functions between topological spaces needs to be con-
ducted.
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7.3.1 The study of functions and their relationships.
The terms “function” and “map” will be used interchangeably, even though the term
map is normally used in the context of taking a subset of one space and linking it to
a counterpart subset in another via a specified function. This process is also called
“projection”, as in the map has projected one subset onto another. The study and
categorising of functions is an expansive field within mathematics, especially so in
topology however for the purposes of this discussion this shall be limited to only two
concepts “homeomorphisms” and ”homotopy”.
Homeomorphisms
Before a definition of homeomorphism can be presented there is a need to define what a
homomorphism is. Take a map f : X → Y this is defined to be a homomorphism if and
only if there exists a unique x ∈ X that maps explicitly onto y ∈ Y . The uniqueness
of the map is an important thing to consider as this implies that that the function will
cover the whole of the space X. If we then define another homomorphic map this time
f−1 : Y → X then we will have every x ∈ X mapping uniquely to a member of Y and
also every y ∈ Y mapping uniquely to a member of X [35].
Then the function f is said to be a homeomorphism if and only if there exist two
homomorphisms f and f−1 such that they are continuous and f◦f−1 = IX and f−1◦f =
IY [62]. Where IX and IY are the identity maps of sets X and Y respectively. This
means that the map f will be one to one between X and Y . The term homeomorphism
is used interchangeably with “isomorphism‘. This class of function is important as it
means that both spaces are equivalent to each other which means any theory that holds
in the first space will automatically hold in the second space because of the invariance
of the spaces under the map f . This is normally said as space X is homeomorphic to
space Y .
CHAPTER 7 126
Ideally all functions being applied to a topology would be homeomorphisms however
this is often not to the case. Another key type of function which also preserves some
properties of one space as it is projected onto another is that of “homotopy”.
Homotopy
Instead of attempting to define a function f and its inverse f−1 to make sure all
properties are mapped onto the opposite space. A set of functions f1, f2, . . . , fn can
be defined such that there exists a continuous transformation between f1 and f2 then
a continuous transform between f2 and f3 and so on. This would mean there exists a
continuous transform between f1 and fn. This continuous transformation between one
and the other is the general idea of homotopy [89].
More formally homotopy is defined to be a map h : X × [0, 1] → Y that is a function
from the cross product of the topological space X and the unit line [0, 1] inclusive of
0 and 1 to the topological space Y such that for an x ∈ X there exists h(x, 0) = f1(x)
and h(x, 1) = fn(x).
There can then be defined a homotpy equivalence which is defined in a similar way
to a homeomorphism except that the compositions only need to be homotopic to the
identity maps instead of equal to them. That is, there will exist two homomorphisms
f : X → Y and g : Y → X such that f ◦g is homotopic to IX and g ◦f is homotopic to
IY . This would mean that the topological space X could be continuously deformed into
the topological space Y . As such, many of the properties in one would be preserved in
the other.
Before any investigation into how these topological concepts could be applied to au-
toregulation modelling an overview of the whole process should be investigated.
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7.4 Autoregulation modelling
All of the autoregulatory models that have been looked at previously in this work
have three things in common: Firstly, they all take a subset of the patient’s vital signs
parameters as an input to the model, secondly they all map these vital signs parameters
onto a prediction for autoregulation and finally they all use a function or algorithm to
perform the mapping.
These things hold true of course for any model of autoregulation not just the small
sample reviewed here. These three processes can be generalised into a set of rules
defining an autoregulatory model:
1. A parameter space P from which a subset can be chosen that will drive the
autoregualtory model.
2. An autoregulatory answer space A which contains a representation for autoreg-
ulation.
3. A model space M from which a model can be picked that maps the parameter
subset on the autoregulatory space A subset.
As all models that can map any subset of P onto a subset of A exist inM then there
must exist a model i than maps pi an existing subset of P onto the whole of A as
the whole set is the trivial subset of itself. This would then be the idealised model for
autoregulation, that is, the model that predicted with a hundred percent accuracy the
autoregulatory state of the system under study. While pi could be the whole of P this
wouldn’t be a desirable outcome as having to know everything about the system would
be impossible to obtain, if for no other reason than because of Heisenberg’s uncertainty
principle. This result can be tightened so that pi is the smallest subset of P for which
the model holds true. All of this allows the generalisation of the search for the best
model to be reduced to: Finding a model which maximises the subset in A while at
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Figure 7.1: Illustration of the three spaces P , A and M and how they relate to one
another.
the same time minimising the subset in P . This is shown in figure 7.1.
Topologies can be constructed easily for both spaces P and A. As P is a contraction of
Rn where n is the number of vital signs parameters used in all models fromM. It has
boundaries that are on the edge of the maximal ranges of each vital signs parameter.
As such, a distance metric can be found to partition P and a topology can be created.
The autoregulatory space A though has to be considered more carefully as if it is, in
our case only a boolean answer space, that is the system is autoregulating yes or no,
then only a very simple discrete topology can be crafted. If however the space is the
set [−1, 1] then another metric space could be constructed. This can radically alter
what is possible to infer topologically and to map between.
7.4.1 Application of homotopy to the modelling process
Homotopy is a powerful idea, one where functions can be classified by family and
type but also supports the concept that two different functions will preserve the same
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topological information between the spaces if they are homotopic to each other [89]. It
is with this core concept of one function being able to be transformed into another that
you can start to build a framework in which functional modelling and more specifically
autoregulatory modelling can be carried out.
If the changes to any model are classified in this way then small changes will be closer
to the original model on the [0, 1] continuous scale than any large changes which would
be closer to the final model destination. On the spectrum of possible changes, simple
parameter changes and substitutions would be considered small to medium changes
much like any model change which results in no outward change only an internal
methodological one. A model alteration that results in a large change in precision or
predictive accuracy of the model would be considered a large change.
This last point of change being measured by predictive accuracy of the model should
be the idea of optimisation. With this in mind the concept of topological space trans-
formation or more specifically restriction should also be considered as the companion
to homotopy of the model functions.
7.4.2 Application of topological space transformations to the
modelling process
As has been stated before there are three main spaces involved in any autoregulatory
modelling process. The parameter space P the model function space M and finally
the autoregulatory prediction space A.
Transformations to A have already been mentioned and maximising the amount of the
space any subset covers is the desired end point of any operation performed in this
framework as this will mean a large proportion of correct predictions for the autoreg-
ulatory status.
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Figure 7.2: Illustration of the how various optimisation processes will interact within
the three spaces.
Restrictions to P has also been mentioned before in the context of the amount of
information that had to be collected to calculate an ideal model. This however is not
the only reason to reduce the parameter space, the second being the application of
classical optimisation techniques such as parameter restriction. This is where some
of the parameter space is constrained to reduce the chance of selecting a non optimal
value with respect to the output of the model function.
Lastly restriction to M has not yet been considered but it is possibly the easiest to
understand. As this space contains all the potential models for autoregulation, any
reduction to this space will effectively remove models from consideration. This type of
restriction is normally achieved via a model comparison study and the rejection of any
under performing models.
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7.4.3 Modelling framework
If both of these ideas of homotopy of the model and transformation of the three spaces
are put together a framework can be defined, illustrated in figure 7.2, with the following
optimisation steps:
1. Model space restriction via model comparison techniques. This only affects the
model space by reducing its size.
2. Parameter space restriction via classical parameter based optimisation techniques.
This affects the dimensions of the parameter space by constraining the size of the
space.
3. Parameter alteration via small to medium homotopic changes in the model pa-
rameters. This affects the parameter space by allowing parameters in the model
to be changed into others.
4. Model alteration via small to large homotopic changes to the model function.
This affects the model space as there is a change of one model into another.
All of these steps should only be carried so that they increase the size of the subset of
the autoregulation (AR) prediction space.
Any modelling performed within the bounds of this framework could then be thought of
as following a number of stages. Firstly a general model or technique would be chosen
for study. Then both parameter space and autoregulatory prediction space would be
defined. The model would then be assessed to give a baseline for predictive accuracy
or fit. The four main optimisations in the framework should then be evaluated for use
with the model (not all of the techniques could or should be applied to all models).
Any which are considered feasible should then be applied in a series of steps and
the predictive accuracy or fit checked again for an improvement against the baseline
recorded earlier after each step.
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As an example of this process the reworked Ursino model was re-evaluated using all of
the applicable techniques described above.
7.5 Application of the full framework to the re-
worked Ursino model
In chapter 3 an initial model comparison technique was performed between the re-
worked Ursino model, the highest modal frequency (HMF) model and the pressure
reactivity index (PRx) model and this showed that before any optimisation was per-
formed the Ursino model had the best predictive accuracy out of the three models
under test. A Matthew’s correlation coefficient (MCC) of 0.3 versus 0.09 of the other
two models. The first framework optimisation in this case would be to focus on the
model which has the most potential.
7.5.1 Dataset preparation
Using the dataset collected in chapter 4 three measures of arterial-arteriolar compli-
ance were calculated. Assessing all of the available options on the flowchart figure
4.11, the venturi method could not be evaluated because of the lack of an artery di-
ameter measurement. The surrogate Ca(t) parameters were initially calculated via the
intracrainial pressure (ICP) pulse amplitude technique as shown in chapter 2 then sub-
sequently with an impedance measurement technique which was detailed in chapter 4.
Finally, scaled and trended ICP measurement could also be used but this represents
the least viable surrogate possible and should give an indication what the models lower
limits of the parameter space.
In the experimental studies described in Chapter 4, the impedance measurements were
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taken multiple times per ICP step during the study and this allowed a rough trend for
impedance to be defined over the whole time course which could then be referenced by
the model when required.
The full dataset was re-sampled into the same time range, a model prediction performed
every six seconds, as with the initial study in chapter 3 this was to minimise systematic
differences in comparison between the initial comparison study and this new one. The
summary measure used was a simple average of both the mean arterial blood pressure
(ABP) and the mean ICP over the six second window.
7.5.2 Baseline model prediction
The initial reworked Ursino model was then applied to this data set and the variance
of the Gain var(G) calculated. The two periods of pre and post impairment were then
separated out and two hundred points were sampled from each period. The MCC
method was then employed again to assess the fit between the predicted autoregulatory
state and the induced state during the study.
The Ca(t) has been calculated in two ways for this baseline study. Firstly with a more
clinically accessible method of basic variable trending and secondly using the ICP pulse
amplitude methodology. An example of each model output is shown in figure 7.3.
7.5.3 Framework optimisation
In general the superficial differences between the original reworked Ursino model and
the framework optimised variant are minimal. Both models, the original and the
framework optimised variant, are already using the new asymmetric sigmoid curve
which would be considered a model alteration optimisation this is used out of necessity
for a working model. There are no parameter restriction optimisations that can be
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Figure 7.3: Two examples of the reworked Ursino model with different surrogates for
Ca(t), (a) simple scaled variable trending and (b) the ICP pulse amplitude technique.
The ABP and ICP waveforms are also shown and the autoregulatory impairment is
denoted via the dashed vertical line. Early assessment of model performance can be
seen in the better discrimination between before and after injury events comparatively
between the two models.
applied here and the reasons for this have also been covered previously.
This leaves two main optimisation approaches that will be applied from the framework,
parameter alteration and model alteration. For parameter alteration, the transcranial
impedance measurement will be used in place of ICP pulse amplitude as a Ca(t) sur-
rogate. The fractal characterisation wavelet noise reduction technique will be applied
to the Ursino model output as a model alteration approach to reduce any non phys-
iological noise and optimise the predictive accuracy as a result. An example of this
framework optimised model output is shown in figure 7.4.
Similarly to the baseline original model prediction the new model var(G) was calculated
over the dataset described above and the MCC for the autoregulatory state in both
pre and post impairment periods was assessed using the same sampled 200 time points
from the original baseline prediction.
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Figure 7.4: An example of the framework optimised model output shown with ABP and
ICP waveforms and the autoregulatory impairment is denoted via the dashed vertical
line. An early assessment of the performance can be seen in the less noisy prediction
of impaired autoregulation in the lower plot.
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Model MCC
Baseline Model with variable trending -0.24
Baseline Model with ICP pulse amplitude 0.19
Framework Optimised Model 0.29
Table 7.1: Table showing the predictive accuracy of both the original reworked Ursino
model and the new framework optimised variant.
7.5.4 Results
The results for the predictive accuracies can be seen in table 7.1. This shows an increase
in predictive accuracy from the poorest surrogate to the normal reworked Ursino model.
The framework optimised model variant then shows a 52.6 percent increase over the
baseline model using the ICP pulse amplitude as the Ca(t) surrogate.
7.6 Discussion
This framework has the potential to make it easier to perform model comparison and
optimisation tasks. It also should provide a basic structure to begin to standardise the
procedures used to perform these types of task not just on autoregulatory modelling
but also modelling in general. This approach is not without its drawbacks however as
there will need to be a more rigorous study and understanding of the topology involved
if any deeper understanding of the relevant spaces is to be achieved. So far while it can
be shown there are topologies over both parameter space and AR status space, are the
models under study homeomorphisms? Is there a second homomorphism from the AR
space back to the parameter space thus defining the spaces to also be homotopic to one
another? Any assessment of these questions can only begin if the AR prediction space
is understood in greater detail, and that will only be achieved if there is some consensus
across the research domain as to how to record the autoregulatory status.
One thing that is clear from these basic topological definitions, is that mathematical
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models based on the physiology have a better chance, over purely statistical models,
of providing more information about the AR prediction space. This is because most
statistical models are not uniquely defined so there will be many variations of the
parameter set to give the same or similar output for the prediction. This precludes
their use as a homeomorphism as an inverse function can not be defined which implies
that any topology under projection with that model will never be directly equivalent
to the dataset used as parameters. In this case, the best that could be hoped for is a
homotopy equivalence.
The application of the topological framework has shown that you can introduce an
overall improvement in a base model. This is achieved via incremental improvements
not just to predictive accuracy but also to the models utility for use in a clinical
setting. Which in this case is a non-invasive estimate of arterial-arteriolar compliance
via transcranial impedance measurements.
However as many of the alterations applied only minimally change the model, as they
are designed to be homotopically close to the original, the change in predictive accuracy
is not as large as those seen in the pervious optimisation study, in chapter 3, which
made use of parameter restriction.
7.7 Conclusion
Generally the modelling framework defined above provides an interesting methodology
for improving the output of any model which, for example in the case of the Ursino
model produced a 52.6 percent improvement when run on new test data. Each stage
of the framework when applied to the basic Ursino model does give a marked improve-
ment over the previous model. This demonstrates that such a structured methodology
can have benefits for improving model fit and efficiency and thus should be applied
before attempting to use a new model in a formal clinical setting. The topological
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underpinnings of the framework enable consideration of what is needed to improve not
just this specific autoregulation model but the research domain in general in particular
considering how autoregulation is interpreted and recorded. When this step is com-
pleted then a much more rigorous study of this topological concept can then be carried
out.
Chapter 8
Conclusions and further work
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In summary the underlying theme of this work has been to look at modelling in a
very generic manner then to specifically focus on how this can be applicable within
the cerebral autoregulatory domain. The techniques that have been used are all linked
through the interplay of the mathematical structures involved and it is only when you
abstract these ideas do you see a larger framework that can apply to any modelling
problem.
What has been proposed here is that this framework should help to improve how any
system is studied and eventually modelled, in this specific case of cerebral autoregula-
tion the model that has been focused on was the simple model published by Ursino in
1997 [102]. This model was chosen for study because of its physiological nature with the
idea that because of this it should initially be a more predictive simulation of the cere-
brovascular system compared with more data driven statistical models. To understand
this reasoning the driving processes behind autoregulation should be explored.
The classical definition of cerebral autoregulation is the process by which blood flow is
maintained over a changing cerebral perfusion pressure, however this is a property of the
overall system not a directly measurable quantity. There are a number of physiological
processes which play a role in cerebral autoregulation principally metabolic and neu-
rogenic. The dominant metabolic process would be the coupling of tissue metabolism
to blood flow through carbon dioxide diffusion which in turn causes vasodilation via
hydrogen ion production in the cerebrospinal fluid by action of carbonic anhydrase [49].
Myogenic processes detect the increase or decrease in the transmural pressure which
will in turn cause the vascular smooth muscle to contact or relax in an attempt to
restore blood vessel diameter. Lastly the overall weak sympathetic processes in cere-
bral autoregulation are explained by the over-riding strong metabolic response that
attenuates sympathetic vasoconstriction during sympathetic activation [49]. If this
didn’t occur then during strenuous exercise, a situation which causes sympathetic ac-
tivation, cerebral perfusion would decrease [49]. It is because of this complex interplay
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of different mechanisms that any attempt to design a model which does not include
the physiology would initially seem to be a poor choice for predicting autoregulation
accurately. To fully comprehend how these processes translate into the mathematical
models of autoregulation a larger picture of the anatomy and physiology needs to be
described.
The cranial space is composed of a number of layers and systems which work in unison
and make it a unique challenge to devise a model that encompasses all of these diverse
factors. The first dominant factor is the bone container all tissues reside within called
the cranial cavity. This structure defines the system’s boundaries and as such makes the
modelling easier because of the simplifications that can be made. The main assumption
of rigidity allows for pressures to equilibrate consistently within the space as there is
no significant deformation of the boundaries. Inside the cranium sits the brain which
is modelled as a viscoelastic solid surrounded by cerebrospinal fluid (CSF) which is
considered a Newtonian or non-compressible fluid. The CSF itself is produced from
the arterial blood supply via the choroid plexus of the ventricles in the brain which
then circulates around the cranial space where it is eventually absorbed again across
the arachnoid villi of the venous circulatory system.
This description lends itself well to compartmental modelling because of the clear
channels of flow between the major systems involved and this is exactly the approach
Ursino took in his 1997 paper. So applying this mathematical model against a data
set to study autoregulation should provide better insights than merely looking for
correlations between vital signs parameters which would be an example of a purely
statistical approach.
The framework, described in full in chapter 7, is loosely based on the mathematical
ideas of topological spaces and of generalised mappings between them. A topology
is best thought about as a collection of partitions of a general set which fulfil three
basic axioms. When a topology exists on different spaces, basic assumptions can then
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be made on how they will behave under mapping as well as beginning to understand
the underlaying multidimensional structure. With this in mind three distinct spaces
have been defined one for which the model parameters or variables are discerned, this
space is in the multi-dimensional space of real numbers (Rn) where the dimension n
equals the number of parameters under study and is usually drawn from the vital signs
patient data in the case of autoregulation. The second space is the model space where
all functions for attempting to evaluate autoregulation exist and draw their input from
the “parameter” space. Lastly the autoregulatory space in which all predictions for
either static or dynamic autoregulation exist, this is essentially the answer space into
which the models map.
This last space needs careful consideration as one of the first problems that comes to
light when looking into autoregulatory modelling is there is no consensus for what the
answer space should contain. The main reason for this stems back to the fact that
autoregulation is a concept not a measurable entity. So for each model that has been
published there is a different view onto this answer space. For example should it be
based upon a boolean value [46], the simplistic “yes” autoregulation is intact or “no” it
isn’t, or alternatively it may be based upon a dichotomous scale [1], possibly numeric or
categorical or lastly the model may be based upon some continuous scale [24]. It could
be argued that a boolean values function is merely an extreme form of the dichotomised
scale and that in turn is merely a continuous scale summarised via some metric which
leads inevitably to the conclusion that a continuous scale is the best way to measure
what is ultimately a dynamical system. However this lack of standardisation poses a
significant hurdle for attempting to apply some of the frameworks suggested.
Once the concept of these three spaces (parameter, model, autoregulaory) has been
understood it is much easier to visualise how interactions will effect the spaces and in
turn any model under study. It also becomes obvious that because of the constraints
on the three spaces there will exist an idealised model which maps some partition or
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subset of the “parameter” space onto the full autoregulatory space which is considered
a “trivial” partition of itself. So any question of creating a “good” model for cerebral
autoregulation becomes one of maximising the mapped partition in the AR space and
attempting to minimise the partition in the “parameter” space with the goal of making
any model under study as equal to this idealised model as possible.
Modelling within this framework of spaces can be thought of as a five stage process.
Firstly define a modelling technique you wish to study, choose a subset of the au-
toregulatory space which can be evaluated by some measurable end point, decide on
the partition of the “parameter” space which can be recorded and then execute and
evaluate the model and finally optimise the model and space partitions to improve the
relationship between all of the spaces. This last step in creating any model is often
skipped in much of the literature but can have a large influence on the overall effec-
tiveness of a model and it is on this topic much of this work is devoted. There have
been a number of optimisation techniques illustrated: Model Comparison, Parameter
Restriction, Parameter Augmentation and Model Alteration.
Model Comparison is a classical model refinement technique that attempts to evaluate
each model against either each other or against some ideal. This normally allows for
the best choice of initial model and technique. The comparison needs to be struc-
tured in such a way as to not bias the analysis towards or away from any model under
test. If all models are refined to output to the same autoregulatory space partition,
for example no model should output ICP while others output a measure of autoreg-
ulation. The dataset used should have a sampling rate as high as any model under
examination requires which is then resampled to lower rates for the remaining models
and finally the statistical test needs to be balanced and easy to use with the output
from the evaluations. The comparison, based on MCC of PRx, Daleys HMF index
and a reworking of Ursino’s 1997 model showed that the reworked Ursino Model had
the greatest predictive accuracy on the dataset tested, 0.3 versus 0.09 of the other two
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models. The optimisation here is the rejection of the PRx and HMF models as they
have less predictive power however even the Ursino model’s accuracy is not optimal.
There could be a number of reasons for the lacklustre performance by all the models
tested. Generally the data set which was initially used to evaluate the models has
a considerable amount of noise in it created by manipulation of the animal during
the experiment which of course limits the amount of usable data to all models under
examination. The second criticism which could be raised here and throughout all of
the analyses is that were are assessing global models for autoregulation and comparing
them against what is essentially a highly focal “gold standard” measure of AR based
upon pial artery diameter. The literature supports that the injury model used and the
pial artery window technique are standardised and acceptable however it is not out of
the question that the dataset and AR assessment method used as a gold-standard could
be a contributing factor to the poor model performance. However, it is believed that
the methodological approach developed in this thesis is relevant and potentially useful
clinically, independently of the quality of the available dataset used for comparison.
Furthermore, the predictive accuracy of all of these models are a very good illustration
for the need of optimisation techniques.
Parameter Restriction is a form of optimisation where the parameter space is con-
strained to maximise the partition in the autoregulatory space or to put it another
way to increase the accuracy of the model. Every model parameter has a range over
which it can be used within that specific model and the process of parameter restriction
is one that allows these ranges to become better defined. This is an automated process
where the model is repeatedly evaluated against a known end point and the accuracy
assessed for values within the chosen parameters range. The automated process can be
as simple as trying all parameters linearly across the range or a more complex strategy
like a Newtonian root appraisal methodology. This can be seen in chapter 3 when eval-
uating the PRx, there is a window of data with which the correlation function between
ABP and ICP is evaluated. Similarly the HMF has a window of data over which the
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correlation with the HMF and cerebral perfusion pressure (CPP) is calculated. When
this analysis is run it is shown that the length of that window with respect to time
has a direct effect on the predictive accuracy and in this case a 66 minute window of
data for the PRx and a 72 minute window for the HMF has been reported to give the
best performance. For the models in question this represents a 278 percent and a 611
percent increase in predictive accuracy. This technique will not work with all models
in the same way because the “parameter” space partitions are either different or used
within the model in different ways. The Ursino model is a good example of this as the
time based ranges it uses are already accounted for within the model so any attempt
at parameter restriction will only result in a smoother output. This is due to the
differential nature of how the model deals with time. All increases to the time range
result in less data being used to calculate the model and thus a smoother output. So
to attempt to optimise Ursino’s or any model with a similar differential time-window
issue, then other forms of parameter restriction techniques need to be sought.
Model Alteration can be thought of as augmenting the structure of the model to include
other modelling techniques. This concept goes straight to the heart of the topologi-
cal idea of homotopy where one function is related to another through a continuous
deformation. In other words, although the functions may be different they all belong
to the same family and therefore share similar properties. With this idea, models are
systematically changed to make them more accurate not only through replacing like
for like but also through altering sections of a model to locally increase precision. In
chapter 2 swapping in a continuous asymmetric sigmoid curve to replace a case based
asymmetric sigmoid is an example of a like for like model alteration and this was done
only so that the model as a whole could be more easily inverted. This optimisation
had no effect on the overall predictive accuracy of the model as it was within a 0.09
percent deviation of the original curve this was due to the numerical nature of the
curve fitting technique. This however allows the model to be used in a form fit for
comparison.
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Another model alteration optimisation that has been proposed in chapter 5 is using
fractal characterisation of the physiological signal as a noise estimate for wavelet noise
reduction. This uses the fractal nature of physiological signals in that if there is an
underlying self similarity in any signal, it will be caused by a physiological response
and not due to some artifact or noise. It relies on wavelets in two stages: firstly to
estimate how much of the recorded signal is related to the fractal component from
which a noise estimate is created. Then a simple wavelet smoothing technique is used
to remove those time-frequencies which are not related to the physiological signal.
When the Ursino model with the wavelet smoothed output signal is compared to the
non smoothed version it shows a 350 percent gain in predictive accuracy. This fractal
characterisation technique is not a panacea for all physiological wave form analysis
however. For example, when summarising the fractal content of stable and unstable
systems was attempted the Ho¨lder exponent histograms show little or no difference
between them suggesting that the underlying physiology wasn’t playing an active role
in causing the instability observed. This interpretation of results is less important
when considering using this approach only as a noise estimate as it is only a measure
of content that is required not if that content can be differentiated from any other.
Parameter Alteration is the inclusion of parameters in a model to add missing or
increase the precision of the domain knowledge in the model. The creation of any
model is a complex process and the goal of which is the creation of something which
mimics a real world situation. One of the key principles in model creation is simplifying
the situation to make it easier to model. The problem with starting simple is that
to make the model more realistic, parts of the model need to be augmented. The
issue balances at that point between making the model less simplistic but not too
complex as to be obscure. Starting with the basic Ursino model there are a number of
parameters that can not easily be measured and have to be simulated in some way. The
arterial-arteriolar compliance is one such parameter. There are a number of attempts
throughout this work at modelling this parameter: The compliance can be estimated
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by using an averaged measurement of the diameter of the blood vessels then using a
venturi flow effect to simulate the pressure differentials through the system. Or by
using the ICP pulse amplitude methodology and estimate it via the area under the
inverse of that curve. If nothing else can be used, then the peak to peak ICP to ABP
relationship can be used as an estimate of the full system compliance which will at
least track the arterial-arteriolar compliance. This is a much less accurate estimation
but is at least one step up from setting it to be a constant and assuming it does not
change.
The last approach investigated may have the most promise for traumatic brain in-
jury management as a whole and that is the inclusion of a non invasive impedance
measurement as an independent surrogate measure of compliance or ICP. The body’s
cell structure can be modelled as a simple electrical circuit containing two paths, one
which is only resistive and the other which is both resistive and also capacitive. One
could consider this structure fractal in nature where a small part of the whole has
the same electrical properties of the whole itself. Or to think about that another
way the impedance measurements that can be, and routinely are clinically, applied to
the whole body should be applicable to a small part of the body such as the cranial
space. The previously mentioned circuit is used already in the calculation of whole
body water readings which is considered a measurement of a subject’s overall level of
health. When this technique is applied to the head the measurement will be of the
water content contained within that container and it has been shown that it is linked
to the measurement of compliance. A number of experiments were carried out where
the relationship between impedance and ICP was studied, the normative ranges in hu-
man volunteers were defined and finally its inclusion as a new parameter in the Ursino
model.
Each of the above techniques yield some gains in predictive ability of the overall Ursino
model, however to fully understand all of these adjustments in context the techniques
CHAPTER 8 148
have to be combined into a cohesive model and to be executed on the data. When this
is done it can be seen that there is a gain in predictive accuracy of 52.6 percent over a
non optimised version of the model.
The usefulness of such a model even with all the optimisation and improvements only
becomes apparent when it is assessed in the context of the clinical environment and not
just as a research tool for advancing the knowledge of autoregulatory modelling. It is to
this end that a study of outcome using the optimised Ursino model was devised. This
was tested in two stages firstly measured directly against outcome and then secondly
as part of a more complex model incorporating other known prognostic factors, where
it could be studied to determine if it increased the predictive nature of the model.
The outcome measure in both arms of this study was a dichotomised 8-point extended
Glasgow outcome scale, measured at 6 months after injury and split into “good” and
“poor” groups around category scale point four (upper severe disability). The data for
this study came from the BrainIT database [73] on a sample of 12 patients in whom the
ICP signal contained both systolic and diastolic components. The results showed that
there was no direct statistical relationship between the first 48 hours of autoregulatory
status and clinical outcome. This is may in part be due to the small sample size.
It was then decided to augment the model with known clinical parameters known to
have prognostic factors on clinical outcome, such as age, sex, Glasgow motor and pupil
scores on admission and then re-run the analysis which proved to be more fruitful as
this model yielded a good relation ship with clinical outcome. Of course this leaves
the question does the autoregulatory prediction variable add any value to the model.
To attempt to assess this the full model was evaluated using an automated parameter
reduction technique in which Akaike’s Information Criterion was used as a measure of
change between subsequent reduced models. Even though this ultimately showed the
autoregulatory prediction value did not increase this model’s ability to correlate with
outcome it was better in general and remained in the model being reduced for longer
than any other term which was automatically reduced.
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All of this work has really only scratched the surface of the techniques that can be
applied and the models that can be developed and tested in the cerebral autoregulatory
domain. It has also begun to highlight some of the inadequacies with the literature in
this area especially with model comparison and optimisation. One major issue is the
lack of readily available data which meets the criteria, set out in chapter 3, that of high
quality data with a high enough sampling rate and containing estimates of the state of
autoregulation. The lack of such data means that any study of models or modelling is
impeded by requiring data to be collected prospectively. This seems counter productive
because every model that has been compared in this work has already been evaluated
on a collected dataset for their original paper by their author, so clearly such data does
exist even if not readily available. Another issue in this area is related to the idea of the
autoregulatory space and the problem of choice, to ease inter-comparison there should
be some agreed standard of what this space should be. This lack of agreement between
investigators hampers all studies from simple optimisation questions such as: “what
is the end point to optimise against?”. Without adherence to an agreed standard of
what is an autoregulation output, is one prediction of intact autoregulation equivalent
to another models prediction?
These issues affect the full cerebral autoregulation research domain, so any solution
should ideally involve the wider research community. To address the lack of consen-
sus researchers in this domain need to come together to foster more collaboration
and in particular to agree on standards of measurement and definition and to ad-
dress the main issue of lack of “good” data. Ideally such a group should administer
a store of donated datasets which would help drive open collaboration and research
into defining standards. The idea of large research networks which are focused on
a research area are not a new one: BrainIT (www.brainit.org), EBIC (www.ebic.nl),
ABIC (www.abic.vcu.edu), COSBID (www.cosbid.org) to name a few of these net-
works. However no network exists in the specific domain of cerebral autoregulation or
cerebral haemodynamics.
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Figure 8.1: Questionnaire form from the SONAR website.
This is a great “ideal” of course which can so easily fall at the first hurdle if no one else in
the wider research community feels that sharing data and fostering collaboration is the
best path forward to drive the future of studies and projects within the autoregulation
domain. To gauge this feeling a small meeting was organised between a small group of
leading UK researchers in the area. This included Tony Birch (Clinical Physics Uni-
versity of Southampton) , Ronney Pannerai (Clinical Physics, University of Leicester),
Ian Piper (Clinical Physics, Greater Glasgow Health board), David Simpson(Clinical
Phyiscs, University of Southampton) and myself. At this meeting I proposed the ques-
tion of whether such a collaboration was a good idea and was met with resounding
agreement. From here, under the working title of Storage Of Normalised Autoregula-
tory Results (SONAR), a web site was designed with a polling form, figure 8.1, asking
the question, “Do you think creating a larger research network for sharing data and
developing standards is practical and if so would you participate”. The link to the
web site was then emailed out to the research community based on email lists supplied
from the other attendees of the original meeting. Out of the 45 emails sent, 60 percent
CHAPTER 8 151
Figure 8.2: Group photograph of the attendees to the inaugural CARNet meeting.
responded and all of those were positive and agreed that it was worth pursuing.
The interim steering group for the project, made up of the original meeting participants
and now included Marek Czosnyka from Cambridge. Having reviewed this survey
response, we set about organising an initial meeting of this network inpotentia. Our aim
being to not only discuss the concept of collaboration but also discussing specifically
technical solutions to sharing not just data but also methods, models and research.
This inaugural meeting was held on the 6th of July 2011 at Imperial College London
where 30 researchers, see figure 8.2 and table 8.1, participated and the name for the
new network was agreed to be Cerebral Autoregulation Research Network or CARNet
and the main goals were to be those that were initially laid out in the first proposal and
are repeated below, table 8.2. A formal steering group was formed (shown in Table 8.3
below), a web site has been created (www.car-net.org) and currently funding is being
sought.
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Photo Key Attendee Name Location
1 Emmanuel Katsogridakis Leicester, UK
2 Bernardo Yelich Uruguay
3 Liu Jia China
4 Johannes van Lieshout Netherlands
5 Corina Puppo Uruguay
6 Ian Piper Glasgow, UK
7 Stephen Hobson York, UK
8 Ronney Panerai Leicester, UK
9 Bart Depreitere Belgium
10 Stephen Payne Oxford, UK
11 Vera Novak USA
12 Thomas Heldt USA
13 Erik Gommer Netherlands
14 David Simpson Southampton, UK
15 Jurgen Claassen Netherlands
16 Tony Birch Southampton, UK
17 Caroline Rickards USA
18 Christina Aubrich Germany
19 Tom Robinson Leicester, UK
20 Elsa Azevedo Portugal
21 John Potter Norfolk, UK
22 Astrid Hoedemaekers Netherlands
23 Karol Budohoski Cambridge, UK
24 Andrew Robertson Canada
25 Jorge Serrador USA
26 Marcel Aries Netherlands
27 Rong Zhang USA
28 Kenichi Iwasaki USA
29 Matthias Reinhard Germany
30 Georgios Mitsis Cyprus
31 Richard Hughson Canada
32 Shieak Tzeng New Zealand
Table 8.1: List of the attendees to the inaugural CARNet meeting.
Number Goal
1 Sharing data
2 Sharing methods for experimental set-ups and data analysis
3 Sharing results, experiences and ideas
Table 8.2: The main goals for the CARNet group. As agreed at the first meeting.
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Member Name Title
David Simpson Chairman
Stephen Payne Secretary
Vera Novak Funding coordinator
Martin Shaw Technical coordinator
Jurgen Claassen Projects coordinator
Erik Gommer Ordinary member
Table 8.3: The steering group members for the CARNet group.
This network is extremely young and has not had a chance to fully attempt to address
these goals but now that it exists it suggests that there is a more hopeful future for
better collaboration of researchers within this important clinical area and the major
problems facing the domain can now start to be tackled as a group.
The four main goals set out at the end of chapter 1 have been met with varying degrees
of success throughout this work. Firstly the assessment of the reworked Ursino model
has shown that it has a predictive power which is equal to if not better than the other
models which were tested, that is not to say the predictive power found would be
classed as good by any means. An effective one in three chance of correctly predicting
the autoregulatory state is only acceptable when assessing the second main aim of the
work, that is comparison of this new index of autoregulation against the other more
widely accepted autoregulatory models of the PRx and the HMF which demonstrate
only a one in ten chance of predicting correctly.
This comparison of models has a number of challenges to keep it fair between all the
models included in the test. The major problem, which has been mentioned before, is
collecting a “clean” dataset which can be used in the comparison, every dataset used
in this work had noise or missing data issues which needed to be addressed. It is the
need to address the limitations which naturally leads to the creation of a framework
to perform these comparison operations in a structured way and to also improve upon
any of the models through a series of optimisation steps. However, this approach was
not a universal solution as all optimisation strategies do not apply in all situations
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which is well illustrated by the fact that even a simple optimisation strategy can not
work on the reworked Ursino model. The rest of the framework and its improvements
and applications have been explored quite thoroughly earlier in this chapter, however
because of its abstract and ubiquitous nature it is one of the most important outcomes
from this work as it reveals some of the issues with autoregulatory research as a whole
such as a lack of a standard for defining how autoregulation should be defined. Should
it be dichotomous, categorical or a continuous function? This naturally leads to the
last aim from chapter 1, the proposal for creating a multi centre collaboration for the
assessment of this model within the wider autoregulatory community.
Cerebral autoregulation has wide reaching clinical implications if a robust and practical
clinical methodology can be developed and validated. Key to this is a structured
approach to compare and optimise models of autoregulation, both those that already
exist and when new ones are developed. I believe that tackling this fundamental lack of
scientific comparison is one of the key ways to advance the knowledge of this research
area. Abstracting the modelling process via topological concepts provides an easier
means to visualise the overall process and to evaluate new functions for modelling and
optimisation. To make this process efficient and to reduce the likelihood of duplication
of effort, a sensible solution is to pool any existing resources and build a community
driven to answer basic issues collectively.
Appendix A
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Variable Meaning
Pa(t) Arterial Blood Pressure
PICP (t) Intracranial pressure
PCPP (t) Cerebral perfusion pressure
Ca(t) Arterial-arteriolar compliance
Rf Cerebrospinal fluid formation resistance
RPv Proximal venous resistance
qn Basal cerebrospinal fluid flow rate
τ Time constant of autoregulation
∆Ca Amplitude of sigmoidal curve
Can Basal arterial compliance for the sigmoid curve
kr Constant of proportion between arterial
resistance and arterial-arteriolar volume
Table A.1: Reworked Ursino model variables
A.1 Introduction
The mathematical reworking for this model has been done both by hand as well as by
the Maple computer algebra system [57] as a check to make sure that it is correct. The
original mathematical model is based on the physiological model shown in figure 2.2
and is discussed in chapter 2. This electric equivalence circuit is used to compute a
number of quantities in the original model.
A.2 The original model
From the original paper [102] the mathematical model is defined by two aspects firstly
a basic set of quantities that are defined in table A.1. These are in general secondary
to the original model and can be considered state variables or constants which only
play an auxiliary role overall. Then, secondly, the base equations that are derived from
the physiological model and its equivalence need be considered.
In total there are seven main equations that are used to rearrange the original model.
The strategy here is to combine the original equations into a cohesive mathematical
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equation then to rearrange this to output the required cerebral autoregulatory state.
To begin with the arterial-arteriolar volume and its relationship to arterial compliance
is defined as
Va(t) = Ca(t)(Pa(t)− PICP (t))
= Ca(t)PCPP (t) (A.1)
then the arterial resistance is shown to be
Ra(t) =
krC
2
an
Va(t)2
(A.2)
The cerebral blood flow is derived in two ways directly from the equivalence dia-
gram
q(t) =
Pa(t)− Pc(t)
Ra(t)
(A.3)
=
Pc(t)− PICP (t)
Rf
+
Pc(t)− PICP (t)
RPv
(A.4)
the flow rate was then normalised as follows
x(t) =
q(t)− qn
qn
(A.5)
The capillary pressure is calculated by letting the flow rate formula A.3 equal to equa-
tion A.4 then rearranging to give
Pc(t) =
Pa(t)RfRPv + PICP (t)Ra(t)RPv + PICP (t)Ra(t)Rf
RfRPv +Ra(t)RPv +Ra(t)Rf
(A.6)
Finally the rate of change of arterial compliance is calculated from the three processes
for autoregulation
d
dt
Ca(t) =
−Ca(t) + σ(G(t)x(t))
τ
(A.7)
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where σ() is the case based sigmoid function defining a part of the autoregulatory
dynamics.
A.3 Mathematical Reworking
From these equations we begin with equation A.1 and differentiate this to give
d
dt
Va(t) = Ca(t)
d
dt
PCPP (t) + PCPP (t)
d
dt
Ca(t) (A.8)
Which when we rearrange equation A.8 for d
dt
Ca(t) we get
d
dt
Ca(t) =
d
dt
Va(t)− Ca(t) ddtPCPP (t)
PCPP (t)
(A.9)
This new equation A.9 can then be equated with the original function A.7 for the rate
of change of arterial compliance so that the main gain function can be assessed:
−Ca(t) + σ(G(t)x(t))
τ
=
d
dt
Va(t)− Ca(t) ddtPCPP (t)
PCPP (t)
⇒
σ(G(t)x(t)) =
τ d
dt
Va(t)− τCa(t) ddtPCPP (t)
PCPP (t)
+ Ca(t) ⇒
G(t) = σ−1
(
τ d
dt
Va(t)− τCa(t) ddtPCPP (t)
PCPP (t)
+ Ca(t)
)
1
x(t)
(A.10)
From this point if we proceed with the original sigmoid function the G(t) function will
also end up bifurcated, split by the same case as is used in the sigmoid function. What
this means is there are two variations of the σ() function dependent on the x(t) value.
Allowing an asymmetric curvature at the top and bottom of the sigmoid curve. This
of course has the knock on effect of causing the G(t) function to have two variations
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also.
σ(z) =
Can +
∆Ca
2
+ (Can − ∆Ca2 ) exp( 4z∆Ca )
1 + exp( 4z
∆Ca
)
(A.11)
x(t)

< 0⇒ ∆Ca = ∆Ca1
> 0⇒ ∆Ca = ∆Ca2
(A.12)
To understand how to calculate G(t) directly there are two main intermediate calcula-
tions that must be combined. The inverse of σ() and the calculation of the normalised
flow x(t). To begin with take the sigmoid equation A.11 and multiply by the denomi-
nator and divide by σ(z) to give
σ(z) =
Can +
∆Ca
2
+ (Can − ∆Ca2 ) exp
(
4z
∆Ca
)
1 + exp
(
4z
∆Ca
)
1 + exp
(
4z
∆Ca
)
=
Can +
∆Ca
2
σ(z)
+
(
Can − ∆Ca2
σ(z)
)
exp
(
4z
∆Ca
)
If we then subtract exp
(
4z
∆Ca
)
from both sides and collect for the exponential terms
1 =
Can +
∆Ca
2
σ(z)
+
(
Can − ∆Ca2
σ(z)
− 1
)
exp
(
4z
∆Ca
)
then we can isolate the exponential
1− Can+ ∆Ca2
σ(z)
Can−∆Ca2
σ(z)
− 1
= exp
(
4z
∆Ca
)
Next we simplify the left hand side and take the log of both sides
log
(
σ(z)− Can − ∆Ca2
Can − ∆Ca2 − σ(z)
)
=
4z
∆Ca
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Finally if we isolate z we have
z =
∆Ca
4
log
(
σ(z)− Can − ∆Ca2
Can − ∆Ca2 − σ(z)
)
(A.13)
If this is placed to one side and we now consider normalised flow and flow equations
A.5 and A.4 respectively we can see that
x(t) =
q(t)− qn
qn
=
q(t)
qn
− 1
and
q(t) =
PC(t)− PICP (t)
Rf
+
PC(t)− PICP (t)
RPv
=
(RPv +Rf )(PC(t)− PICP (t))
RfRPv
if we then combine these equations together we get
x(t) =
(RPv +Rf )(PC(t)− PICP (t))
qnRfRPv
− 1
=
(RPv +Rf )(PC(t)− PICP (t))− qnRfRPv
qnRfRPv
(A.14)
To complete this rearrangement we will let z = G(t)x(t) and substitute this into
equation A.13
G(t)x(t) =
∆Ca
4
log
(
σ(G(t)x(t))− Can − ∆Ca2
Can − ∆Ca2 − σ(G(t)x(t))
)
(A.15)
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and we know from equation A.10 what σ(G(t)x(t)) is equal to
G(t)x(t) =
∆Ca
4
log
 τ ddtVa(t)−τCa(t) ddtPCPP (t)PCPP (t) + Ca(t)− Can − ∆Ca2
Can − ∆Ca2 −
τ d
dt
Va(t)−τCa(t) ddtPCPP (t)
PCPP (t)
+ Ca(t)
 (A.16)
To simplify this slightly let us take the numerator and denominator into their own
functions
=
∆Ca
4
log
(
Fnum(t)
Fden(t)
)
(A.17)
This now allows us to look at Fnum(t) and Fden(t) independently of one another
Fnum(t) =
τ d
dt
Va(t)− τCa(t) ddtPCPP (t)
PCPP (t)
+ Ca(t)− Can − ∆Ca
2
=
τ d
dt
Va(t)− τCa(t) ddtPCPP (t) + Ca(t)PCPP (t)− CanPCPP (t)− ∆Ca2 PCPP (t)
PCPP (t)
(A.18)
From equation A.1 we can change the Ca(t) into a function in Va(t)
Fnum(t) =
τ d
dt
Va(t)− τ Va(t)PCPP (t) ddtPCPP (t) +
Va(t)
PCPP (t)
PCPP (t)− CanPCPP (t)− ∆Ca2 PCPP (t)
PCPP (t)
=
τ d
dt
Va(t)− τ Va(t)PCPP (t) ddtPCPP (t) + Va(t)− (Can + ∆Ca2 )PCPP (t)
PCPP (t)
=
τPCPP (t)
d
dt
Va(t)− τVa(t) ddtPCPP (t) + Va(t)PCPP (t)− (Can + ∆Ca2 )(PCPP (t))2
(PCPP (t))2
=
(
τ d
dt
Va(t) + Va(t)
)
PCPP (t)− τVa(t) ddtPCPP (t)− (Can + ∆Ca2 )(PCPP (t))2
(PCPP (t))2
=
2
(
τ d
dt
Va(t) + Va(t)
)
PCPP (t)− 2τVa(t) ddtPCPP (t)− (2Can + ∆Ca)(PCPP (t))2
2(PCPP (t))2
(A.19)
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If we now apply the same simplification technique we find that
Fnum(t) =
Hnum(t)
2(PCPP (t))2
(A.20)
Then a set of similar steps can be carried out on Fden(t) to show that
Fden(t) =
−2 (τ d
dt
Va(t) + Va(t)
)
PCPP (t) + 2τVa(t)
d
dt
PCPP (t) + (2Can −∆Ca)(PCPP (t))2
2(PCPP (t))2
(A.21)
=
Hden(t)
2(PCPP (t))2
(A.22)
When we now take the numerator equation A.20 and the denominator equation A.22
back into equation A.17 we get
G(t)x(t) =
∆Ca
4
log
( Hnum(t)
2(PCPP (t))2
Hden(t)
2(PCPP (t))2
)
G(t) =
∆Ca log
(
Hnum(t)
Hden(t)
)
4x(t)
(A.23)
Finally if we substitute equation A.14 into equation A.23 we end up with equation
A.24. With the case split as is shown in equation A.12 that is ∆Ca = ∆Ca1 when
x(t) is less than zero and ∆Ca = ∆Ca2 when the normalised flow rate is greater than
zero.
G(t) =
− log
(
Hnum(t)
Hdem(t)
)
∆CaqnRfRPv
4((RPv +Rf )(PICP (t)− PC(t)) + qnRfRPv) (A.24)
Hnum(t) = −(2Can + ∆Ca)PCPP (t)2 +
(
2τ
d
dt
Va(t) + 2Va(t)
)
PCPP (t)− 2τVa(t) d
dt
PCPP (t)
(A.25)
Hdem(t) = (2Can −∆Ca)PCPP (t)2 −
(
2τ
d
dt
Va(t) + 2Va(t)
)
PCPP (t) + 2τVa(t)
d
dt
PCPP (t)
(A.26)
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This is a relatively complex model however that can be simplified from equations A.25
and A.26 so that the main G(t) function becomes
Hdem(t) +Hnum(t) = (2Can −∆Ca)PCPP (t)2 − (2Can + ∆Ca)PCPP (t)2
= −2∆CaPCPP (t)2
Hnum(t) = −2∆CaPCPP (t)2 −Hdem(t)
Hnum(t)
Hden(t)
=
−2∆CaPCPP (t)2
Hden(t)
− 1 (A.27)
substituting equation A.27 into function A.24 we finally get
G(t) =
− log
(
−2∆CaPCPP (t)2
Hden(t)
− 1
)
∆CaqnRfRPv
4((RPv +Rf )(PICP (t)− PC(t)) + qnRfRPv) (A.28)
where ∆Ca changes based on the original sigmoid case split as detailed above and
Hden(t) is described in equation A.26. This form (equation A.28) of the reworked
Ursino model has a two main issues to direct use in most clinical situations. These
issues are addressed in chapter 2.
Appendix B
Methodology to model an
asymmetric sigmoid curve.
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B.1 Introduction
During the modelling of many processes in the medical arena there is a need for func-
tions that are both continuous and differentiable at all points. This is to aid in the
creation of medical models that are mathematically robust under transformations that
may be applied to them. One such set of models that have frequently been used are
the sigmoid family of curves. These are useful in many areas especially in pharmacoki-
netic modelling and physiological modelling. Normally the curves that are used will be
symmetric in their curvature at the top and bottom but there is a call for more control
in creation and fitting of these curves to data where the top and bottom curvature is
distinct from each other.
In the past there have been at least two popular asymmetric sigmoid curves Richards
[80] and Gompertz [34] both of which could be classed as proportionally asymmetric,
that is the difference in curvature of one is proportional to the difference in the other.
This is of course an advancement over purely symmetric functions however this may not
go far enough to address the needs of some of the models currently in use today.
The classical symmetric sigmoid function has the form (equation B.1) which is easily
recognised in figure B.1.
f(x) =
A
1 +Be−Cx
(B.1)
There needs to be more control over all the aspects of the function, both top and bottom
curvature should be individually configurable as well as the various asymptotes.
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Figure B.1: Classic Sigmoid
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Figure B.2: General Asymmetric Sigmoid
B.2 Asymmetric Sigmoids
B.2.1 General Sigmoid Form
The classic generalised sigmoid function [80] has the form (equation B.2) and can be
evaluated as both a standard sigmoid and as a proportional asymmetric sigmoid.
f(x) = A+
B − A
(1 + Ce−D(x−G))
1
H
(B.2)
Where {A,B,C,D,G,H} are all constants defining the shape of the sigmoid (see figure
B.2) and e is Euler’s number 2.718. Notice in equation B.2 that variables A and
B specify the lower and upper asymptote respectively, C and D giving the general
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curvature of the upper and lower turning points and it is from these that the general
limits of the width of the sigmoid can be derived. The variable G defines a translation
in the x axis for the sigmoid. Lastly H will specify the inflection point for the curve
and hence how proportionally asymmetric it is.
The inflection point setting is misleading however as it only alters essentially where
the upper and lower curves meet leaving the general slope of the sigmoid at the mercy
of the width. To get a truly configurable sigmoid this minor problem need to be
overcome.
B.2.2 Gompertz Function
The second most widely used form of asymmetric sigmoid is the Gomperz function [34]
and has the form
f(x) = A+Be−Ce
−D(x−G)
(B.3)
this function is exponentially asymptotic at the lower asymptote hence as a sigmoid
proportionally asymmetric. This can be seen if you compare the Gompertz function to
a general symmetric sigmoid (figure B.3). Where the upper curve hardly changes and
the lower curve is exponentially faster to reach the asymptote. However, a limitation of
this is that the curves will always be exponentially proportional to each other.
B.2.3 Case Based Asymmetry
The last asymmetric sigmoid in common use with good control over both the upper
and lower curvature is through a basic case switch
f(x) =

A
1+Be−Cx x ≤ 0
D
1+Ge−Hx x > 0
(B.4)
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Figure B.3: Gomperz Sigmoid
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Figure B.4: Case Based Sigmoid
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where the first case defines the lower curvature and the second case would affect the
upper curvature (figure B.4). The main problem with this approach is it is not a
continuously differentiable function and is discontinuous at the switch over point in
this case 0. This if treated carefully isn’t much of a problem however it can introduce
issues, which have to be worked around, into any larger analysis that is being performed
with the sigmoid function. A good example of such a problem is trying to statistically
fit data to the inverse of the above sigmoid can often cause the discontinuity point to
become a disassociation. That is the limits of each half of the function are not equal
as x tends to the discontinuity point or 0 in this case.
Each of these sigmoid curves have their uses however even with the most generic of the
above functions, equation B.4, its not applicable in all situations.
B.3 Methodology
The technique used to construct the new asymmetric sigmoid isn’t a new one [99]
however what is presented below does extend this methodology to give better handling
of the asymptotic nature of the sigmoid. At the heart of this idea is modification of
an existing symmetric sigmoid curve. This is via multiplication and addition of other
curves on one half of the sigmoid.
The three main participating curves are a general sigmoid minus the asymmetry term
H which is shown in equation B.5.
f(x) = A+
B − A
1 + Ce−D(x−I)
(B.5)
The first additional function can be seen in equation B.6 which is a skewed Gaussian
type curve that when matched properly with equation B.5 will allow the manipulation
of the upper curve of the original sigmoid. Where J defines the scaling of the function,
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Figure B.5: New Asymmetric sigmoid curve examples.
K defines the width of the function and L defines its placement on the x axis.
g(x) = Je−K<((log(−x−L))
2) (B.6)
The second additional sigmoid clamped between 1 and 0 will improve the tail of the
additional function B.6, this can be seen in equation B.7.
h(x) =
1
1 + e−M(x−N)
(B.7)
The new sigmoid is a linear combination of these three functions. This is shown in
equation B.8 and in figure B.5.
s(x) = f(x)− g(x)h(x)
s(x) = A+
B − A
1 + Ce−D(x−I)
− Je
−K<((log(−x−L))2)
1 + e−M(x−N)
(B.8)
This is only the general form of this equation and the parameter set
P = {A,B,C,D, I, J,K, L,M,N}
can be simplified to PFin = {A,B,C,D, I, J,K} giving the final form of the sigmoid
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in equation B.9.
s(x) = A+
B − A
1 + Ce−D(x−I)
− Je
−K<((log(−x−log(I))2)
1 + e−D(x−I)
(B.9)
The set PFin should then be created through a non linear least squares fit to an original
data set or original quasi-asymmetric curve.
B.4 Discussion
With each new attempt at a fully asymmetric sigmoid curve the parameter set increases
at the same time generally making the function more complex to use. This has to be
balanced against the gains to the accuracy and the versatility of the new curve function.
With this new function B.9 this balance has been achieved through the use of related
parameters in the main parameter set. Also because the placement of each of the
additional functions is based on the properties of the original base sigmoid (equation
B.5) then each of the fitting variables are linked to the previous parameter set. So there
exists a function q(X) that given the subset P2 ∪P3 ={J,K, L,M,N} ∈ P, where P2
and P3 are the parameter sets from functions B.6 and B.7 respectively, the function
would generate a set based on P1 ={A,B,C,D, I} ∈ P.
Through general investigation of the combination of the three curves a number of rules
can be found that satisfy this q(X) criteria. Firstly only one of the curvatures should
be affected. So to fix the lower curvature h(x) should be as close to the main function
f(x) as possible. So P3 should be fixed to {D, I}. Secondly g(x) should always be
greater than both f(x) and h(x) at the start of the lower curvature this means {L}
needs to be specified so that it is always proportionally less than {I} so in this case
log(I) has been chosen. Lastly to guarantee a smooth transition to and from 0 on
g(x)h(x) the parameter set {J,K} should be limited to make sure where g(x) and h(x)
cross happens on the slope of h(x). This then fixes the function q(X) as is shown in
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Variable fitted value
A 0.113
B 0.525
C 54.598
D 53.333
I -0.075
J -0.0001
K 0.876
Table B.1: Fitted values for the asymmetric sigmoid parameters
equation B.10.
q({p : p ∈ P2 ∪P3}) =

log(I) p = L
I p = N
D p = M
(B.10)
When this is then introduced into the generalised form B.8 this will create the more
practical final form of the function B.9.
B.5 Comparison of the new model to a case based
sigmoid
For this new asymmetric sigmoid curve to be useful it needs to mimic any of the
existing asymmetric strategies. To test this within the autoregulatory domain the case
based curve from the Ursino paper was chosen and evaluated based on the static values
in the paper. This creates the dashed curve in figure B.6. Then using a simple non
linear least squares fitting technique on the new asymmetric sigmoid function to find
the values for the unknown parameters this gives the curve shown by the solid line on
figure B.6. The values of the parameters are shown in table B.1. The goodness of fit
is measured by the comparison between the old model and the new which gives an r
value of 0.9991. This error is explained by the nature of the curve fitting algorithm
used in generating the unknown parameters.
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Figure B.6: Comparison of the original Ursino sigmoid to the new fitted asymetric
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B.6 Inversion of the new sigmoid function
It is often useful to be able to invert a function which can increase its utility in many
situations. Firstly to fully understand how this can be achieved with the new asymmet-
ric sigmoid it should be first stated that because there is an increase in mathematical
complexity this adversely effects any simple algebraic solution. An algebraic solution
to the inverse of each sub function that makes up the new sigmoid can be found.
Even for function B.6 which makes use of <(). This function cant be inverted directly
but because of apriori knowledge of the original sigmoid it is possible to create an
inverse function. All of this, however, doesn’t help in crafting a working inverse for the
combined sigmoid.
The first thing to realise about the sigmoid is that any working inverse has a very
restricted range of values for the independent variable which is because the asymmetric
sigmoid is bound above and below by its asymptotes. This translates into two vertical
bounds on the inverse function and this is a range restriction on the variable. Anything
which are outside these bounds will be imaginary in nature. The second point that
should be made about sigmoid’s in general is that they have no oscillations, which
means that when they are inverted there will be no ambiguity over which value to use
as there will only ever be one value. This is not true, for example, with a sine wave
and this can be seen with the arc sine function in its full form has an infinite number
of values it can take for a single independent value. Then lastly the fact that multiple
transcendental functions, that is a function whose value can not be represented as a
set of polynomial equations, tend to make purely mathematical inverse solutions very
difficult to construct.
Both of these points mean that an inverse solution should be achievable, especially since
there is a one to one relationship with input and output. However the solution may
not be as elegant as a purely algebraic one because of the fact the function has three
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distinct bounded sections and g(x)/h(x) is a non trivial combination of transcendental
functions. From this the best strategy for creating the inverse is to simplify the model
and attempt to invert it as far as possible to obtain a partial inverse. Then you would
use a number of numerical techniques to solve what remained. This has its limitations
of course but these are mostly in the implementation of the numeric algorithm in order
for it to be able to accurately find all the values. This is made easer because of the
one to one relationship with the function values as there should only ever be a single
value to numerically find.
So by starting with the more general equation B.8, as this will allow us the greatest
scope with simplification approaches, the simplest partial inverse that could be found
is shown in equations B.12 and B.11.
ro(z, y) =yMe(Ne
z+NL−P ) − yCMe(Nez+NL−P+Fez+FL−E)
− AMe(Nez+NL−P ) + ACMe(Nez+NL−P+Fez+FL−E)
−BMe(Nez+NL−P ) − y + yCe(Fez+FL−E)
+ A− ACe(Fez+FL−E) +B + Je(−Kz2+K arg2(ez))
− JCe(−Kz2+K arg2(ez)+Fez+FL−E) (B.11)
σ−1z (y) =e
(ro(z,y)) − L (B.12)
To then calculate the inverse value, the roots of ro(z, y) = 0 should be found for
the specific value of y. Then this singular root should be then used with equation
B.12.
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B.7 Conclusion
This methodology for construction of an asymmetric sigmoid function has improved
control over creating the asymmetry in the curve with only a slight increase in com-
plexity of the equation which uses only one more parameter to fit that of the general
sigmoid function. It has the property that it is continuous and differentiable at all
points on the curve overcoming any problems that arise in a case based sigmoid ap-
proach. As such its use in the various clinical modelling applications would both be
straight forward to implement and beneficial to the overall model.
Appendix C
Mathematical derivation of a model
comparison method.
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C.1 Introduction
To be confident that the comparisons methodology used is adequate for use with the
cerebral autoregulation models under test a study of the most common techniques was
under taken.
C.2 Methods
Firstly let M be defined as the contingency table or confusion matrix of the autoregu-
lation model comparison:
M =
 TP FN
FP TN

Where TP , TN , FP , FN are the usual number of true positives, true negatives, false
positives and false negatives respectively this shall be the basis for most of the tests to
work from. Each of the tests was addressed in turn:
The Fishers exact test needs a balanced number of positive and negatives tests to
be performed and in the case of the data set used this is not the case, so any testing
performed will be skewed. Most comparisons of this type would use the F-measure [81],
from information theory, to assess how well a model corresponds to a given known
response:
Fβ =
(1 + β2)TP
(1 + β2)TP + β2FN + FP
(C.1)
Where β = FN
(TP+FN)
is the false negative rate. The F-measure is normalised between
the values of zero and one giving a contained range of model rating. However I feel
this normalised value isn’t as useful as the determinant of M or in the more general
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case the Matthew’s correlation coefficient (MCC).
MCC =
TPTN − FPFN√
(TP + FP )(Tp + FN)(TN + FP )(TN + FN)
(C.2)
=
χ√
n
(C.3)
= φ (C.4)
The glsMCC [6] can be thought of as a normalised determinant of the comparisons
contingency table M . It is also equivalent to the phi coefficient and in turn is related
to Chi-squared testing, as such the Matthews correlation coefficient ranges, like the
F-value, between zero and one.
One thing to note about the MCC is if any of the sums in the denominator equals 0
then we assume MCC = 0. This is a consequence of:
lim
x→0
x√
x
= 0 (C.5)
The receiver operating characteristic (ROC) is a generally accepted methodology for
assessing the accuracy or predictive ability of a model however in this case the ROC
would not be appropriate. The ROC is usually calculated by running the experiment
at different predictor levels and then plotting true positives against false negatives at
each of these levels, however in this case there is only one set level for prediction per
model so the ROC is not as useful in this context.
The area under the ROC curve (AUC) can be calculated via a trapezoid method for
numerical integration. With a single point of interest on the ROC curve the AUC
equation can be simplified to
AUC =
(TPFP + FNTN + 2TPTN)
2(TP + FN)(FP + TN)
(C.6)
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It can be shown mathematically that the one point AUC is bounded on either side by
the MCC and the F-measure:
MCC ≤ AUC ≤ Fβ ≤ 1 (C.7)
Let a ∈ N then assume MCC > AUC this implies:
TPTN − FPFN√
(TP + FP )(Tp + FN)(TN + FP )(TN + FN)
>
(TPFP + FNTN + 2TPTN)
2(TP + FN)(FP + TN)
(C.8)
Then let TP , TN , FP , FN = a so equation C.8 becomes:
a2 − a2√
(2a)(2a)(2a)(2a)
>
(a2 + a2 + 2a2)
2(2a)(2a)
0√
(16a4)
>
4a2
8a2
0 >
1
2
Hence MCC > AUC can not be true so MCC ≤ AUC. A similar argument can be
constructed for AUC ≤ Fβ. From equation C.3 we can see the MCC is proportional to
the χ2 distribution which has a tendency to only over estimate the fit if the number of
points are too small. Or put another way as N increases the MCC tends to the correct
fit and from equation C.7 the MCC will never give a goodness of fit estimate more
than the AUC as it is bounded by it and will always be at least as accurate in this
situation. This implies that choosing the MCC as the predictive accuracy measure, or
goodness of fit, will always be a good compromise between all the tests available.
For a more numeric example of the applicability of this choice it can be argued thus:
Consider if the model only ever predicts intact autoregulation, information theory
would rate this model above average because at least half of the time it would be
correct however in this case this is a problem because it is the ability to separate both
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types (intact and non-intact) accurately, not just the ability to derive an answer which
is important in classification of these models. So instead of using the F-measure, by
using instead the MCC this model would perform very poorly. The use of the MCC
also has the added advantage of assessing inverted models, that is models which still
have a high degree of specificity and sensitivity but are predicting the exact opposite
of what has initially been set out as its goal. In a general comparison of the equations
C.2 and C.6 we can see that the argument above against the F-measure also still
holds.
C.3 Conclusion
As can be seen from the above analysis that the MCC is a good all round fit for a
general model comparison technique and will be useful when used with the different
autoregulation models.
Appendix D
Differencing to Differentiable.
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D.1 Introduction
The algorithm used by Daley to calculate the highest modal frequency from his 2004
paper in stroke [27] can be summarised as follows. The original physiological model [22]
assessed can be represented as a third order differentiable model relating the dynamic
relationship of pressure transmission between intracrainial pressure (ICP) and arterial
blood pressure (ABP) as shown in equation D.1. Where Y (t) is ICP at time t and U(t)
is ABP at time t.
d 3
dt
Y (t) + α2
d 2
dt
Y (t) + α1
d
dt
Y (t) + α0Y (t) = β3
d 2
dt
U(t) + β2
d
dt
U(t) + β1U(t) (D.1)
Daley describes modal analysis as investigating the energy transaction between the
pressure systems (ABP and ICP) by way of looking at the general dynamic character-
istics, in particular focusing on the resonant frequencies. These frequencies are directly
tied to the pressure transmission with the high frequencies being reduced by vasocon-
striction and increased by vasodilation. So if the highest modal frequency is chosen for
study the effects of these physiological changes in the system should be discernable.
To calculate these frequencies the solution to equation D.2 needs to be found.
x3 + α2x
2 + α1x+ α0 = 0 (D.2)
This will only give the radian modal frequencies, the highest of these will then be
divided by 2pi to find the highest modal frequency (HMF).
This is all still quite theoretical, as the data collected will not be a continuous signal
so can not be considered directly differentiable. Using the recorded data the system
would be defined more like equation D.3. Where Y[n] is the ICP value recorded at index
n and similar for U[n] is the ABP at index n. If m is the total number of points in the
APPENDIX D 186
data set then n ∈ [1,m].
Y[n] + a2Y[n−1] + a1Y[n−2] + a0Y[n−3] = b3U[n] + b2U[n−1] + b1U[n−2] (D.3)
Finding the constant values for D.3 can easily be achieved using an autoregressive
moving average with exogenous inputs (ARMAX) technique. However going from
equation D.3 to equation D.1 in [27] is performed using a black box software program.
To understand the actual process required to transform the equation constants a1, a2, a3
into the necessary α1, α2, α3 parameters, the basic relationship between the difference
equation and its differential counterpart needs to be understood.
D.2 Difference Equations.
The classical definition of a difference equation would be expressed as successive differ-
ences of a function applied to sequential values of a variable as can be seen in equation
D.4. This can be extended to a second order difference equation D.5 and then more
generally to D.6.
∆(Y[s]) = Y[s+1] − Y[s] (D.4)
∆2(Y[s]) = ∆(Y[s+1])−∆(Y[s]) (D.5)
∆r(Y[s]) = ∆
r−1(Y[s+1])−∆r−1(Y[s]) (D.6)
APPENDIX D 187
Combining these above equations into a set
∆3(Y[s]) + p∆
2(Y[s]) + q∆(Y[s]) + rY[s] (D.7)
=∆2(Y[s+1])−∆2(Y[s]) + p∆(Y[s+1])− p∆(Y[s]) + qY[s+1] − qY[s] + rY[s] (D.8)
=∆(Y[s+2])−∆(Y[s+1])−∆(Y[s+1]) + ∆(Y[s]) + pY[s+2] − pY[s+1]
− pY[s+1] + pY[s] + qY[s+1] − qY[s] + rY[s]
(D.9)
=Y[s+3] − Y[s+2] − Y[s+2] + Y[s+1] − Y[s+2] + Y[s+1] + Y[s+1] − Y[s]
+ pY[s+2] − pY[s+1] − pY[s+1] + pY[s] + qY[s+1] − qY[s] + rY[s]
(D.10)
=Y[s+3] + (p− 3)Y[s+2] + (3− 2p+ q)Y[s+1] + (p− q + r − 1)Y[s] (D.11)
Then let s = n− 3 equation D.11 would then become
∆3(Y[n−3]) + p∆2(Y[n−3]) + q∆(Y[n−3]) + rY[n−3] = Y[n] + a2Y[n−1] + a1Y[n−2] + a0Y[n−3]
(D.12)
It is now easy to see that D.3 is a difference equation of the form D.12.
D.3 Taylor series expansions.
The Taylor series of a continuous complex valued function f about a point a is defined
to be equation D.13.
f(x) =
∞∑
n=0
f (n)(a)
n!
(x− a)n (D.13)
where f (n)(a) is the n-th differential with respect to x evaluated at a point a.
Consider the finite expansion of three functions f(t+ x), f(t− x) and f(t− 2x) up to
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order 4 about a point t which can be seen in equations D.14, D.15 and D.16.
f(t+ x) = f(t) + x
d
dx
f(t) +
x2
2
d 2
dx
f(t) +
x3
6
d 3
dx
f(t) +O(x4) (D.14)
f(t− x) = f(t)− x d
dx
f(t) +
x2
2
d 2
dx
f(t)− x
3
6
d 3
dx
f(t) +O(x4) (D.15)
f(t− 2x) = f(t)− 2x d
dx
f(t) + 2x2
d 2
dx
f(t)− 4x
3
3
d 3
dx
f(t) +O(x4) (D.16)
Then by performing a set of linear operations on the above equations each of the
differential terms can be isolated. Firstly adding equations D.14 and D.15 we get
f(t+ x) + f(t− x) = 2f(t) + x2 d
2
dx
f(t) +O(x4) (D.17)
d 2
dx
f(t) =
f(t+ x) + f(t− x)− 2f(t)
x2
+O(x4) (D.18)
then by subtracting equations D.14 and D.15 we get
f(t+ x)− f(t− x) = 2x d
dx
f(t) +
2x3
6
d 3
dx
f(t) +O(x4)
= 2x
d
dx
f(t) +
x3
3
d 3
dx
f(t) +O(x4) (D.19)
if we now add equation D.16 and two times equation D.14 we get
f(t− 2x) + 2f(t+ x) =f(t)− 2x d
dx
f(t) + 2x2
d 2
dx
f(t)− 4x
3
3
d 3
dx
f(t)
+ 2(f(t) + x
d
dx
f(t) +
x2
2
d 2
dx
f(t) +
x3
6
d 3
dx
f(t)) +O(x4)
=3f(t) + 3x2
d 2
dx
f(t)− x3 d
3
dx
f(t) +O(x4) (D.20)
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Then using a linear combinations of equations D.19, D.17 and D.20 we get
3(f(t+ x)− f(t− x))
+f(t− 2x) + 2f(t+ x)
−3(f(t+ x) + f(t− x)) = f(t− 2x) + 2f(t+ x)− 6f(t− x)
= −3f(t) + 6x d
dx
f(t) +O(x4)
d
dx
f(t) =
2f(t+ x) + 3f(t)− 6f(t− x) + f(t− 2x)
6x
+O(x4)
(D.21)
Using a similar combination for only equations D.17 and D.20
f(t− 2x) + 2f(t+ x)
−3(f(t+ x) + f(t− x)) = f(t− 2x)− f(t+ x)− 3f(t− x)
= −3f(t)− x3 d
3
dx
f(t) +O(x4)
d 3
dx
f(t) =
f(t+ x) + 3f(t) + 3f(t− x)− f(t− 2x)
x3
+O(x4) (D.22)
If t is considered to be any given time point at which the function f is evaluated at and
δ is the difference between successive time points then t+ δ will convert the continuous
function into a discontinuous one, that is f(t+δ) ≡ f[n+1]. As this switch will cause the
function to lose accuracy, especially in the points that would lie between t and t + δ,
it will be safe to ignore the functions terms with orders higher than four. Taking all of
this into account would give for equations D.21, D.18 and D.22:
d
dx
f(t) =
2f(t+ δ) + 3f(t)− 6f(t− δ) + f(t− 2δ)
6δ
(D.23)
d 2
dx
f(t) =
f(t+ δ)− 2f(t) + f(t− δ)
δ2
(D.24)
d 3
dx
f(t) =
f(t+ δ) + 3f(t) + 3f(t− δ)− f(t− 2δ)
δ3
(D.25)
With the base work now done we can take these three equations and apply them as
APPENDIX D 190
shown below
d 3
dx
f(t) + p
d 2
dx
f(t)+q
d
dx
f(t) + rf(t)
=
f(t+ δ) + 3f(t) + 3f(t− δ)− f(t− 2δ)
δ3
+
p
δ2
(f(t+ δ)− 2f(t) + f(t− δ))
+
q
6δ
(2f(t+ δ) + 3f(t)− 6f(t− δ) + f(t− 2δ)) + rf(t)
=
f(t+ δ)
δ3
+
3f(t)
δ3
+
3f(t− δ)
δ3
− f(t− 2δ)
δ3
+
pf(t+ δ)
δ2
− 2pf(t)
δ2
+
pf(t− δ)
δ2
+
qf(t+ δ)
3δ
+
qf(t)
2δ
− qf(t− δ)
δ
+
qf(t− 2δ)
6δ
+ rf(t)
=
(
1
δ3
+
p
δ2
+
q
3δ
)
f(t+ δ) +
(
3
δ3
− 2p
δ2
+
q
2δ
+ r
)
f(t)
+
(
3
δ3
+
p
δ2
− q
δ
)
f(t− δ) +
(
q
6δ
− 1
δ3
)
f(t− 2δ) (D.26)
D.4 Solving the original model
This is of course only the ICP side of equation D.1. To fully solve for equation D.2
the ABP side of the equation needs to be considered. As this is also a differencing
equation the same theory will apply to it but it only needs a second order solution.
This second order disparity between the ABP and ICP is a consequence of the solution
of the physiological model on which the HMF methodology is based. The solution
would then become equation D.27.
i
d 2
dx
g(t)+j
d
dx
g(t) + kg(t)
=
(
−2i
δ2
+ k
)
g(t) +
(
i
δ2
− 1
2
j
)
g(t− δ) +
(
i
δ2
+
1
2
j
)
g(t+ δ) (D.27)
APPENDIX D 191
If equation D.27 is allowed to equal equation D.26 and it is then normalised for f(t+δ).
We get equation D.28
(
1
δ3
+
p
δ2
+
q
3δ
)
f(t+ δ) +
(
3
δ3
− 2p
δ2
+
q
2δ
+ r
)
f(t)
+
(
3
δ3
+
p
δ2
− q
δ
)
f(t− δ) +
(
q
6δ
− 1
δ3
)
f(t− 2δ)
=
(
−2i
δ2
+ k
)
g(t) +
(
i
δ2
− 1
2
j
)
g(t− δ)
+
(
i
δ2
+
1
2
j
)
g(t+ δ) (D.28)
f(t+ δ) +
(
3
δ3
− 2p
δ2
+ q
2δ
+ r
1
δ3
+ p
δ2
+ q
3δ
)
f(t) +
( 3
δ3
+ p
δ2
− q
δ
1
δ3
+ p
δ2
+ q
3δ
)
f(t− δ)
+
( q
6δ
− 1
δ3
1
δ3
+ p
δ2
+ q
3δ
)
f(t− 2δ)
=
( − 2i
δ2
+ k
1
δ3
+ p
δ2
+ q
3δ
)
g(t) +
( i
δ2
− 1
2
j
1
δ3
+ p
δ2
+ q
3δ
)
g(t− δ)
+
( i
δ2
+ 1
2
j
1
δ3
+ p
δ2
+ q
3δ
)
g(t+ δ) (D.29)
Then equation D.29 gives six basic functions which contain the six unknowns {p, q, r, i, j, k}.
a2 =
3
δ3
− 2p
δ2
+ q
2δ
+ r
1
δ3
+ p
δ2
+ q
3δ
a1 =
3
δ3
+ p
δ2
− q
δ
1
δ3
+ p
δ2
+ q
3δ
a0 =
q
6δ
− 1
δ3
1
δ3
+ p
δ2
+ q
3δ
b3 =
i
δ2
+ 1
2
j
1
δ3
+ p
δ2
+ q
3δ
b2 =
i
δ2
− 1
2
j
1
δ3
+ p
δ2
+ q
3δ
b1 =
− 2i
δ2
+ k
1
δ3
+ p
δ2
+ q
3δ
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Solving this linear set of equations yields
p =
3 + 12a0 + a1
(8a0 + a1 − 1)δ (D.30)
q =
12a0 + 6a1 − 1
(8a0 + a1 − 1)δ2 (D.31)
r =
54a0 + 12a1 + a2
(8a0 + a1 − 1)δ3 (D.32)
i =
3b1 + 3b3
(8a0 + a1 − 1)δ (D.33)
j =
6b1 + 6b3
(8a0 + a1 − 1)δ3 (D.34)
k =
6b1 + 6b2 + 6b3
(8a0 + a1 − 1)δ3 (D.35)
It is then only a simple task of calculating the roots of the equation D.36
λ3 + pλ2 + qλ+ r = 0 (D.36)
These are then the radian modal frequencies which need to be converted via division
by 2pi to be come actual frequencies.
D.5 Conclusion
When the solutions to the differential to differencing linear equations are known, the
calculation of the modal frequencies becomes trivial. This technique of transforming
between continuous differentials and a point set difference equation has also been shown
to extend from second order to third order and will also extend to any order above
that as well. This may be a useful tool to study any non linear dynamical system
encountered in future autoregulatory models.
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